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Abstract 
Our medical information is perhaps considered the most personal and valuable of all. On the other hand, the 
rapid increase in the digitization of the healthcare industry nowadays is giving the patient identification and elec-
tronic medical record maintenance a key role to improve patient safety, protect against medical identity theft, en-
hance patient satisfaction, not to mention financial performances. Regulatory pressures and compliance guide-
lines naturally require health care providers to handle patient information with the highest degree of privacy and 
care. In this scenario, innovative healthcare organizations are increasingly using biometric technologies to sup-
port smoother and safer patient access and information sharing to improve security. Biometric identifiers are 
measurable unique characteristics of an individual physiological (such as fingerprints, iris, retina, DNA) or behav-
ioural (such as typing rhythm, voice, and gait) traits that can be used to positively identify a person. Among 
them, voice biometrics is actually a convenient and secure method of authenticating a speaker’s identity using 
just a few words, which has many advantages over other forms of biometric identification especially in the 
healthcare sector. After briefly discussing the impact of biometric technologies from a general point of view, the 
present paper focuses on voice biometrics, to give a technical  understanding of how it works according to the 
current state of art and the forthcoming progress, and how it can be successfully integrated in the healthcare sys-
tems. 
 
Keywords: voice biometrics, speaker recognition, patients identification, staff authentication. 
 
 
Introduction 
Among the many challenges facing healthcare 
today is the need of costs containment while 
improving the quality of care. To overcome 
these challenges, it seems increasingly necessary 
to efficiently ensure the proper identification of 
all the healthcare constituencies (staff, provid-
ers, payers and patients). The failure to correct-
ly identify patients opens the doors to frauds 
and, even more seriously, to patient identity 
(ID) theft. The identity security is even more 
important in the healthcare sector than in oth-
ers, because other than costly medical errors, 
identity theft can prevent legitimate people to 
access critical medical services, with conse-
quences that can become dramatic. Moreover, 
unlike other sectors such as financial, frauds 
can easily go undetected for a long time. 
Healthcare frauds can be done, for example, by 
providing false information when applying for 
programs or services, forging prescriptions or 
selling prescription drugs. Also, medical records 
have a very high transactional value in black 
markets compared, for instance, to stolen credit 
information, because of the huge amount of da-
ta about a particular victim that is available 
through these records. Moreover, patient rec-
ords are sensitive and their safety is a regulatory 
requirement. Although statistics do not always 
agree about the costs of healthcare frauds, 
some authoritative estimates ranged around 
6.19% of global healthcare expenditure, equiva-
lent to €350 billion (PKF Lillteljohn LLP and 
University of Portsmouth, 2015). 
The most important reason why such kind of 
attacks have been able to occur is the vulnera-
bility of account protection and authentication 
methods, and this is why the healthcare indus-
try is being increasingly attracted by the bio-
metric technologies. This is confirmed also by 
the most recent market researches, that esti-
mate that the global healthcare biometrics mar-
ket will grow at an impressive CAGR of 22.9% 
to surpass $13.9 million in revenue in 2025 
Voice Biometrics Technologies and Applications for Healthcare: an overview. 
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(http://www.credenceresearch.com/report/hea
lthcare-biometrics-market), with North Ameri-
ca and Europe together capturing over 70% of 
the global healthcare biometrics market. 
Biometrics in the healthcare industry can be 
used for applications in doctors’ offices, hospi-
tals, or for use in monitoring patients, to im-
plement logical access control to centralized ar-
chives of digitized patients’ data, physical access 
control to buildings and hospital wards, work-
force management, patient record storage, au-
thenticate medical and social support personnel. 
Voice biometrics is a mature enough technolo-
gy to provide the required levels of security, 
versatility, cost effectiveness, preference by us-
ers, which only are required to speak to get au-
tomatically recognized. 
This paper is organized as follows. Section 2 in-
troduces some essentials about biometric 
recognition principles and definitions. Sections 
3 and 4 gives a more technical overview of the 
voice biometrics concepts and the techniques 
used up to the current state of the art. In Sec-
tion 5 the main advantages of voice biometrics 
over other kinds of biometric recognition in 
healthcare are discussed. Finally, conclusions 
are presented in Section 6. 
 
Biometrics: some fundamentals. 
The terms “Biometrics” and “Biometry”, from 
the Greek root of βίος (bíos, i.e. “life”) and  
μέτρο (mètron, i.e. “measure”), literally mean 
the “measurement of life”, and refer to a meth-
odological process that confirms its classifica-
tion as a science. Biometrics, therefore, is a sys-
tematization of applicable knowledge to exper-
imentally controllable hypotheses (Preite, 2016). 
Since the studies started in 1890 by Francis 
Galton (1822-1911) and later by Karl Pearson 
(1857-1936), the terms “Biometrics” and “Bi-
ometry”, have been used traditionally in refer-
ence to mathematical methods to address data 
analysis problems in the biological sciences, in-
deed they are also referred to as “biological sta-
tistics” or “biostatistics”. 
On the other hand, recently, the term “Biomet-
rics” is increasingly used to refer to the (auto-
matic) identification and authentication of an 
individual by means of one or more measurable 
unique traits (Figure 1). Such biometric identifi-
ers can be divided in two categories:   “Ana-
tomic-Physiological”, and “Behavioural”. The 
first category includes face traits and thermog-
raphy, fingerprints, hand geometry, palm veins, 
iris, retina and DNA recognition, while typing 
rhythm, voice and gait come under behavioural 
biometrics.  
With respect to traditional approaches that 
identify a person on the basis of a key or a to-
ken, physical (something an individual has) or 
intangible (something an individual knows, e.g. 
a password, a Personal Identification Number, 
PIN), in the biometric approach the individual 
itself becomes the key (something an individual 
is). Moreover, biometrics can be used in com-
bination with those traditional approaches, 
leading to three-factors security level (Figure 2). 
Generally, biometric schemes fall into two cate-
gories: “Authentication” and “Identification”. 
In the authentication, the individual makes a 
claim of identity and the biometric recognizer 
has to verify if that claim is true or not, com-
paring the input features with those of the 
claimed identity (which was stored within an 
early enrollment stage). Authentication is there-
fore also referred to as “Verification”, and has a 
binary output: accepted or rejected. In the iden-
tification approach there is no identity claim 
and the recognizer has to compare the input 
biometric features of the unknown individual 
against those of each individual in a set of pre-
enrolled ones, producing a score for each com-
parison, and returning the identity of the en-
rolled person corresponding to the best score. 
If the system is allowed to reject the identifica-
tion request when the highest score is still very 
low compared to a certain threshold, the identi-
fication is named “open-set”; on the contrary, if 
the system must return in any case the best 
matching identity, the identification is named 
“closed-set”. 
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Figure 2: combining biometrics with traditional approaches 
improves the security level of authentication (Smart Card Alli-
ance 2002). 
 
As one can already guess by the above state-
ments, biometric approaches are “Probabilis-
tic”, in the sense that the outcome is always in-
trinsically provided together with an estimate of 
the decision error. On the contrary, identifica-
tion approaches such as the password-based 
one, in which the system can provide a sure 
match of all of the characters and case of the 
password, are named “Authoritative”. 
Performances of biometric approaches can 
therefore be measured on the basis of the ex-
tent of the errors they make while providing the 
outcome. Considering for instance a biometric 
authentication system, two kind of errors can 
be done: a “False Accept” (or “Miss”), when 
the system authenticates an impostor, and a 
“False Reject” when the system refuse a true 
identity claim. Accordingly, the system is de-
signed to achieve an average “False Reject 
Rate” (FRR, also named type I error) and an 
average “False Accept Rate” (FAR, also named 
type II error), as a result of a trade-off between 
the two error types. Many other metrics can be 
defined on the basis of  FAR and FRR, such as 
the “Equal Error Rate” (EER), which is the de-
fined as the operating point where FAR equals 
the FRR, corresponding to an optimally chosen 
value of some parameter, which is typically a 
threshold for a some kind of similarity scoring 
function (see Figure 3). 
 
 
 
a)      b)     c)   d)          e)          f)    g)             h) 
Figure 1. Some biometric identifiers and related devices. a) Fingerprint recognition looks for the unique patterns of ridges and valleys that 
are present in an individual’s fingerprint, that is acquired by a specific hardware scanner, often in combination of temperature and pulse to 
improve the authority of the image; b) Iris recognition methodologies rely on image processing techniques to identify patterns in iris imag-
es, that need to be acquired by a scanning device; c) Retina recognition relies on the property of the blood vessels to absorb light more 
readily than the surrounding tissue; a retinal scanner is able to produce the appropriate lighting and acquiring the resulting pattern; d) Gait 
biometrics identifies and recognises people by the way they walk; individuals may be required to provide “gait” samples by walking 
through a tunnel where sensors are able to capture the relevant features; e) Face recognition algorithms typically identify facial features by 
extracting landmarks, or features, from an image of the subject's face; f) Palm vein recognition is generally based on the capability of deox-
idized haemoglobin flowing through the veins to absorb near-infrared light, provided by a palm scanner., making them appear as dark pat-
tern; g) Hand geometry recognition is based on measuring and recording the length, width, thickness, and surface area of an individual’s 
hand while guided on a plate, by means of a specific device; h) voice biometrics is discussed more in detail in the present work. 
Voice Biometrics Technologies and Applications for Healthcare: an overview. 
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Figure 3: The score distributions for non-target (left) and tar-
get (right) trials. The grey areas left and right of the threshold 
represent PMISS (which is equivalent to FRR) and PFA (equiva-
lent to FAR) respectively (van Leeuwen and Brümmer 2007).  
 
On the other hand, the optimal operating point 
can also be chosen considering unequal costs 
for FA and FR errors (e.g. when higher FRR 
can be tolerated with respect to FAR), trying to 
minimize the following Detection Cost Func-
tion (DCF) introduced by the NIST (the well-
known American National Institute of Stand-
ards and Technologies) over years: 
 
 
 
where  is the prior probability of a spe-
cific target speaker,  and  are fixed 
costs, that depend on the specific application, 
for the False Reject (i.e. Miss) and False Accept 
events, and  and  are the probability 
of False Reject and False Accept events both as 
function of the score threshold . Both FAR 
and FRR depends dramatically on the chosen 
biometric identifiers and on the actual features 
that can be extracted from them. Provided that, 
in general, in biometric applications, no feature 
can assume always the same value over time, or, 
at least, can be extracted without some kind of 
superimposed noise,  the key point is that the 
best features are those that, at the input of the 
biometric system, exhibit the smaller variability 
within the same individual, the greater variabil-
ity across different individuals and the best ro-
bustness against noise. This is extremely im-
portant mainly for biometric identifiers such as 
the human voice, which is intrinsically charac-
terized by a high degree of variability and, due 
to its versatility, can be used in many different 
scenarios and use cases in different environ-
mental conditions. 
 
Speaker recognition: the voice as biometric 
identifier. 
Many dictionaries and textbooks use the term 
“Voice” and “Speech” interchangeably. How-
ever, from a scientific perspective, the two 
terms have different meanings. Voice (or vocal-
ization) is the sound produced by the vibration 
of the vocal folds, in the larynx (or voice box), 
as the result of the pressure of the airflow pro-
duced by the lungs. Speech is an information-
rich signal produced by a series of complex 
movements that, by means of frequency, ampli-
tude and time modulation, change the basic 
tone created by voice into specific, decodable 
sounds (phonemes), that actually can be voiced 
or unvoiced (i.e. with or without vibration of 
the vocal cords), to convey information about 
words, identity, accent, expression, speaking 
style, emotion and the state of the speaker1. 
 
Figure 4: The peripheral phonation system (Purves, 2012). 
 
 
                                                          
1For sake of completeness, we report also a definition of “Lan-
guage”, as “the expression of human communication through 
which knowledge, belief, and behaviour can be experienced, 
explained, and shared. This sharing is based on systematic, con-
ventionally used signs, sounds, gestures, or marks that convey 
understood meanings within a group or community” (National 
Institute on Deafness and Other Communication Disorders, 
https://www.nidcd.nih.gov/). 
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The distinction between Voice and Speech is 
also relevant to distinguish “Voice recognition” 
from “Speech recognition” applications. Voice 
recognition, Speaker recognition (or “Identifi-
cation”, “Authentication”, “Verification”)  are 
all about the recognition of the speaker identity, 
i.e. the aim of Voice biometrics, while “Speech 
recognition” is largely used to address the task 
to recognize the spoken phonemes, words and 
sentences, i.e. the content of the speech. Strictly 
speaking, the recognition of what is said is not 
the field of voice biometrics, but as will be ex-
plained later in the present work, it can be suc-
cessful combined with speaker recognition to 
increase the security of the voice-based recogni-
tion system, preventing impostors to be 
acknowledged thanks to fake pre-recorded ut-
terances. 
Speaker recognition is a complex operation that 
always start with the capture and processing of 
the speech signal, therefore, for this purpose, 
“Voice” and “Speech” can continue to be used 
interchangeably. 
Speaker recognition is not a very recent con-
cept, but, along with other biometric identifica-
tion methodologies, it has become more acces-
sible and affordable in recent times. Based on 
the pioneering studies started in 1960 by Gun-
nar Fant at the KTH Royal Institute of Tech-
nology (KTH, Swedish: Kungliga Tekniska 
högskolan) in Stockholm, Sweden, about the 
physiological components of acoustic speech 
production, and later expanded also by Joseph 
Perkell, in 1976 Texas Instruments built a first 
speaker recognition prototype system that was 
tested by the U.S. Air Force and the MITRE 
Corporation. Since then, a constant increasing 
interest has grown for the biometry of speech, 
and many progresses have been made in parallel 
with the development of technologies in the 
field of electronics, software engineering and 
digital signal processing and analysis. 
The task of infer the identity of an individual by 
his/her voice is a challenging one, also because 
of the large intrinsic variability of the speech 
signal (other than the many factors depicted in 
Figure 5). However, this variability is associated 
with the ability to convey a huge variety and 
quantity of information, and it is what makes 
the voice the most natural form of human 
communication. 
 
 
Figure 5: Source of variability in Speaker Recognition (Hansen 
and Hasan 2015). 
 
In order the determine the identity of a speaker 
given one or more utterance, not the whole 
speech signal is considered, but only a set of 
measurements or “features”. As the speech 
production is influenced by a given speaker in 
many different ways, features can be extracted 
at different levels as depicted in Figure 6. Other 
than maximizing the variability among different 
individuals and minimizing the variability within 
a given person, the ideal speaker features for 
biometric applications should also be difficult 
to mimic, be robust against the change in the 
speaker's health or long-term variations in 
voice, occur frequently and naturally in speech, 
be robust against noises and distortions.  
 
Figure 6: identity levels in the speech signal (Ramos et al. 
2015). 
 
Despite several studies shows the significance 
of suprasegmental  (high level) features in 
speaker recognition systems (Demenko 2000, 
Yegnanarayana et al. 2001 and 2005), the low-
level short-term spectral features are the most 
used, also because they reflect, more or less, the 
physical characteristics of the vocal tract. The 
concept of short-term spectral features can be 
easily depicted considering for example the 
Mel-Frequency Cepstral Coefficients (MFCCs, 
Voice Biometrics Technologies and Applications for Healthcare: an overview. 
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Davis and Mermelstein, 1980), widely adopted 
features that have been proved to provide quite 
low error rates for clean signal conditions. Basi-
cally, the MFCCs are based on a linear cosine 
transform of a log power spectrum on a non-
linear mel scale of frequency. 
The whole utterance is divided in segments of 
duration of approximately 20-30 ms (hence the 
expression “short-term”) with a certain amount 
of overlap (Figure 7). As depicted in Figure 8, 
for each frame, a power spectrum estimate is 
computed by means of Discrete Fourier Trans-
form (DFT) and several other processing steps 
occur in order to achieve a bunch of numerical 
coefficients, which are the actual features. In 
the case of MFCCs, the power spectrum is in-
put to a filter bank whose bands are equally 
spaced on the mel scale (see Figure 9), to better 
approximates the human auditory system's re-
sponse. 
 
 
Figure 7: Overlapping framing of the acoustic waveform and 
frame-by-frame feature extractions. (Ramos et al. 2015).  
 
Feature extraction outputs a temporal sequence 
of acoustic vectors  of 
length N with each vector on having a constant 
dimension D. 
Many other “flavours” of short-term spectral 
features have been proposed in order to in-
crease robustness against noise and other dis-
turbance affecting the speech signal, such as the 
Gammatone Frequency Cepstral Coefficients, 
GFCCs (Chanwoo et al. 2012), the Power 
Normalized Cepstral Coefficients, PNCCs (Al-
Kaltakchi et al. 2016), and many others. Moti-
vated by the fact that the neural responses are 
robust against noise, a research group has also 
proposed “neural” features as extracted from 
the responses of a physiologically-based com-
putational model of the peripheral level of the 
auditory system (Islam et al. 2016). 
The robustness against noise and channel mis-
match is one of the true challenge for speaker 
recognition systems, mainly for those applica-
tions where the quality of the captured speech 
signal cannot be guaranteed. Even the envi-
ronmental noise cannot always guaranteed to be 
a stationary process, because of the large varia-
bility of noise sources (reverberations, mechan-
ical noises, even undesired voices of other 
speakers – the “cocktail party” effect).  The 
speaker features may also get affected by the so 
called “channel mismatch”, when the same in-
dividual could present himself to the recognizer 
using many devices – PC, smartphone, etc.- and 
transmission channels – mobile or landline tel-
ephone, data connections with different encod-
ings and capacity), depending on the use cases. 
 
 
Figure 8: Steps in MFCCs feature extraction from a speech 
frame: (a) 200-sample frame representing 25 milliseconds of 
speech sampled at a rate of 8 kHz, (b) DFT power spectrum 
showing first 101 points, (c) 24-channel triangular Mel-filter 
bank, (d) log filter-bank energy outputs from Mel-filter, (e) 12 
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static MFCCs obtained by performing DCT on filter-bank en-
ergy coefficients and retaining the first 12 values (Hansen and 
Hasan 2015). 
 
Figure 9: A plot of the mel transform. Horizontal axis: the fre-
quency in Hz. Vertical axis: the corresponding mel values.  
 
For examples, a doctor may need to be authen-
ticated to access a reserved patient record from 
the desktop computer in the silence of his own 
office, or in a crowded loud department 
through a mobile handheld, or even through a 
simple voice call. In order to achieve robust-
ness, i.e. low error rates, a huge amount of op-
timizations have been proposed by researchers 
all around the world, not only at the feature ex-
traction level, but also throughout at architec-
tural level and at each building block. 
Anatomy and functioning of an Automatic 
Speaker Recognition system. 
Figure 10 shows a schematic of a typical speak-
er recognition system. In a first phase, the sys-
tem needs to be trained with a number of voice 
samples coming from many individuals, which 
represent the background population, bringing 
information about the variability of speech 
among different individuals (inter-speakers var-
iability). In a next phase, the models of single 
authorized speakers can be trained, taking ad-
vantage of the background model computed in 
the first stage. Once the background and the 
authorized speaker models have been trained, 
the recognizer is ready to infer the identity of 
the incoming speakers (the “test” phase). In all 
phases, the voice samples must be captured and 
digitally converted, pre-processed (e.g. de-
noised), then entered in the feature extraction 
block, which typically produces a time series of 
features vectors. In each training phase, the fea-
tures are processed to get a model of the speak-
er, which is stored in a database. In the test 
phase, the features of the test speaker are 
matched against the model(s) of the enrolled 
speaker(s) stored in the database for authentica-
tion (or identification). 
So, after the feature extraction, a key role is 
played by the speaker modelling, i.e. the com-
putation of a summary description of the fea-
ture distribution of a given speaker, and the re-
lated matching strategy. Many models have 
been proposed, such as the Vector Quantiza-
tion technique, VQ (Burton 1987), where the 
feature vectors of the enrolled speakers are 
used to learn an optimal clustering (a code-
book), specific to each speaker, of the feature 
space. However, a first breakthrough came 
when the probabilistic approach was intro-
duced, with the idea of modelling the variability 
Figure 10: Schematics of a speaker recognition system. 
Voice Biometrics Technologies and Applications for Healthcare: an overview. 
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of each speaker with a probability density given 
by a mixture of multidimensional Gaussian 
components (GMM, Gaussian Mixture Model, 
Reynolds and Rose 1995), trained applying an 
Expectation Maximization (EM) algorithm. 
In a basic identification task, the system returns 
the identity of the enrolled speaker whose 
GMM exhibits the highest statistical likelihood, 
given the feature vectors of the test speaker. In 
order to address the authentication task, a 
GMM is also trained with a large set of feature 
vectors coming from the utterances of many 
speakers, in order to get a so-called “Universal 
Background Model”, UBM), for a reference 
population of speakers (Reynold et al. 2000). In 
this case, the feature vectors of the test speaker 
could be used to compute a likelihood ratio 
(LR) between the GMM of the claimed identity 
and the UBM, while the final response, Accept 
or Reject, could be provided comparing the LR 
to a threshold value. 
A second breakthrough came with the intro-
duction of the “supervectors”, fixed-length vec-
tors built by stacking the centroids of the 
GMMs components, that could be used in oth-
er processing steps, such as Support Vectors 
Machines, SVMs (Campbell et al. 2006). The 
latter is a machine learning classification tech-
nique that aims at optimally separating multi-
dimensional data points (as the supervectors) 
from two classes (e.g. the enrolled speaker and 
the reference population) using a hyperplane, as 
depicted in Figure 11. 
After the learning phase, if the supervector of 
the test speaker falls in the region associated to 
the claimed identity, the speaker is accepted. 
Supervectors opened the doors to further im-
provements, because they made possible to ap-
ply Factor Analysis (FA), such as the  Join Fac-
tor Analysis, JFA (Kenny 2005, Kenny et al. 
2007) to separate (and discard) estimated con-
tributes of noise and channel from that of the 
speaker, and, at the same time, to allow a some 
dimensionality reduction that make more prac-
ticable computational expensive tasks such as 
SVM training.  
 
 
Figure 11: A conceptual illustration of a SVM classifier (Han-
sen and Hasan 2015). When applied to speaker identification, 
positive (+) points represent the vectors of utterances of the 
claimed identity, while negative (-) points represent utterances 
of the speakers belonging to the background population. 
 
Moving from JFA, which was the yesterday 
state-of-art, some researchers introduced a new 
low-dimensional speaker- and channel-
dependent space, defined using a simple factor 
analysis. The so called  Total variability Space 
modelling (TVS, also known as “i-vectors” ap-
proach, cfr. Dehak et al. 2009 and 2011) pro-
vided a way to more effectively summarize the 
speakers utterances allowing at the same time a 
further dimensionality reduction and the use of 
noise and channel compensation methods that 
were not practical in large dimensional super-
vectors, such as Linear Discriminant Analysis, 
LDA (Vogt et al. 2008), Nuisance Attribute 
Projection, NAP (Campbell et al. 2006b), With-
in-Class Covariance Normalization, WCCN 
(Hatch et al. 2006). In the current state-of- 
start, the GMM-UBM/i-vector approach is 
combined with Probabilistic Linear Discrimi-
nant Analysis, PLDA (see Kenny 2011, Garcia-
Romero and Espy-Wilson, 2011), a technique 
first used for session variability compensation 
for facial recognition, which works in principle 
as factor analysis in the i-vectors space (instead 
of the supervectors space). This allows an even 
further effective dimensionality reduction, 
which results in a more effective training phase 
and a simpler implementation. In the GMM-
UBM/i-vectors/PLDA framework, the recog-
nition is finally achieved comparing the LR of 
two alternative hypothesis, i.e. that the speaker-
dependent component of the i-vectors of the 
test speaker and the claimed identity belong to 
the same identity, or not, with a threshold val-
ue. 
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The current state of art is rapidly moving to-
ward Artificial Neural Networks (ANN), in re-
placement or in addition to some module in the 
traditional architecture. Deep Neural Networks 
(DNNs), large feed-forward ANNs with several  
(roughly 5-7) hidden layers and thousands of 
nodes, have recently been successfully used for 
acoustic modelling for the Automatic Speech 
Recognition task, achieving large improvements 
compared to standard GMM models. Research-
ers in the field of speaker recognition are pro-
posing to use DNNs, and other kinds of ANNs 
such as the Convolutional Neural Networks 
(CNNs, see McLaren et al. 2015), as replace-
ment of the UBM module (leading to a 
DNN/i-vector framework; see Lei et al. 2014), 
as de-noising module, as feature extractor 
module, leading to EER values up to  1-2% 
mainly in clean conditions, with an improve-
ment over the traditional approach up to 30%. 
Although in the field of voice biometrics there 
is still a lot of room for improvements, as for 
other biometrics technologies, the current state-
of-art is ready to be successfully used in many 
sectors, including healthcare. 
 
Voice biometrics for healthcare. 
As already mentioned, biometric identifiers can 
be anything from fingerprints, palm veins, and 
iris scans to gait, facial, other than speaker 
recognition. Each one has its own benefits and 
disadvantages, but the latter has unique features 
that make it ideal for the healthcare sector, such 
as: 
- Familiarity: using their own voice to 
interact with devices is becoming more 
and more familiar as voice-activated 
personal assistants and mobile apps 
spread.  
- Little hardware required and cost ef-
fectiveness: any device equipped with a 
microphone and a network connection 
(voice or data) is ready. Voice biomet-
rics user interfaces require no expensive 
scanning devices, only existing phone 
systems and everyday technology. 
- No training is required to use a voice 
biometric system, because speaking is a 
natural activity. 
- Mobility: voice biometrics works with 
any telephony technology, from any-
where in the world. Moreover, it is the 
only practical biometric option for au-
thentication/identification over tele-
phone channel. 
- Accuracy: improvements in speech 
digital signal processing, such as noise 
cancelling and voice activity detection, 
as well as machine learning and deep 
learning are shrinking error rate under 
1% in the most operative conditions. 
- Effectiveness: as voice biometrics is 
actually a combination of both physical 
attributes (the shape of one’s vocal 
tract) and behavioural attributes (speak-
ing style), with a single interaction it 
provides authentication as well as 
“liveness testing.” When used with 
speech recognition, voice biometrics 
can also be used to gather additional in-
formation such as a passwords, PIN, 
user-acknowledgement of prompted 
questions and so on, if required, with 
little or no extra cost. 
- Integration with existing security sys-
tems: voice biometrics can be used with 
existing authentication methods to pro-
vide high-security multi-factor user-
authentication. 
Thanks to these concurrent properties, voice 
biometrics is an optimal solution, both as a 
stand-alone strategy and combined with tradi-
tional security approaches or other biometric 
identifiers for critical security needs, to improve 
the quality of healthcare services reducing costs 
at the same time. 
Not only doctors but in general the healthcare 
staff as well as patients can get used easily with 
voice authentication and identification because 
recognition can happen in a seamless way, as if 
they speak at their own voice-activated personal 
app. 
Electronic patient records can be safely re-
trieved by authorized personnel only, every-
where in the medical facility, by means of ordi-
nary tablets and smartphones, other than desk-
top personal computers. 
Simply using the intercom at the entrance to a 
department, a ward or any reserved area, could 
unlock access for authorized people, as the 
most natural gesture. 
At-home healthcare services appear a perfect fit 
for voice biometrics and remote authentication, 
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that can perfectly work through a simple con-
nection to landline or mobile phone networks. 
In addition, the combination of voice biomet-
rics and speech recognition unlocks many other 
opportunities, as voice assistants are entering 
the healthcare. For instance, patients can use 
such new devices as conversational interface, to 
get information and request something needed 
(see 
http://www.healthcareitnews.com/news/speci
al-report-ai-voice-assistants-have-officially-
arrived-healthcare). Within the same communi-
cation channel, doctors can both authenticate 
themselves and deploying accurate speech-to-
text capabilities to transcribe notes and pre-
scriptions, avoiding illegible handwriting and 
insufficient documentation of procedures 
(http://www.rightpatient.com/blog/voice-
assistants-technology-healthcare/). 
 
Conclusions 
In the healthcare sector, biometrics are general-
ly used in combination with traditional identifi-
cation approaches (password, PIN, tokens) to 
authenticate/identify patients and staff, to im-
prove security, cost containment and quality of 
service. Implementing biometric identification 
can address both, physical access control for 
computer/server rooms, hospital ward, and 
logical access control for login to the work-
stations and servers providing access to sensi-
tive patient records. 
Voice biometrics relies on the most natural 
form of human communication, requires only 
cheap hardware for user interface or no new 
hardware at all thanks to the large diffusion of 
personal mobile devices. Moreover, voice bio-
metrics allows integration with existing tradi-
tional or biometric identification systems, im-
proves mobility and allows at-home healthcare 
services. All this makes voice biometrics ideal 
for the  healthcare sector in most use cases (ex-
cept those cases where patients are temporary 
or permanently unable to speak, that can occur 
in emergency situations or in some hospital de-
partment). 
Most of other biometric identifiers, also while 
successfully employed, require more or less ex-
pensive scanners, or cannot easily support re-
mote (such as at-home) authentication), or are 
invasive with respect to the naturalness of the 
act of speaking. 
Last but not least, voice biometrics technology 
has reached very high accuracy levels in most 
operating conditions, and can be successfully 
integrated in the state-of-art voice-activated 
personal assistant for many purposes, such as to 
boost patient engage 
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Abstract 
Reflectance confocal microscopy (RCM) is a new technique enabling the visualization of the skin at a quasi-
histological resolution, allowing the identification of clues for the diagnosis of skin diseases. The aim of this anal-
ysis was to provide new insights into the role of RCM in the diagnosis of skin cancers. Data comes from the 
most recent literature, taking into account previous essential reported information in this field. The study eligibil-
ity criteria were: studies providing update information, focusing on RCM findings in melanoma and non-
melanoma skin cancers (NMSC), without restrictions for age, sex, ethnicity. Duplicated studies and single case 
report were excluded from this study. A search concerning the role of RCM in melanoma and NMSC was per-
formed on the Medline. RCM clues were analyzed for different skin cancers, in particular melanoma and NMSC, 
in association with clinical, dermoscopic and histopathologic findings. Diagnostic accuracy, sensibility and speci-
ficity of the technique were reviewed. Furthermore, some new findings have been described and recent applica-
tions have been discussed. The selection of articles was limited in order to provide an up-todate revision. In con-
clusion, several RCM features were implemented for the diagnosis of melanoma and NMSC, leading to a confo-
cal-based classification in most cases. 
 
Keywords: Microscopy, confocal - Skin neoplasms - Melanoma. 
 
Introduction 
Reflectance confocal microscopy (RCM) is one 
of the latest tools introduced in non-invasive 
imaging in dermatology. This technique enables 
in vivo observation at a quasi-histological reso-
lution of the epidermis, dermoepidermal junc-
tion (DEJ) and upper dermis, providing hori-
zontal grayscale color images related to refrac-
tive index of different tissues and cell structures 
(Calzavara-Pinton et al. 2008, 1421–30). The 
highest refractivity is shown by melanin, con-
tained in melanosomes, melanocytes, mel-
anophages and pigmented keratinocytes, fol-
lowed by structures containing keratin (Rajadh-
yaksha et al. 1995, 946–52). Noteworthy, cellu-
lar contrast in tissue can also be obtained when 
melanin is present in very small quantities, 
thanks also to the brightness of some subcellu-
lar organelles or surrounding structures (Ra-
jadhyaksha et al. 1999, 293–303). Therefore, 
RCM can be used for the evaluation of both 
melanocytic and nonmelanocytic skin lesions. 
Several criteria have been described in order to 
improve diagnostic accuracy (Pellacani, Ce-
sinaro and Seidenari 2005, 979–85). Further-
more, the maximum depth achieved by RCM is 
approximately 250 μm,3 thus impairing the vis-
ualization of the deepest part of skin (Segura et 
al. 2008, 1311–20; Longo et al. 2013, 58–67). 
With increasing knowledge, RCM is giving 
more dynamic insights in the diagnosis of skin 
cancers. 
In order to provide an updated review on the 
application of RCM, data coming from the 
most recent literature will be reported and criti-
cally revised. A focus on diagnostic accuracy 
and diagnostic criteria for malignant melanomas 
and non-melanoma skin cancers (NMSCs) will 
be provided. 
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RCM updates for examination of skin can-
cers 
 
Basic principles of RCM 
RCM is a non-invasive method for high-
resolution diagnostics of tissue. While conven-
tional microscopes work by using transmitted 
light technology with thin tissue layers being il-
luminated from below, RCM works with inci-
dent light technology. The skin is illuminated 
from above with a focused laser thus the re-
flected light is directed through a pinhole onto 
a detector so that only signals from a defined 
horizontal plane are used for high-resolution 
imaging allows the penetration depth into the 
skin. This non-invasive technique permits in vivo 
and in real time examinations, allowing micro-
scopic images of skin layers close to the surface 
and opens up new possibilities for dermatology 
to monitor both diagnose and progression, in 
particular in the cases of dynamic changes. It 
also can be used ex vivo with freshly excised 
tissue, resembling a frozen section analysis, 
which is interesting especially for the field of 
microscopically controlled surgery of skin tu-
mors.  
RCM uses a diode laser as a source of mono-
chromatic light that penetrates into the skin and 
illuminated a small points inside the tissue. The 
light is reflected, goes through a small pinhole 
and forms an image in the detector. This small 
pinhole allows only reflected light from the fo-
cal region (confocal) to reach the detector, re-
jecting all the coming light from out-of-focus 
plane (Kolm and Braun 2012, 7–10). The re-
flected light signals from a horizontal plane is 
then detected, where the refractive index 
changes. Structures with a higher refractive in-
dex appears bright in RCM, such as keratin, 
melanin and collagen, that result white in RCM. 
 
Notes on the imaging technique 
Examinations of a skin lesion is easy. A poly-
mer or glass window is attached to a metal ring 
ad fixed to the skin with a special adhesive tape 
to reduce skin movement, where a small 
amount of immersion oil is applied to the skin. 
Afterwards, a water-based gel is applied inside 
the ring. This  immersion liquid have refractive 
index close to that of the epidermis (1.34), thus 
reducing the spherical aberration of the beam 
passing through air and therefore allowing suf-
ficient imaging through the epidermis and into 
the dermis The ring is then magnetically con-
nected  to the objective lens housing to stabilize 
the site of imaging (Kolm and Braun 2012, 7–
10; Wurm, Kolm and Ahlgrimm-Siess 2012, 
11–19).  
RCM images are obtained horizontally from the 
lesion. Each single image displays a 500µM x 
500µM large field-of-view on the screen. It is 
therefore possible to scan the entire area of the 
lesion up to 8mm x 8mm. In this way, it is gen-
erated a mosaic grid of contiguous horizontal 
images. This two-diensional composite mosaic 
is called VivaBlock. Additionally, an automated 
vertical sequence of images, each 500µM field-
of-view, can be captured in depth, providing a 
three-dimensional view of certain area. This is 
called VivaStack. The distance between each 
section and the  section depth can be adjusted. 
Another useful function is recording a video at 
15-20 frames per second, to document dynamic 
events such as blood flow, or migration of leu-
cocytes. For easier correlation of the macro-
scopic image and the confocal image, a digital 
macro camera (Vivacam; Lucid Inc) is linked to 
the RCM. This camera produces a 5 mega-pixel 
dermoscopic image of a 10mm field of interest 
enabling direct viewing of the dermoscopic 
structures on the RCM monitor. It is possible 
to navigate within the dermoscopic image and 
to specify areas for the subsequent RCM view-
ing and therefore allows choosing the interest-
ing areas in this larger lesion and better asses 
the borders of a lesion which can be very help-
ful for surgical planning (Kolm and Braun 
2012, 7–10). 
RCM acquisition can be carried out with differ-
ent available tools. The introduction of the 
handheld RCM device, Vivascope 3000® (Cali-
ber Imaging and Diagnostics, Rochester, NY, 
USA), permits a better access to difficult ana-
tomic locations and can be used for clinically 
and dermoscopically equivocal lesions in areas 
including nasal region, scalp, eyelids, ears and 
mucosae in order to differentiate benign lesions 
from skin cancer or for a rapid determination 
of the nature of the lesion for example melano-
cytic versus nonmelanocytic (Castro et al. 2015, 
1164–69; Fraga-Braghiroli et al. 2014, 933–42; 
Cinotti et al. 2014, 912–918.e2; García-
Hernández et al. 2013, 205256). Clinical appli-
cations include the evaluation of recurrences, 
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assessment of margins for excision like for len-
tigo maligna (LM)/lentigo maligna melanoma 
(LMM) and basal cell carcinoma (BCC) and 
monitoring of non-invasive treatments for AKs 
(Champin et al. 2014, 247–56; Guitera et al. 
2013, 692–98; Longo et al. 2014, 716–724.e1; 
Ulrich et al. 2010, 15–24). 
On the other hand, the wide-probe (Vivascope 
1500®, MAVIG GmbH, Munich, Germany) 
allows a broad non-invasive examination of the 
epidermis and papillary dermis at cellular-level 
resolution viewing mosaics (Vivablock®), with 
a maximum size of 8x8 mm, at epidermis, DEJ 
and upper dermis level. This probe is the most 
appropriate for differential diagnosis between 
nevus and melanoma, because the visualization 
of the entire lesion is possible and the Viva-
cam® (Caliber Imaging and Diagnostics, Roch-
ester, NY, USA) (Longo et al. 2015, 31–41) 
guarantees an overlap with dermoscopic and, 
recently, also clinical features. 
RCM provides substrates for dermoscopic pat-
terns, corresponding to specific histopathologi-
cal criteria (Pellacani et al. 2008, 1597–1608). 
This means that, in specific cases, RCM can 
avoid a skin biopsy while possibly reducing pa-
tientrelated costs for excisions. Furthermore, 
RCM allows the non-invasive exploration of 
the entire lesion, similarly to what obtained with 
a shaving biopsy (Wolberink et al. 2013, 985–
89). 
 
Diagnostic accuracy and number needed to 
excise 
While histopathology remains the gold standard 
for the diagnosis of skin cancers, dermoscopy 
and RCM analysis can improve an early recog-
nition of these lesions.6 Previous reports de-
scribed the high sensibility and the increased 
specificity supporting the analysis of equivocal 
melanocytic and nonmelanocytic lesions 
(Guitera et al. 2012, 2386–94; Lovatto et al. 
2015, 1918–25), with a better differentiation 
among skin cancer simulators and interpreta-
tion of clinical and pathological correlation 
(Larre Borges et al. 2014, 833–45; Longo et al. 
2012, 799–814; Pellacani et al. 2014, 864–72; 
Longo et al. 2013, 125–31;). It has been proved 
that systematic application of RCM diagnostic 
algorithms showed a specificity ranging be-
tween 50% and 70% when evaluating equivocal 
lesions (Guitera et al. 2012, 2386–94; Pellacani 
et al. 2014, 1044–51). 
Interestingly, differences in diagnostic accuracy 
between expert and recent RCM users have 
been reported (Farnetani et al. 2015, 1075–80), 
considering that formal training programs have 
been recently introduced. The mean sensitivity 
was 88.9% while the mean specificity was 
79.3%; experienced RCM users showed higher 
sensitivity compared with recent users. 
Another important issue addressed in the last 
few years regarded the number needed to excise 
(NNE). A reduced number of benign lesions 
excised associated with an improved diagnostic 
accuracy were obtained with RCM evaluation of 
lesions eligible for surgical excision because 
dermoscopically suspected to be malignant or 
showing dermoscopic changes during the fol-
low-up (Pellacani et al. 2014, 1044–51; Ferrari 
et al. 2015, 1135–40; Alarcon et al. 2014, 802–8; 
Stanganelli et al. 2015, 365–71). In particular, in 
a cohort study enrolling 1005 patients, 423 of 
which presenting lesions suspected to be malig-
nant, RCM examination reduced the number of 
lesions for excision to less than one half of be-
nign lesions, passing from a NNE ranging from 
8.7 to 29.4 with dermoscopy to 6.8 after RCM 
evaluation (Pellacani et al. 2014, 1044–51). A 
previous study (Alarcon et al. 2014, 802–8), 
performed in a different setting, reported a 
lower NNE from 3.73 to 2.87. 
 
Dysplastic nevi 
Dysplastic nevi represent major risk factors for 
melanoma and they are challenging lesions both 
clinically and histopathologically (Elder 2010, 
112–20; Duffy and Grossman 2012, e1-16). A 
simplified algorithm was developed by Pellacani 
et al. (Pellacani et al. 2012, e109-121) in order 
to differentiate nevi, dysplastic and nondysplas-
tic, from melanomas. 60 lesions among which 
19 nondysplastic nevi, 27 dysplastic nevi and 14 
melanomas were analyzed by RCM and histo-
pathology. 
RCM criteria found in melanocytic lesions are 
presented in Table I. 
Upon RCM, dysplastic nevi were usually char-
acterized by a ringed and meshwork patterns 
with irregular junctional nests showing short 
interconnections or atypical junctional cells 
mostly located in the center of the lesion. In de-
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tails, the presence of cytologic atypia in associa-
tion with atypical junctional nests (showing 
short interconnections or characterized by 
nonhomogeneous cellularity) was suggestive of 
dysplasia, while widespreading pagetoid cells 
scattered in the epidermis or atypical cells dif-
fused throughout the DEJ associated with 
nonedged papillae were tipically found in mela-
noma (Pellacani et al. 2012, e109-21) 
 
A focus on pink and nodular lesions 
Many studies regarding pigmented lesions, 
showing bright components due to the high 
content of melanin, have been performed, 
while hypopigmented/amelanotic lesions were 
not so extensively investigated. A stepwise ap-
proach was described in order to study hy-
popigmented/amelanotic lesions (Longo et al. 
2015, 31–41). Initially, the distinction between 
inflammatory versus skin cancer has to be for-
mulated. Then, RCM evaluation can be helpful 
in determining the nature of the lesion, under-
lining the importance of identifying specific 
morphological clues in order to classify 
nonpigmented skin neoplasms into melanocytic 
versus nonmelanocytic and benign versus ma-
lignant. More specifically, the presence of a 
nested melanocytic proliferation at the DEJ or 
dermis level allowed to ascribe a given lesion as 
melanocytic; the presence of basaloid bright 
tumour islands was a key RCM feature for the 
diagnosis of BCC; and an epidermal disar-
rangement associated with small demarcated 
papillae was suggestive for the diagnosis of SCC 
(Longo et al. 2015, 31–41). 
The second issue, depth exploration, was ana-
lyzed in a retrospective study involving 140 
nodular lesions. Nodular neoplasias belonging 
to both melanocytic (among which 23 “pure” 
nodular melanomas [NMs], nine melanoma me-
tastasis) and nonmelanocytic tumours (among 
which 28 BCCs and six invasive SCCs) have 
been explored, concluding that RCM was a val-
uable tool for nodules because, in many cases, a 
thinned epidermis allowed a good visualization 
of peculiar diagnostic structures located in the 
superficial dermis (Longo et al. 2013, 58–67). 
The key concept of this study was that cases 
characterized by the absence of criteria should 
lead to prompt excision because a deep malig-
nant tumour proliferation cannot be assessed 
and thus melanoma diagnosis cannot be ruled 
out. 
 
RCM updates for examination of melanoma 
Melanoma is one of the tumors with the high-
est rising in incidence. Only an early detection 
of melanoma can led to a better prognosis 
(Garbe and Leiter 2009, 3–9). 
The original histopathologic classification of 
melanoma is based on growth pattern and bio-
logic behavior and it included LM/LMM, su-
perficial spreading (SSM) and NM. Then, other 
types of melanoma have been added to this 
classification (Clark et al. 1969, 705–27). 
 
Superficial Spreading Melanoma (SSM) 
SSM is the most common type of melanoma in 
Caucasian (Jemal et al. 2008, 71–96). It is char-
acterized by a radial growth in the initial phase, 
followed by vertical proliferation after invasion. 
A 3-steps model of progression in SSM has 
been described (Scope et al. 2008, 1644–49). 
The first step was the proliferation of single 
cells or melanocyte nests along the DEJ occur-
ring in the rete ridges, in the suprapapillary 
plate and in suprabasal layer of epidermis, then 
a remodeling with a progressive flattening of 
DEJ associated with inflammation, angiogene-
sis and fibroplasia followed by dermal invasion. 
This means that to each step corresponded an 
increased degree of atypia. Pagetoid cells, mild 
to moderate cytological  atypia and non-edged 
papillae can be described in superficial lesions 
(Gareau et al. 2010, 61713). With increasing 
thickness, epidermal disarrangement, cell pleo-
morphism, progressive papillary infiltration 
with bright cells or cerebriform melanocyte 
nests can be added to the list of  features ob-
served (Pellacani, Cesinaro and Seidenari 2005, 
469–74). 
In particular, considering epidemiologic and 
RCM characteristics, SSM included: pagetoid 
and solar melanoma (Longo, Casari and Pel-
lacani 2012, 151–78). Pagetoid melanoma was 
described in adults with a history of intermit-
tent solar exposure and several nevi. Upon 
dermoscopy, reticular, globular, multicompo-
nent or nonspecific pattern could be identified. 
Histologically, this tumor is typified by an in-
traepidermal growth, corresponding to RCM 
findings of pagetoid infiltration (Pellacani, Ce-
sinaro and Seidenari 2005, 532–37) of the epi-
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dermis that showed an atypical honeycomb or 
cobblestone or fully disarrayed pattern. 
Pagetoid cells were mainly roundish and dis-
tributed throughout the lesion or  located at the 
periphery (Figure 1A, B). When centrally locat-
ed, a differential diagnosis with Spitz, congeni-
tal, traumatized and dysplastic nevi should al-
ways be considered (Pellacani et al. 2009, 236–
47). DEJ was predominantly represented by 
meshwork with edged and nonedged papillae 
with admixed atypical cells. Going deeper to the 
upper dermis, melanocytic homogeneous nests 
or, in over the half of cases, dense and sparse 
nest were prevalent. Inflammation presented as 
plump bright cells and bright particles (Longo, 
Casari and Pellacani 2012, 151–78). 
Melanoma on sun-damaged skin is located by 
definition in the most sun-exposed areas of pa-
tients with a low nevus count. Dermoscopically 
regression features such as white combined 
with blue-gray color and/or peppering. Histo-
logically, atypical melanocytes in the basal layer 
and a lymphocytic infiltrate were commonly 
presented in the superficial portions of the 
dermis while the surrounding skin showed pho-
todamage. Peculiar RCM findings were 
pagetoid cells with variable shape, usually den-
dritic, mainly located around the hair follicle, in 
the context of an atypical or disarranged epi-
dermis. At the DEJ, ringed or meshwork or un-
even pattern could be observed in association 
with atypical cells. Upper dermis was predomi-
nantly characterized by solar elastosis and in-
flammation. Polycyclic papillary contours and 
bulbous projections, sometimes detectable at 
the periphery of the lesion could led to a misdi-
agnosis with a benign lesion, underlying the im-
portance of a fully evaluation of the lesion 
(Longo, Casari and Pellacani 2012, 151–78). 
 
Nodular Melanoma (NM) 
NM is the most aggressive type of melanoma 
(Chang, Karnell and Menck 1998, 1664–78). A 
difference should be made between vertical 
growth phase in a context of radial growth 
phase of SSM and “pure” NMs, these latter 
representing a separated subgroup of melano-
mas (Segura et al. 2008, 1311–20). 
Pigmented NMs usually appeared as symmetric 
lesions, with a homogeneous blue pigmenta-
tion, showing also a blue-white veil, pink 
and/or black color and milky-red/pink areas 
with large-diameter vessels predominantly lo-
cated in the periphery, with pure NMs showing 
less dermoscopic features than SSMs with a 
vertical growth phase (Menzies et al. 2013, 699–
709). 
 
Table 1. RCM criteria for the evaluation of melanocytic lesions 
 
 
 
Histologically, a flattening of the epidermis and 
eventual ulceration overcoming the nodular 
component could be found whereas a cohesive 
nodule or smaller nests of malignant melano-
cytes with a pushing or expansive pattern of 
growth at the dermis level were found. Upon 
RCM, “epidermal consumption” was detected 
while acquiring RCM image stacks in NMs. 
This feature was characterized by a rapid of 
transition from epidermal to dermal compart-
ment, due to the thinning of the epidermis 
down to two to three layers of keratinocytes 
(Hantschke, Bastian and LeBoit 2004, 1621–
25). 
Epidermal layers were characterized by regular 
honeycombed or, sometimes, polygonal cells 
with demarcated, bright borders and black nu-
clei forming a broadened honeycombed pat-
tern. Pagetoid cells, with either a roundish or 
dendritic shape, were identified in vertical 
growth phases whereas in NMs the pagetoid 
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infiltration was not detectable or focally repre-
sented. 
Ulceration represented a common finding, ap-
pearing as dark areas, usually with sharp bor-
ders and irregular contours, filled with amor-
phous material and/or clotted bright small par-
ticles. Ulcerations covering over than one half 
of the surface of the lesion hampered penetra-
tion of RCM light and visualization of underly-
ing structures. At the DEJ, typical dermal papil-
lae were absent and the basal layer was com-
posed of pleomorphic cells, arranged in sheet-
like structures. 
Within the dermis, cerebriform melanocyte 
nests with prominent cellularity and moderate 
inflammatory infiltrate with the absence of re-
gression were identified. Cerebriform nests, 
showing up as hyporefrective aggregates of 
small cells outlined by bright collagen septae, 
were considered highly specific of malignancy 
and suggestive of invasion of the deepest part 
of dermis in NMs (Figure 1C, D) (Segura et al. 
2008, 1311–20). Interestingly, RCM features 
found within dermal component of nodules 
arising from a SSM or to pure NMs were not 
distinguishable. 
Furthermore, vascularization was found to be 
an important clue at this stage of invasion. 
Convolute and tortuous vessels, in proximity of 
tumoral proliferation or even crossing malig-
nant cell growth, were frequently decribed. Live 
imaging unrevealed the presence of vessels with 
large caliber and fast blood flow. 
Recently, Longo et al. (Longo et al. 2015, 31–
41) described the role of RCM in the evaluation 
of 140 nodular lesions including NMs, mela-
noma metastasis and other benign and malig-
nant skin lesions. 
Considering that the nodular portion of NMs 
shared morphologic findings with metastasis, 
these two entities where grouped in the discri-
minant analysis, highlighting that widespread 
pagetoid distribution, many atypical cells and 
cerebriform nests were peculiar elements for 
the diagnosis of melanocytic malignancy. 
Whitmore, confocal microscopy reached 96.5% 
sensitivity and 94.1% specificity in the diagnosis 
of NMs and melanoma metastasis versus all 
other nodular lesions, regardless of the limited 
laser depth penetration of RCM. Limitations 
were represented above all by wide ulcerations 
or marked hyperkeratosis (Longo et al. 2015, 
31–41). This means that, once again, biopsy and 
histopathological examination should always be 
performed in doubtful cases. 
 
 
 
Figure 1. Dermoscopic and confocal pictures of melanomas. 
A) Dermoscopic image of superficial spreading melanoma. It 
presents multi component pattern with central area of regres-
sion, eccentric hyperpigmentation, inverse network; B) confocal 
image of melanoma. Several roundish pagetoid cells (green ar-
rows) within the epidermis with a consumption of he epidermis 
itself; C) dermoscopic image of nodular amelanotic melanoma 
showing irregular vessel, central ulceration; D) confocal image 
of nodular melanoma showing the  presence of cerebriform 
nest (yellow arrows) in the dermis. These nests are rarely notic-
es in melanoma because they are too deep in the dermis but 
they are typical of more invasive melanoma; E) dermoscopic 
image of lentigo maligna (LM) of left cheek. A hyperpigmenta-
tion around follicular openings can be noticed; F) confocal im-
age of LM with numerous dendritic pagetoid cells around fol-
licular openings (red asterisks).  This is a typical sign of LM 
(Guida et al. 2015, 547–63).  
 
Lentigo Maligna (LM) / Lentigo Maligna 
Melanoma (LMM) 
LM and LMM are melanomas mainly occurring 
on the face and other sun-exposed areas. Der-
moscopy identified several peculiar aspects like 
asymmetrical follicle pigmentation, annular 
granular pattern, pigmented rhomboidal struc-
tures and/or obliterated hair follicles (Pralong 
et al. 2012, 280–87). RCM examination of 
LM/LMM revealed a significant similarity to 
solar SSM. Epidermal disarrangement with the 
presence of numerous round or dendritic ple-
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omorphic cells, distributed in all of its layers, 
was reported (Langley et al. 2006, 88–97). An 
important clue was the presence of atypical cells 
grouping around the hair follicle (Langley et al. 
2006, 88–97; Tannous et al. 2002, 260–63). In 
the papillary dermis, the presence of mel-
anophages and reticulated bright collagen bun-
dles, ascribable to solar damage were observed. 
Nests of atypical and nucleated melanocytes 
could also be seen and these structures corre-
sponded, coming back to dermoscopy, to glob-
ules (de Carvalho et al. 2016, 878–80). 
In a recent study (de Carvalho et al. 2015, 128–
33), RCM examination of 60 lesion revealed 
that the most relevant differences between the 
nonmelanoma skin neoplasms and melanomas  
involved the presence of atypical cells both at 
th junction and spreading upwards in a pagetoid 
fashion, usually with a dendritic morphology 
(Figure 1E, F). Furthermore, a meshwork pat-
tern was observed in LM/LMM, compared 
with the most common ringed pattern in asso-
ciation with polycyclic contours in benign le-
sions. An important clue, known as ‘Medu-
sahead-like’ structures, characterized by elon-
gated buddings bulging from the hair follicle 
and populated by dendritic/pleomorphic cells, 
was found in 11 of 30 LMs of the case series 
analyzed, usually in relation to asymmetric fol-
licular pigmentation and/or around hyperpig-
mented follicles, whereas folliculotropism of 
atypical cells was detected in one half of cases. 
Another important aspect concerned the help-
fulness of RCM in the analysis of hyperpig-
mented areas, suspicious for malignancy (Tran, 
Wright and Cockerell 2008, 852–71). In fact, 
when evaluating each dermoscopic pattern in 
lesion with different biological nature, RCM 
substrates helped in providing the correct diag-
nosis avoiding a skin biopsy (de Carvalho et al. 
2015, 128–33). 
Noteworthy, suggestive RCM features for LM 
can be found in early melanomas, providing dif-
ferential diagnosis from solar lentigo, sebor-
rhoeic keratoses and lichen planus-like keratosis 
(de Carvalho et al. 2015, 128–33). Finally, dif-
ferent attempts have been made in order to de-
fine margins of LM/LMM more accurately us-
ing RCM (Champin et al. 2014, 247–56; Guitera 
et al. 2013, 692–98). Preoperative mapping is 
extremely important because these lesions often 
show ill-defined margins, not easily detectable 
with the naked eye and with the help of der-
moscopy. The assumption is that a careful pre-
operative mapping guiding surgical excision 
could led to a reduction of local recurrences. 
Intuitively, the analysis of LMs/LMMs with the 
handheld RCM device Vivascope 3000 can be 
useful in difficult-toexplore sites and in lesions 
bigger than 8x8 mm. 
 
Amelanotic melanoma 
The diagnosis of amelanotic melanoma (AM) 
has been challenging clinically and instrumen-
tally (Guitera et al. 2013, 692–98). RCM fea-
tures described for SSM and NM can also be 
applied for AMs (Longo et al. 2015, 31–41). 
Nevertheless, considering that melanin and 
melanosomes usually create a source of con-
trast, (Stoecker and Stolz 2008, 1207–10) the 
identification of clues became fundamental. In-
terestingly, Losi et al. (Losi et al. 2014, 48–54) 
detected a new confocal feature called hypore-
flective pagetoid cells (HPCs). HPCs were de-
scribed as large cells, round to oval in shape, 
appearing as well-demarcated structures within 
the epidermal layer. At a higher magnification, 
these structures, with a particular shape and 
size, presented a dark round central area corre-
sponding to the nucleus, within a dark grey 
grainy material corresponding to the cytoplasm. 
A difference should be operated between flat 
and papular/nodular lesions. Flat AMs were 
characterized by honeycombed pattern in asso-
ciation with HPCs, single or organized in nests, 
and dendritic-shaped particles corresponding to 
melanocyte or Langerhans cells (Hashemi et al. 
2012, 452–62). At the DEJ level, different ar-
chitectural patterns were identified: nonedged 
dermal papillae, nonspecific pattern with a loss 
of dermal papillae, due to the flattening of the 
DEJ or a meshwork pattern with focal or wide 
spreading irregular junctional nests composed 
by atypical melanocytes (Pellacani et al. 2014, 
414–18). In upper dermis melanocyte nests 
were usually less bight than nests belonging to 
pigmented tumors. 
In palpable-to-nodular AMs, honeycombed ep-
idermal pattern with a more evident brightness 
of the intercellular borders of keratinocytes was 
observed. 
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HPCs were found more commonly in SSM 
with a nodular component than in pure NMs, 
like pagetoid cells in pigmented NMs (Longo et 
al. 2013, 58–67). 
As previously described for pigmented NMs, 
ulceration was a common finding also in nodu-
lar AMs while cerebriform nests, although rare 
and presenting a weak reflectivity, represented 
the most important clue for the diagnosis of 
NM (Segura et al. 2008, 1311–20). 
In order to validate this feature, a retrospective 
study has been performed, including 20 
amelanotic MMs and controls represented by 
10 melanocytic nevi, 20 hypo/nonpigmented 
nonmelanocytic 
lesions and 20 pigmented melanomas. HPCs 
were abundantly found in 85% of AMs. They 
were also described in Spitz nevi. In these cases 
they were correlated with pagetoid infiltration 
of hypomelanotic melanocytes on histopathol-
ogy. This is an important finding when consid-
ering that few HPCs were also highlighted in 
nonmelanocytic lesions (three SCCs, two sebor-
rhoeic keratoses and one BCC), corresponding 
to enlarged or dyskeratotic keratinocytes by his-
topathology (Losi et al. 2014, 48–54). 
 
Mucosal melanoma 
This is a rare form of melanoma. Although 
most mucosal pigmented macules are benign, it 
can be clinically and dermoscopically challeng-
ing to rule out an early melanoma, above all 
when considering that most cases of malignan-
cy in oral mucosa and anogenital are relatively 
advanced at diagnosis. 
Early detection and appropriate treatment sig-
nificantly increases survival. RCM findings for 
this type of melanoma included: roundish cells, 
a high density of atypical dendritic cells and in-
traepithelial bright cells in a case series includ-
ing labial or genital pigmented macules among 
which 10 macular melanomas (Debarbieux et al. 
2014, 1276–84). 
 
Toward a confocal-based classification of 
melanoma 
A previous report 4 described a RCM-based di-
agnostic algorithm consisting of 2 major and 4 
minor criteria to evaluate the degree of atypia 
of melanocytic lesions. Major criteria (scoring 
two points each) included non-edged papillae 
and the presence of atypical melanocytes. Mi-
nor criteria (scoring one point each) included 
pagetoid cells in the epidermis, wide spreading 
pagetoid cells, cerebriform melanocytic clusters, 
and individual, nucleated melanocytes within 
dermal papillae. A score of ≥ three points led 
to a confocal-based diagnosis of melanoma. 
A web-based multicenter study involving RCM 
users from 6 different countries, evaluated 
characteristic features of 55 melanocytic nevi, 
20 melanomas and other nonmelanocytic skin 
neoplasms. The discriminant analysis of these 
lesions identified three important features for 
melanoma diagnosis. Pagetoid cells spreading 
within epidermis, atypical cells at the DEJ and 
irregular architecture of epidermis; these latter 
showed a low interobserver reproducibility 
(Farnetani et al. 2015, 1075–80). 
Recently, Pellacani et al. (Hashemi et al. 2012, 
452–62) have described a confocal- based clas-
sification. The study included 100 melanomas, 
of which 11 LMs, nine LMMs, 74 SSMs (15 of 
which in situ) and six NMs. Dendritic and 
round cell, dermal nest, combined and non-
classifiable melanomas have been described, 
depending on prevalent RCM features. 
Dendritic cells were found in large melanomas 
showing a pigmented network in subjects with 
a low number of atypical nevi. Dendritic cells 
characterized a slow-growing group of mela-
nomas, described by Argenziano et al. (Argen-
ziano et al. 2010, 267–73) in which round cells 
and dermal nests could also be found with the 
progression of the disease. This observation al-
lowed to formulate the hypothesis that the ini-
tial growth of melanoma could be represented 
by intraepidermal proliferation of dendritic 
melanocytes that, when de-differentiating, 
could leave the place to cells with a roundish 
shape and invasive capability (Zalaudek et al. 
2008, 1375–79). LMs and SSMs were predomi-
nantly observed in this group of melanomas 
(Pellacani et al. 2014, 414–18). 
Round cells were commonly associated with 
thicker but smaller melanomas compared to 
dendritic ones, occurring in patients with many 
atypical nevi. The degree of invasiveness was 
variable. The next step for melanoma progres-
sion could be exemplified by a further cell de-
differentiation in order to create less cohesive 
cells aggregated into dense-andsparse clusters 
and/or cerebriform nests (Pellacani, Cesinaro 
and Seidenari 2005, 469–74). 
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Dermal nests typified NM, characterized by a 
rapid  pattern of growth, a deep dermal inva-
sion, limited epidermotropism and poorly dif-
ferentiated melanocytes, (Zalaudek et al. 2008, 
1375–79) while combined melanomas were the 
biggest ones. Nonclassifiable type melanomas 
showed ringed architecture with few atypical 
cells, usually roundish; these were supposed to 
represent an early phase of round cell melano-
mas (Pellacani et al. 2014, 414–18). 
Finally, Longo et al. (Longo et al. 2013, 941–
45), used RCM in support to dermoscopy and 
histopathology, and described a new melanoma 
entity called “nested melanoma of the elderly”, 
characterized by the presence of a clod pattern 
in which compact nests with variable atypia. 
 
RCM for the examination of NMSC 
Skin cancer is the most commonly diagnosed 
cancer in the Caucasian population, with rapid 
further increasing incidence rates (Rubin, Chen 
and Ratner 2005, 2262–69). SCC and BCC are 
considered as NMSCs. The incidence ratio be-
tween those two NMSC types is approximately 
1:4, while in immunosuppressed patients this 
ratio is inverted (Ridky 2007, 484–501; Lomas, 
Leonardi-Bee and Bath-Hextall 2012, 1069–80). 
RCM criteria for NMSCs are summarized in 
Table II. 
 
 
 
 
 
 
Table 2. RCM criteria for the diagnosis of non-melanocytic 
skin cancer 
(NMSCs)
 
 
 
 
 
 
Confocal patterns and characteristics of 
BCC 
BCC is the most common skin cancer world-
wide, mainly affecting fair-skinned adults. BCC 
is a slow-growing tumor that rarely metastasiz-
es. It is one of the most studied skin cancers 
upon RCM, and this can be related to its high 
incidence. Clinically, BCC is characterized by 
pink to red-brown patches or papules, central 
erosion or ulceration with or without the pres-
ence of crusts, a pearly shine and a raised bor-
der with the presence of telangiectasias (Web-
ber et al. 2011, 179–85). 
Some differences in diagnostic accuracy have 
been evaluated in a recent study involving 54 
lesions of which 45 histologically proven BCCs. 
Castro et al. (Castro et al. 2015, 1164–69) hi-
ghlighted a high positive predictive value obtai-
ned with both RCM probes, while a higher ne-
gative predictive value was associated with the 
use of the traditional wide probe, probably be-
cause its broader field-of-view allows a more 
exhaustive search for BCC criteria. 
Several dermoscopic patterns were identified 
but they will be taken into account for BCC 
subtype classification that follows. On histo-
pathology, most BCC subtypes show aggregates 
of atypical basaloid cells with peripheral palisad-
ing of nuclei, stroma with fibroplasia, and fre-
quently clefting between tumor aggregates and 
stroma. 
González et al. firstly described five relevant 
criteria for the confocal diagnosis of BCC, 
which were later validated in a larger study 
(González and Tannous 2002, 869–74; Nori et 
al. 2004, 923–30). These criteria included: elon-
gated monomorphic nuclei, polarization of 
these nuclei along the same axis, a prominent 
inflammatory infiltrate, increased dermal vascu-
lature and pleomorphism of the overlying epi-
dermis. 
Later on, further descriptors were added, such 
as the presence of tumor islands and cords con-
sidered the RCM hallmark of the tumor. These 
structures were characterized by a bright outline 
and clearly defined shape, especially in the pres-
ence of pigmentation. 
However, they were usually clearly visible also 
in hypopigmented tumors, although less con-
trasted. 
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Dark silhouettes represented a different mor-
phologic presentation of BCC tumor islands, 
corresponding to hypopigmented tumor prolif-
eration visible as a dark, footprint-like shadow 
in a context of bright compact collagen (Figure 
2A, B) (Agero et al. 2006, 638–43; Segura et al. 
2007, 883–86; Scope, Mecca and Marghoob 
2009, 106–7; Braga et al. 2009, 230–41; Segura 
et al. 2009, 216–29; Ulrich et al. 2011, 190–95; 
Casari et al. 2011, 406859). 
Additionally, the presence of dendritic cells in 
BCC nests was correlated with melanocytes, 
typically found in pigmented BCCs where they 
appeared as long dendritic shaped cells en-
trapped inside the tumor islands (Segura et al. 
2007, 883–86). Along with melanocytes, the 
pigmentation upon RCM was related to the 
presence of inflammatory infiltrate showing up 
as bright spots or to ill-defined plump bright 
cells corresponding to melanin-rich mel-
anophages (Figure 2C, D). (Guitera et al. 2012, 
2386–94). 
Blood flow was typically altered in BCC and 
was described as an elongation of blood capil-
laries, which were increased in number and size. 
In a recently published large prospective study, 
Guitera et al. (Guitera et al. 2012, 2386–94) in-
troduced a new concept called “epidermal 
shadowing”, described as a large dark feature-
less area disrupting the epidermis due to en face 
clefting of the underlying tumor nests. 
 
RCM subtypes of BCC 
The identification of different subtypes of BCC 
is important in order to choice the most appro-
priate treatment and to determine surgical exci-
sion margin. 
BCC can be divided into 3 main subtypes based 
on the histopathologic growth pattern: nodular 
(nBCC), infiltrating (iBCC) and superficial 
(sBCC). Longo et al. (Longo et al. 2014, 716–
724.e1) presented a study to identify specific 
criteria to differentiate subtypes of BCC thanks 
to the retrospective analysis of 88 lesions, in-
cluding 44 sBCCs, 22 nBCCs, and 22 iBCCs. 
Firstly, different BCC subtypes were differenti-
ated dermoscopically being sBCC characterized 
by fine telangiectasias, multiple small erosions, 
and structures corresponding to dermoepider-
mal pigmentation. In contrast, the detection of 
ovoid nests, arborizing vessels and large ulcera-
tions were associated with nBCCs or iBCCs. 
iBCC has been reported to have a peculiar 
dermatoscopic pattern, consisting of shiny 
white-red structureless areas and arborizing 
vessels of a smaller caliber and less tendency to 
branch into finer capillaries compared to those 
seen in nBCC tumors (Lallas et al. 2014, 303–
11). Upon RCM, the presence of cords con-
nected to the epidermis was significantly associ-
ated with sBCC. nBCC was primarily typified 
by the presence of large tumors nests. 
Furthermore the presence of clefting was much 
more frequent in nBCC compared to sBCC and 
iBCCs. 
Finally, although increased vascularization was 
detected in all subtypes, the caliber of vessel 
was larger in nBCC compared to sBCC and 
iBCC. iBCC was characterized, upon RCM, by 
the presence of dark silhouettes and abundant 
bright compact collagen. 
Moreover, iBCC was the most common diag-
nosis in presence of dark silhouettes and in ab-
sence of small tumor islands, big tumor islands, 
and cords connected to the epidermis. Periph-
eral palisading was present in the majority of 
tumors of all subtypes, while inflammation was 
less frequently observed (Horn et al. 2008, 620–
25). 
A previous study (Peppelman et al. 2013, 255–
62) involved also micronodular (mnBCC) and 
mixed-type variants. 27 patients with 43 biop-
sied lesions with a histopathological diagnosis 
of BCC were included. Of these, 23 were 
sBCC, 11 nBCC, three mnBCC and six 
mixedtype BCC. 
Tumor nests with peripheral palisading, branch-
like structures, fibrotic septa and increase in 
vascular caliber were the main RCM features 
for nBCC and mnBCC. Then size, shape and 
location of the tumor nests allowed a differenti-
ation between nBCC and mnBCC. Solar elasto-
sis and the location of the tumor nests just be-
low or in connection with the basal cell layer 
characterize sBCC. Criteria for iBCC were not 
easily detectable in this study because 
mixedtype but not “pure” iBCC were included 
(Peppelman et al. 2013, 255–62). 
Another variant that should be mentioned is fi-
broepithelioma of Pinkus (FeP), representing 
an unusual form of basal cell carcinoma, which 
may clinically mimic a range of benign skin tu-
mors that are not routinely excised. 20 pub-
lished cases of FeP reported in the literature 
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were reviewed, suggesting that dermoscopy and 
RCM could help the clinical diagnosis and, con-
sequently, management of FeP (Reggiani et al. 
2013, 207–11). On characterhistopathology, 
FeP showed tumor islands and anastomosing 
strands of basaloid, often palisading cells, in-
cluded in a fibromatous stroma. Upon RCM, 
the analysis of 9 cases (6 nonpigmented and 3 
pigmented) revealed the presence of a “fenes-
trated pattern”, consisting of tumor islands or 
cords with palisading cells at the periphery, 
which outline hyporefractile ‘holes’ correspond-
ing to the fibrous stroma (Longo et al. 2012, 
556). 
 
 
 
Figure 2. Dermoscopic and confocal pictures of basal cell car-
cinomas (BBCs). A) dermoscopic image of invasive BCC, light-
ly pigmented. There are multiple ulcerations, fine multiple tel-
angiectasia and blue-grey dots; B) confocal image (square 
0.5x0.25) showing typical features enabling the diagnosis: dark 
silhouette (green star) and bright filaments corresponding to 
melanophages (red arrow) that create the light pigmentation 
visible dermoscopically; C)  dermoscopic image of nodular 
pigmented BCC: grey-blue ovoidal nest, leaf-like maple; D) 
confocal image of multiple tightly packed (violet stars) and nu-
merous melanophages (yellow arrows). The major number  of 
melanophages is related to the pigmentation more evident in 
this BBC (Guida et al. 2015, 547–63). 
 
Confocal patterns and characteristics of AK 
AKs represent the earliest stage in the devel-
opment of SCC and relevant biomarkers for in-
dividuals at risk for development of invasive 
SCC. 
The main risk factors are fair skin, intermittent 
or prolonged exposure to UV radiation, genetic 
predisposition, and immunosuppression (Ulrich 
et al. 2008, 610–19). Usually the diagnosis of 
AK is based on clinical examination, but biop-
sies are routinely performed in order to rule out 
invasive SCC or other skin diseases like poro-
keratoses, seborrheic keratoses, basal cell carci-
noma or Bowen’s disease. Dermoscopy has re-
cently been applied for the diagnosis of AK, the 
classic features include the presence pink-to-red 
“pseudonetwork” surrounding the hair follicles, 
scale, fine and linear 
vessels surrounding the hair follicles and kera-
totic plugs within the hair follicles (Horn et al. 
2008, 620–25). Histopathological features in-
cluded: proliferation of atypical keratinocytes 
AKs, starting at the basal cell layer, inducing an 
architectural disarray due to basal crowding of 
keratinocytes with different degrees of in-
volvement of epidermis. Mitoses and nuclear 
pleomorphism represented a common finding 
together with parakeratosis alternated with or-
thokeratosis at the follicle ostia in the stratum 
corneum, solar elastosis and inflammation in 
the dermis. 
Confocal laser microscopy could be useful in 
order to perform the correct diagnosis. First of 
all, keratinocytes in the stratum corneum ap-
peared detached from one another and are seen 
as highly refractive polygonal structures. More-
over, nuclear retention, corresponding to 
parakeratosis in histology, was visualized as 
dark round structures in the center of the cor-
neocytes. RCM images showed an atypical hon-
eycomb pattern (disruption of the characteristic 
honeycomb pattern) and cells with dark nuclei 
of irregular shapes and sizes (Figure 3A, B). 
Images of the superficial dermis showed differ-
ent degrees of solar elastosis, which is visual-
ized as bundles of lace-like collagen (Horn et al. 
2008, 620–25). 
 
Confocal grading of AKs 
Several options are nowadays available for the 
treatment of AKs. This means that specific pat-
terns corresponding to different grades and 
subtypes may aid to choose the most appropri-
ate treatment and in monitoring of the response 
to the therapy. Interestingly, preliminary confo-
cal microscopy data based on keratinocyte atyp-
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ia allowed the creation of a grading of AK. 
Grade 1 AK presented focal areas of atypical 
honeycombed pattern at the level of the stra-
tum spinosum, intermingled with areas of pre-
served, typical honeycombed pattern. In grade 
2 AK, the atypia of keratinocytes was more dif-
fuse, involving the stratum spinosum and gran-
ulosum. Keratinocytes presented a marked 
atypia, with different sizes and shapes of the 
cells. Grade 3 AK was characterized by a mark-
edly atypical honeycombed pattern with areas 
of partial disruption of the normal epidermal 
layers, defined as a disarranged pattern. Pleo-
morphic keratinocytes showed a wide variability 
in cellular size and shapes, and irregular inter-
cellular keratinocyte connections were detected 
(Zalaudek et al. 2014, 80–87). 
 
Confocal patterns and characteristics of 
SCC 
SCC is a common skin tumor derived from ep-
idermal keratinocytes. It typically presents as a 
red scaling plaque, with or without ulceration. 
SCC is complicated by its metastatic potential 
(Soter, Wilkinson and Fitzpatrick 1973, 296–
302). Dermoscopy features of SCC were dotted 
or glomerular vessels, when present, and a scaly 
surface that, when too wide, could impair the 
visualization of vessels (Zalaudek et al. 2004, 
1112–16). 
Histopathologically, crowded, enlarged, and 
pleomorphic nuclei, dykeratosis, and parakera-
tosis were typically found in SCCs (Ackerman 
and Mones 2006, 9–22). Bowen disease (BD) is 
SCC in situ that is histologically characterized 
by a proliferation of atypical pleomorphic 
keratinocytes throughout the epidermis. 
RCM features of keratinocytic atypia have been 
described in recent studies (Horn et al. 2008, 
620–25; Ulrich et al. 2008, 610–19; Rishpon et 
al. 2009, 766–72), but nowadays no detailed de-
scription of RCM features of BD exists in the 
literature. 
Ulrich et al. (Ulrich et al. 2012, 451–53) recently 
published a study of 10 BD. The most common 
confocal findings were disruption of the stra-
tum corneum, an atypical honeycomb pattern 
in the epidermis with a greater degree of archi-
tectural disorder and cellular atypia than in AK 
(Figure 3C, D), S-shaped blood vessels in the 
center of the dermal papillae, and two types of 
characteristic targetoid cells. The first type were 
large cells with a dark center, a bright rim, and a 
dark halo, and the second type were large cells 
with a bright centerand a dark halo. Cells are 
thought to correspond to the different degrees 
of dyskeratosis seen by conventional histology. 
Other features observed were parakeratosis, 
multinucleated cells, and solar elastosis. 
In 2009 Rishpon et al. (Rishpon et al. 2009, 
766–72) published a study of the confocal char-
acteristics of 38 clinically suspected SCC le-
sions. The features identified were an atypical 
honeycomb or disarranged pattern in the epi-
dermis (Figure 3E, F), rare round cells with nu-
clear atypia in the stratum spinosum and stra-
tum granulosum, and round blood vessels 
crossing the dermal papillae. 
RCM images of the stratum corneum typically 
revealed bright amorphous structures corre-
sponding to the presence of crusts on the tu-
mor surface and polygonal nucleated cells with 
a bright rim around a dark nucleus (parakerato-
sis). Hyperkeratosis and ulceration could impair 
the evaluation of the lesion. 
Currently, the diagnostic distinction between 
AK and SCC, especially when solely based on 
clinical aspects, may not always be easily. Ob-
taining biopsies is an invasive method and it is 
not always possible to do. Peppelman et al. 
(Peppelman et al. 2015, 1302–9) try to assess in 
vivo RCM features that are specific enough to 
make a distinction between AK and SCC using 
RCM as a non-invasive in vivo diagnostic me-
thod. They demonstrated that the presence of 
architectural disarray in the stratum granulosum 
in combination with architectural disarray in the 
spinous layer and/or tumor nest in the dermis 
were the main RCM features to distinguish SCC 
from AK. 
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Figure 3. Dermoscopic and confocal pictures of aktinic kerato-
sis (AKs) and squamous cell carcinoma (SCCs). A) Dermoscop-
ic image of AK with strawberry pattern; B) confocal image of 
the epidermis showing a light atypical honeycombed, with the 
presence of irregular keratinocytes for shape and size; C) der-
moscopic image of Bowel disease showing scales and glomeru-
lar vessels; D) confocal image showing mild irregular honey-
combed; E) dermoscopic image of invasive squamous cell car-
cinoma showing scales, erosion and atypical vessels; F) confocal 
image showing a severe atypical honeycombed typical of SCC 
(Guida et al. 2015, 547–63). 
 
From in vivo to ex vivo 
Advantages related to in vivo RCM consist of 
real-time observation, underlying different clin-
ical applications of RCM in the evaluation of 
melanocytic and non-melanocytic lesions, and 
in particular in the study of facial maculae and 
amelanotic/hypopigmented tumors and man-
agement of subclinical margins, recurrences, or 
monitoring noninvasive treatment of tumors 
(Castro et al. 2015, 1164–69; Fraga-Braghiroli et 
al. 2014, 933–42; Cinotti et al. 2014, 912–
918.e2; García-Hernández et al. 2013, 205256). 
In the last few years a new technique became 
available: ex vivo fluorescence confocal micros-
copy (FCM). FCM enables real-time imaging of 
skin morphology directly in freshly excised tis-
sue. For this reason, the application of interest 
is rapid detection of residual BCC in skin exci-
sions during Mohs surgery (Bennàssar et al. 
2014, 360–65) . 
FCM requires a contrast agent that is able to 
highlight nucleated cells; this means that with 
the use of this technique only a few fluores-
cence is collected from the dermis while one of 
limit of RCM is the reflectance coming from 
the dermis consisting of a strong bright scatter-
ing interference. 
Other perspectives are now available in this 
field considering that a new generation ex vivo 
confocal laser scanning microscopy (CLSM) 
device is now available. This tool enables the 
identification of different layers of the epider-
mis, differentiating keratinocytes from melano-
cytes and permitting the visualization in detail 
of skin appendages including hair follicle, seba-
ceous and sweat glands (Hartmann et al. 2016, 
376–87). 
 
Conclusions 
RCM is a developing technology that allows op-
tical sectioning of an area of skin without the 
nedd for physical sectioning: it is thus ideal for 
dermatologists examining detailed features of a 
skin lesion without troubling the patient for a 
biopsy specimen, for selection of the optimal 
site when an invasive biopsy is indicated, and 
for dermatological surgeons determining the 
margins of a lesion to be excised. The devel-
opment of advanced non-invasive diagnostic 
techniques allows tissue imaging in vivo, and 
recently also ex vivo, contributing to a more ac-
curate diagnosis of skin cancers. 
While histopathology remains the gold standard 
for the diagnosis of skin cancers, RCM is a piv-
otal  tool that provides clues for diagnosis of 
pigmented and non-pigmented lesions, flat or 
nodular. This technique enables non-invasive 
exploration of skin lesions, also in difficult-to-
explore sites, identifying clues of malignancy, 
monitoring efficacy of topical therapies, provid-
ing a support for surgical margins and recogniz-
ing different tumor subtypes. 
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Abstract 
COPD is often accompanied by other chronic diseases that are also associated with systemic inflammation, such 
as obesity, diabetes, and arteriosclerosis. Recent data indicate that nocturnal oxygen desaturation and coexisting 
metabolic syndrome are related to systemic inflammation in patients with COPD. Alveolar hypoxia and conse-
quent hypoxemia increase in prevalence as COPD severity increases. Chronic hypoxemia contributes to the de-
velopment of adverse sequelae of COPD, such as pulmonary hypertension, atherosclerosis, lung microbiome di-
versity and systemic inflammation. COPD is a heterogeneous disease with airway inflammation driven by bacte-
rial infections, few studies to date they examined microbiology or infection. The introduction of culture-
independent techniques for the microbiological analysis of respiratory samples confirmed that respiratory system 
hosts a large number of microorganisms, which include a wide range of bacteria. Regular exposure to tobacco 
smoke, lifestyle and food pattern can change the microbiome in healthy smokers and at-risk COPD patients, in-
creasing the presence of a limited number of genres that reach a high relative abundance, a pattern, which can be 
considered as a dysbiosis. We assume that in patients with COPD and concurrent obesity and lung dysbiosis at 
least three factors play a role in the systemic inflammatory syndrome. Recent data showed that changes in the 
lung microbiome are associated with numerous exacerbations of COPD and are involved in mediating inflamma-
tory responses of the host in some patients. Further research should elucidate the complex relationship between 
obstructive lung disease, obesity and lung microbiome diversity systemic inflammation accompanying these dif-
ferent conditions, and the causative role of systemic inflammation in obese COPD with nocturnal oxygen desat-
uration. 
 
Keywords: COPD, BPCO, microbiome. 
 
 
Introduction 
Chronic obstructive pulmonary disease 
(COPD) is a disease associated with chronic in-
flammation of the airways and lung parenchy-
ma. (Faner and Agustí 2017) Yet, COPD is a 
complex, multi-component, heterogeneous dis-
ease, whose clinical, functional presentation 
greatly varies from patient to patient despite 
similar degree of airflow limitation. (Faner and 
Agustí 2017; Burgel et al. 2017) The current 
classification of airways disorders is imprecise 
with an overlap of phenotypes (e.g. asthma, 
chronic bronchitis and emphysema), resulting 
in difficulties of differentiating the disorders 
from one another. 
The prevalence, distribution and inter-
relationships of the main clinical and functional 
manifestations of the disease in a large, well-
characterised and controlled population of pa-
tients are lacking. Comorbidities such as chron-
ic heart failure, cardiovascular disease, depres-
sion, diabetes, muscle wasting, weight loss, lung 
cancer, and osteoporosis can frequently be 
found in patients with COPD and are consid-
ered part of the commonly prevalent non-
pulmonary sequelae of the disease. (Barnes and 
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Celli 2009, 1165–85; Chatila et al. 2008, 549–
55) Sleep-disordered breathing and COPD are 
among the most common pulmonary diseases. 
Nevertheless, the pathological mechanisms and 
clinical manifestations of COPD are not re-
stricted only to pulmonary inflammation and 
airway remodelling. In contrast, over the last 
decade, the recognition of COPD as a systemic 
disease has developed. (Barnes and Celli 2009, 
1165–85) 
Low-grade systemic inflammation can be de-
fined as a two- to fourfold elevation in circulat-
ing levels of proinflammatory and anti-
inflammatory cytokines, naturally occurring cy-
tokine antagonists, acute phase proteins, as well 
as minor increases in counts of neutrophil and 
natural killer cells. (Brüünsgaard and Pedersen 
2003, 15–39) Systemic inflammation is consid-
ered a hallmark of COPD and one of the key 
mechanisms that may be responsible for the in-
creased rate of comorbidities, including cardio-
vascular complications, cachexia and muscle 
dysfunction, osteoporosis, anaemia, clinical de-
pression and anxiety in COPD (Sin and Man 
2003, 1514–19)  
The human microbiota consists of 10-100 bil-
lion symbiotic microbial cells hosted by each 
person, mainly bacteria in the lung; the human 
microbiome is made up of the genes that these 
cells host (Turnbaugh et al. 2007, 804–10). 
These cells are likely to influence genetic influ-
ences outcomes of pulmonary disease and mi-
crobiota composition through the modulation 
of the host's defense mechanisms. 
There are few studies on genetic modifiers of 
exacerbation risk in COPD (Erb-Downward et 
al. 2011, e16384). 
We assume that in patients with obese COPD 
and diabetes mellitus type II both genes and 
lifestyle are influenced. All this is known, but 
the genes in the human microbiome also may 
play an important role in the systemic inflam-
matory syndrome: the severity of pulmonary 
impairment, the degree of obesity-related adi-
pose tissue hypoxia, and the severity of system-
ic hypoxia due to reduced pulmonary functions. 
The gut bacteria synthesize vitamins and pro-
teins and help degrade toxins. Many genes in 
the human microbiome produces hormones, 
neurotransmitters, cytokines and molecules of 
inflammation, which are released into the sys-
temic circulation and affect health. 
Recent evidence demonstrated that the micro-
biome might affect in the COPD patients in-
cluding patients with obesity and diabetes type 
II (Eduard Monsó 2017, 251). Exposure to to-
bacco smoke modifies the lung microbiome in 
healthy smokers, first in the oropharynx, in-
creasing the presence of a limited number of 
bacteria that reach a high concentration in the 
lower respiratory tract, a pattern that can be 
considered pathological as a dysbiosis pulmo-
nary. In the COPD, the microbiome analyzes 
of the sputum samples have shown an im-
portant change in bacterial diversity, with a var-
iation in a restricted flora with an over-
representation of the Proteobacteria strand, 
which includes most of the bacteria considered 
to be pathogenic microorganisms, together with 
a decrease of the relative abundance of micro-
organisms’ part of the phylum Firmicute-s. Se-
verity of COPD also influences degree of oxy-
gen desaturation and obesity and lifestyle. Sev-
eral data suggest that the pulmonary microbi-
ome plays a fundamental role during the exac-
erbations of COPD and its role in the aetiology 
of the disease remains poorly understood. 
This brief review focuses on COPD and noc-
turnal hypoxaemia with obesity and lung mi-
crobiome and dysbiosis that can be the cause of 
systemic inflammation and vascular atheroscle-
rosis. 
 
Systemic and airway inflammation 
Several studies have found markers of systemic 
inflammation, such as high-sensitivity C-
reactive protein (hs-CRP), to be higher in blood 
of patients with COPD when compared with 
the blood values of subjects without COPD. 
(Pinto-Plata et al. 2006, 23–28; Leonardo M 
Fabbri and Rabe 2007, 797–99).  A question 
arises whether systemic inflammation is the re-
sult of a local inflammation spill-over to the 
systemic compartments or a systemic compo-
nent of COPD not necessarily related to the lo-
cal inflammatory processes in the lung. (L M 
Fabbri et al. 2008, 204–12; Broekhuizen et al. 
2006, 17–22) 
As a point of interest, it should be noted that 
systemic inflammation has failed, so far, to 
show substantial correlations with airway ob-
struction, (de Torres et al. 2006, 902–7; Watz et 
al. 2009, 1039–46) whereas a connection has 
been reported between local inflammatory pro-
Domenico Maurizio Toraldo, Francesco De Nuccio, Luana Conte, Michele De Benedetto 
39 
cesses and airway obstruction. (Peleman et al. 
1999, 839–43; Turato et al. 2002, 105–10; Bar-
aldo et al. 2004, 308–12) Markers of systemic 
inflammation have been shown to be elevated 
in blood of patients with COPD when com-
pared with control subjects without COPD. 
COPD is often accompanied by other chronic 
diseases that are also associated with systemic 
inflammation, such as chronic heart failure, di-
abetes, and arteriosclerosis. (Roy et al. 2009, 41) 
Alternatively, increased levels of inflammatory 
mediators in the blood of COPD patients may 
stem from extra pulmonary cells (circulating 
leukocytes, endothelium or muscle cells). A par-
ticular problem in COPD patients with marked 
alveolar wall destruction is intermittent and 
continuous hypoxia. Significant inverse correla-
tion between arterial oxygen tension (PaO2) and 
circulating tumor necrosis factor alpha (TNF-a) 
and soluble tumor necrosis factor receptor 
(sTNF-R) levels in patients with COPD has 
been reported. (Takabatake et al. 2000, 1179–
84) Similarly, a significant relationship between 
reduced oxygen delivery and TNF-levels in the 
peripheral circulation, highlighting the role of 
nocturnal hypoxia of the tissue was found (Yu 
et al. 1998, L818-26)  
It has been suggested that systemic inflamma-
tion may explain part of the heterogeneity of 
COPD phenotypes, such as loss of lean body 
mass and the higher prevalence of co morbid 
disorders such as coronary heart disease 
(CHD), depression and hypertension. Finally, 
this study reinforces the view that systemic in-
flammation is an important phenotypic feature 
of COPD (Eagan et al. 2010, 540–48). Future 
prospective studies should investigate whether 
these markers will give important prognostic 
information in relation to disease progression 
and severity in COPD.  
 
Sleep disturbance in COPD 
COPD alone can cause subjective and objective 
changes during sleep. When patients with either 
chronic bronchitis or emphysema were sur-
veyed across a broad range of symptoms, “sleep 
difficulties” were endorsed as occurring “almost 
always” or “always” in 43% of subjects (third 
most common, after dyspnoea and fatigue). 
(Kinsman et al. 1983, 755–61) More than just 
the diagnosis of COPD, the presence of COPD 
symptoms such as cough or sputum production 
or wheezing strongly correlated with difficulty 
in falling or staying asleep.(Klink, Dodge and 
Quan 1994, 151–54) Other investigations have 
objectively confirmed poor sleep quality, with 
decreased total sleep-time and decreased sleep 
efficiency. (Douglas et al. 1982, 840–44). A 
brief review of the normal changes in respira-
tion that occur with sleep onset and the various 
sleep stages is useful to understand the changes 
occurring during sleep in patients with COPD. 
In healthy subjects, minute ventilation drops 
from wakefulness to non-rapid-eye-movement 
(non-REM) sleep, and drops further during 
REM sleep (about 15%,compared to the awake 
value) (Douglas et al. 1982, 286–89). Most of 
the drop in minute ventilation is due to a de-
crease in tidal volume not fully compensated by 
a concomitant increase in respiratory rate. 
There is a blunted ventilatory response to hy-
poxia and hypercapnia, again with the greatest 
changes during REM sleep. (Douglas et al. 
1982, 758–62) Sleep-related hypoventilation has 
been demonstrated in COPD, particularly dur-
ing REM sleep, with associated oxygen desatu-
ration. (Hudgel et al. 1983, 669–77). 
 Nocturnal oxygen desaturation in COPD is 
likely to be the consequence of the combined 
effects of physiological hypoventilation during 
sleep. However, there is evidence that some pa-
tients with awake PaO2 levels in the mildly hy-
poxaemic range can also develop clinically sig-
nificant nocturnal oxygen desaturation, which 
may predispose to pulmonary hypertension. 
(Fletcher et al. 1987, 604–8)  
Finally, possible mechanisms responsible for 
this reduction include respiratory muscle hypo-
tonia, cephalic displacement of the diaphragm 
and a decrease in lung compliance. (Johnson 
and Remmers 1984, 1011–17). 
 
Sleep-related breathing disturbances: noc-
turnal oxygen desaturation and alveolar 
hypoventilation. 
Sleep-related hypoventilation has been demon-
strated in COPD, particularly during REM, 
with associated oxygen desaturation (Hudgel et 
al. 1983, 669–77) There is a close relationship 
between the awake arterial oxygen tension PaO2 
and nocturnal oxygen saturation SatO2 levels, 
(Connaughton et al. 1988, 341–44) although 
hypercapnia is associated with a more pro-
nounced nocturnal oxygen desaturation than 
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normocapnia for any given level of waking 
SatO2 .(Bradley et al. 1990, 308–12)  
Nocturnal hypoxemia has been defined as a 
SatO2 of ≤ 90% for at least 5 min with a Nadir 
SatO2 of ≤ 85%. Time in bed has been defined 
as the time from the start to the end of the re-
cording. The percentage of total recording time 
(TRT) has been defined as the time spent in 
bed -- sleep latency + intrasleep wakefulness. 
The TRT spent in bed with a SatO2≤ of 90% 
has been defined as the T90%. The minimal 
TRT required for a satisfactory analysis of noc-
turnal recordings was/has been 2 hours. COPD 
patients with a T90 ≥ of 30% and a Nadir SatO2 
of 85% have been defined as Desaturators (D) 
and the others as Non-Desaturators (ND). 
(Toraldo et al. 2005, 3828–37) In this study the 
authors, as revealed by cluster analysis, have 
shown that clinical parameter predictors when 
awake from nocturnal desaturation were differ-
ent. COPD D patients may be identified by a 
clinical pattern of variables T90, Mean Pressury 
Artery Pulmonary (MPAP), and PaCO2 values, 
rather than by T90 alone, with the latter two var-
iables being predictors of nocturnal desatura-
tion severity. This study has revealed the com-
plexity of the nocturnal desaturation that many 
clinical variables describe not only as respirato-
ry when awake. Alveolar hypoventilation prob-
ably accounts for most of the oxygen desatura-
tion. Becker and colleagues (Becker et al. 1999, 
112–18) measured minute ventilation during 
wakefulness, non-REM sleep, and REM sleep 
in normal subjects and patients with COPD. 
The greater drop in minute ventilation in sub-
jects with COPD may reflect increased depend-
ence on accessory muscles that become hypo-
tonic during sleep, particularly during REM 
sleep. 
An alternative explanation comes from the 
work by O’ Donoghue and colleagues 
(O’Donoghue et al. 2004, 663–73) who have 
found an even greater drop in minute ventila-
tion during non-REM sleep in hypercapnic 
COPD patients. 
 
 
 
 
Clinical impact of nocturnal oxygen desatu-
ration  
The exact prevalence of Pulmonary Hyperten-
sion (PH) in patients with COPD is unclear. 
(Naeije 2005, 20–22) PH is a complication of 
advanced COPD observed in patients who 
show severe longstanding hypoxaemia. Even if 
PH is generally mild to moderate in most 
COPD patients, it may markedly worsen during 
acute exacerbations, sleep and exercise and 
these acute increases in PH could facilitate the 
development of right heart failure. (RHF) The 
diagnosis of PH in COPD patients is difficult. 
The published studies differ not only in their 
definition but also for conditions under which 
PH has been reported (rest, exercise, and exac-
erbation). According the European Society 
Cardiology and European Respiratory Society 
(Galie et al. 2009, 1219–63) PH has been de-
fined as an increase in mean pulmonary arterial 
pressure PAP ≥ 25 mmHg at rest as assessed 
by right heart catheterisation. (RCH) The defi-
nition of PH on exercise as a Pulmonary Artery 
Pressure (PAP) ≥ 30 mmHg as assessed by 
RHC is not supported by published data and 
healthy individuals can reach much higher val-
ues. 
The incidence of PH in COPD patients has 
been evaluated by Kessler and colleagues. 
(Kessler et al. 2001, 219–24) The authors have 
performed a longitudinal study on 131 patients 
with COPD by performing serial RHC at base-
line and then at follow-up (mean follow-up was 
6.8 ± 2.9 years). All subjects have had normal 
mean PAP at rest (≤ 20 mm Hg). They have 
been divided into two groups based on pres-
ence or absence of elevated mean PAP with ex-
ercise (≥30 mm Hg) 25% of patients developed 
PH on follow up and was mild by hemodynam-
ic criteria (mean PAP 26.8 ± 6.6 mm Hg). Sub-
jects who showed elevated PH with exercise 
were more likely to exhibit resting mean PAP 
elevation upon follow up. The rate of progres-
sion was +0.4 mm Hg per year.  
Nocturnal oxygen desaturation seems to con-
tribute to the development of PH; even in the 
absence of significant awake hypoxemias. 
(Fletcher et al. 1989, 757–64) REM-associated 
falls in SatO2 are associated with increases in 
pulmonary artery pressure during sleep that can 
be reversed by supplemental oxygen, although 
most COPD patients with sustained pulmonary 
hypertension are also hypoxaemic during the 
daytime. Various arrhythmias are also reported 
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during episodes of nocturnal desaturation. 
(Douglas et al. 1982, 758–62) These conse-
quences might help to explain why nocturnal 
oxygen desaturation is a marker of increased 
mortality, and why COPD patients are reported 
to die more frequently at night than expected 
(W T McNicholas and Fitzgerald 1984, 878)  
Tissue hypoxia is another mechanism that can 
contribute to systemic inflammation in COPD. 
In a clinical study (Yu et al. 1998, L818-26) it 
has been shown that TNF-a and receptor levels 
were significantly higher in patients with 
COPD, but significantly correlated with the se-
verity of arterial hypoxaemia. These results sug-
gest that arterial hypoxaemia in COPD is asso-
ciated with activation of the TNF-a system in 
vivo. 
The systemic effects of inflammation may sig-
nificantly contribute not only to respiratory ab-
normalities, symptoms and functional impair-
ment (e.g. exercise intolerance) associated with 
COPD but also to its chronic marked changes 
of vasomotor and endothelial function as pul-
monary vascular disease (Mal 2007, 114–19) 
The nocturnal desaturation–reoxygenation se-
quence is a typical pattern coupled with the ma-
jority of respiratory events. This sequence, de-
fining intermittent hypoxia (IH), leads to oxida-
tive stress, with production of reactive oxygen 
species. (ROS) (Lavie 2003, 35–51) Hypoxia in-
duced pulmonary vasoconstriction is a protec-
tive response to keep ventilation-perfusion ratio 
optimum by shunting blood away from the hy-
poxemic areas. The traditional hypoxic model 
of PH is based on the hypothesis that chronic 
hypoxia initiates vascular remodelling leading to 
permanent changes in pulmonary vasculature. 
Studies performed in vitro elucidated the mech-
anisms underlying hypoxia driven vascular 
changes. Barbera et al., (Barberà et al. 1994, 
423–29) have evaluated COPD patients under-
going lung resection and demonstrated that 
vascular changes contribute to vascular remod-
elling and reputedly may have an effect on vas-
cular dynamics leading to PH. Nocturnal hy-
poxia may induce endothelial cells to release 
proliferate cytokine leading to cellular hyper-
trophy in the vessel wall and increase in extra 
cellular matrix. In conclusion, the nocturnal hy-
poxic insult occurring during sleep-disordered 
breathing may also contribute to chronic vascu-
lar remodelling; these mechanisms generate 
vascular endothelial damage and dysfunction 
increasing the risk of pulmonary hypertension 
in COPD. (Jyothula and Safdar 2009, 351–63) 
The review by Mc Nicholas shows how disease 
act through similar pathways to cause cardio-
vascular disease. (Walter T McNicholas 2009, 
692–700) Another intriguing possibility report-
ed in that study is that nocturnal desaturation in 
COPD may contribute to an increased inci-
dence of COPD exacerbations, which may ac-
celerate lung-function decline and be associated 
with greater mortality (Donaldson et al. 2002, 
847–52; Soler-Cataluña et al. 2005, 925–31).  
 
Interaction of COPD and Obesity in Sys-
temic Inflammation 
Recently, the concept of systemic inflammation 
as a consequence of spill over of inflammatory 
mediators from the lungs to the systemic com-
partment in COPD has been broadly discussed. 
(Chung and Adcock 2008, 1334–56; van Eeden 
and Sin 2008, 224–38; Kim, Rogers and Criner 
2008, 478–85) Several factors likely play a role 
in the genesis of systemic inflammation of 
COPD. These include tobacco use, airway in-
flammation, airflow obstruction, and hyperin-
flation. However, an independent role for tissue 
hypoxia seems likely. (Agusti 2005, 367–70)  
The transcription factor nuclear factor κB 
(NFκB) is the master regulator of cellular in-
flammatory responses, controlling expression 
of key inflammatory cytokines, such as tumor 
necrosis factor alpha (TNFα) and interleukin-8. 
(Garvey, Taylor and McNicholas 2009, 1195–
1205) Evidence of a role for hypoxia in the in-
duction of an NFκB response comes from in 
vitro, in vivo, and clinical studies. Intermittent 
hypoxia is classically seen in patients with ob-
structive sleep apnea syndrome, but may arise 
in COPD, particularly during sleep or exertion. 
In sustained hypoxia, NFκB appears to interact 
with HIF-1α to promote the expression of in-
flammatory genes, such as cyclo-oygenase II. 
(Fitzpatrick et al. 2011, 1091–96)  
Similarly, in a rodent model, 24 hours of sus-
tained hypoxia has been shown to up regulate 
NFκB activity in pulmonary and cardiac tissue. 
(Fitzpatrick et al. 2011, 1091–96) Meanwhile, 
clinical studies in COPD patients have found 
that circulating levels of TNFα and soluble 
TNF receptors increase as arterial oxygen ten-
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sion decreases. (Takabatake et al. 2000, 1179–
84).  
A number of studies have suggested it may re-
sult from “overspill” of inflammatory mediators 
from the lungs and pulmonary circulation, 
while others have failed to find any correlation 
between measurable pulmonary and circulating 
inflammatory mediators. (Sinden and Stockley 
2010, 930–36) One potentially important 
source of inflammation in 
obese patients with COPD with nocturnal hy-
poxaemia is white adipose tissue. In patients 
with COPD, obesity is characterized by an ab-
solute abundance of fat mass (FM), similar to 
other diseases associated with excessive adiposi-
ty. The prevalence of obesity is the highest 
among patients with milder forms of the dis-
ease (GOLD Stages 1 and 2), and the lowest in 
patients with the most severe lung function im-
pairment in Stage 4. (Sin and Man 2003, 1514–
19; M Poulain et al. 2008, 35–41)  Marquis et al. 
(Marquis et al., 226-32-4) demonstrated the 
presence of one or more components of the 
metabolic syndrome in almost 50% of COPD 
patients. High adiposity and fat tissue accumu-
lation impair pulmonary functions and exercise 
performance. (Magali Poulain et al. 2006, 1293–
99) Obesity and the presence of metabolic syn-
drome are related to increased insulin resistance 
in overweight and obese COPD patients (Bol-
ton et al. 2007, 121–26) 
The study by Bolton et al. (Bolton et al. 2007, 
121–26) suggests that insulin resistance is ag-
gravated by both, high BMI and increases in 
circulatory inflammatory mediators such as IL-6 
in these patients. Indeed, inflammatory media-
tors TNF-α, IL-6, and leptin were significantly 
higher while plasma adiponectin levels were re-
duced in the presence of excess weight in 
COPD patients. Chronic low-grade adipose tis-
sue inflammation in obesity may represent a 
specific response to relative hypoxia of adiposi-
ties. (Trayhurn and Wood 2004, 347–55) Sever-
al factors may contribute to cell hypoxia within 
adipose tissue in association with high adiposi-
ty: (a) blood flow per unit adipose tissue mass is 
reduced in obese humans resulting in decreased 
blood supply to the tissue; (b) large adipocytes 
are further from the vasculature than the nor-
mal diffusion distance for O2. 
Adipocyte tissue hypoxia has detrimental ef-
fects on cell metabolism and function, as evi-
denced by studies in 
vitro and animal models. Studies in vitro have 
shown that hypoxia results in enhanced TNF-α 
production, increased expression of PAI-1, and 
reduced adiponectin and peroxisome prolifera-
tors-activated receptor gamma (PPARγ) expres-
sion (Chen et al. 2006, 549–56; Hosogai et al. 
2007, 901–11)  
On the other hand, however, obesity-related 
hypoxia evokes local inflammatory response 
within adipose tissue per se, and systemic hy-
poxia likely contributes to the adipose tissue in-
flammation. If so, elevated circulating levels of 
inflammation-related proteins may reflect also 
spill over from the adipose tissue to the system-
ic circulation in patients with COPD and con-
current obesity. 
Even in the absence of COPD, obesity is asso-
ciated with small airways dysfunction, decreased 
chest wall 
compliance, V/Q mismatch, and increased pe-
ripheral oxygen consumption, all potentially 
leading to relative hypoxemia. Risk of sleep-
disordered breathing and consequent nocturnal 
hypoxemia correlates with the degree of obesi-
ty, (Young et al. 1993, 1230–35) and in extreme 
cases, morbid obesity can lead to profound al-
veolar hypoventilation, with chronic hypercap-
nic respiratory failure. Dysregulated ventilatory 
control is another factor contributing 
to the occurrence and persistence of hypoxemia 
in COPD patients (Kessler et al. 2001, 369–76) 
 
The lung microbiome diversity plays an 
important role in COPD exacerbations: mi-
crobiota study.  
The introduction of bacterial culture techniques 
for the microbiological analysis of respiratory 
samples confirmed that the respiratory system 
hosts many microorganisms (microbiome), in-
cluding bacteria, viruses and broad-spectrum 
fungi. Studies using culture-independent tech-
niques such as PCR amplification and sequenc-
ing the ribosomal RNA 16 (R) 16S gene have 
investigated a distinct bacterial community in 
the airways of COPD patients compared to 
healthy subjects and suggest that changes in the 
microbiota pulmonary disease could be associ-
ated with inflammation and airway exacerba-
tions and disease progression. However, most 
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studies on pulmonary microbiome involved 
small groups of subjects with limited longitudi-
nal sampling and modest clinical information. 
(Huang et al. 2014, 2813–23; Zakharkina et al. 
2013, e68302) Acute exacerbations of COPD 
are a rapid worsening of symptoms in which 
the role of bacteria is one of the major etiologi-
cal factors (E Monsó et al. 1995, 1316–20; Soler 
et al. 1998, 1498–1505) Then, the dynamics of 
bacterial prevalence during exacerbations and 
its role in the pathogenesis of the disease re-
main poorly known. 
Most of the studies on COPD lung microbiota 
have used sputum as a representative sample of 
the respiratory system, thanks to its easy recov-
ery and standardized processing procedure. In 
the respiratory microbiome analysis, it should 
be considered that the sputum comes mainly 
from the proximal airways, which possess a flo-
ra that showed clear differences with the mi-
crobial pattern found in the distal bronchi and 
in the alveolar space (Cabrera-Rubio et al. 2012, 
3562–68; Pragman et al. 2012, e47305) which is 
studied on the contrary through bronchial bi-
opsies, and / or bronchoalveolar lavage, while 
in COPD the microbial diversity model has 
been shown to be different between the micro-
biological examination of the sputum (upper 
airways) and the microbiological examination 
coming from the distal samples (lower airways), 
a finding that confirms the differences between 
proximal and distal bronchial flora. Microbial 
cultures have correlated respiratory symptoms 
in COPD exacerbations to the detection of new 
strains in bronchial flora (Sethi and Murphy 
2008, 2355–65) but this change in bacterial flo-
ra does not occur in all disease exacerbations. 
The microbiome analyzes show a high relative 
abundance of specific bacterial genera, which 
can be considered etiological, for most exacer-
bations, while the remaining bacterial flora does 
not change significantly (Millares et al. 2014, 
1101–11; Dy and Sethi 2016, 196–202) Fur-
thermore, exacerbations are not only related to 
the prevalence of isolated bacterial genes, but 
are also associated with changes in the compo-
sition of the microbiome as a whole, but not 
always identifiable through the measurement of 
the relative infectious microbial load 
(Molyneaux et al. 2013, 1224–31). 
An increase in the relative abundance of a spe-
cific bacterial genus can be considered causal in 
a COPD, but often subsequently, it is not con-
firmed by culture results. Several studies have 
showed that bacteria prevalent in the analysis of 
bronchial secretions may not be confirmed by 
the examination of the culture, while the mi-
croorganisms of the culture grow easily from 
the sample analysed, although their relative 
abundance has not changed compared to the 
previous stability (Sethi et al. 2006, 991–98; Mil-
lares et al. 2014, 1101–11) The microbiome 
analyses demonstrated a different pattern in in-
fectious and eosinophilic exacerbations, with a 
clear prevalence of the Firmicutes genus in eo-
sinophilic exacerbation, in the face of the pre-
dominance of Proteobacteria in exacerbations 
that show positive cultures for bacteria (Wang 
et al. 2016, 1082–92) This finding supports the 
clinical characterization of exacerbations in 
these two categories (bacterial and eosino-
philic), considering that their microbial pattern 
is completely different and will require different 
therapeutic approaches. The interaction be-
tween different bacterial microorganisms can be 
addressed through analysis of microbiomes and 
in a clinical model; an important role of viral 
infection on the composition of the microbi-
ome in patients with COPD has been demon-
strated. Induced rhinovirus infection showed 
no effect on the microbiome of bronchial se-
cretions in healthy subjects, but was associated 
with an increase in the prevalence of Proteo-
bacteria in patients with COPD (Molyneaux et 
al. 2013, 1224–31). This observation confirms 
the role of rhinovirus infection as an inducer of 
changes in respiratory bacterial flora with 
prevalence of Proteobacteria and justifies the 
virus-virus detection of coinfections in one 
quarter of COPD exacerbations (Papi et al. 
2006, 1114–21) The presence of bacterial diver-
sity, often related to a relative increase in the 
bacterium Proteobacteria, is associated with 
greater severity in COPD and may be one of 
the determinants influencing the progression of 
exacerbations and pulmonary disease, as previ-
ously demonstrated in idiopathic pulmonary fi-
brosis (Molyneaux and Maher 2013, 376–81).  
 
Conclusion 
The hypoxic insult occurring during sleep-
disordered breathing to COPD varies from one 
condition to another. However, there are com-
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mon cardiovascular and metabolic morbidities 
in these various conditions 
There are major differences with continuous 
hypoxia, suggesting specific pathways originat-
ing from the occurrence of oxidative stress and 
inflammatory cascade activation. Nocturnal hy-
poxaemia during sleep and diurnal hypoxaemia 
seems to be the major factor in morbidity. Also, 
the hypothesis that adipose tissue may contrib-
ute to the overall systemic inflammatory pheno-
type in patients with early stages COPD with 
obesity or relative abundant fat mass is novel 
(Millares et al. 2014, 1101–11). The recent role 
played by the lung microbiota in systemic in-
flammation is been presented. The microbial 
composition of the lung bacterial flora in 
COPD has been studied through microbiome 
analysis, the involvement of respiratory flora in 
the pathogenesis of the disease, it is practically 
unknow. In conclusion, recent data showed that 
lung microbiota is dynamic in which rapid 
changes appeared to be associated with exacer-
bations and disease progression events indica-
tive of specific exacerbation phenotypes.  
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Abstract 
Diabetes mellitus is a chronic disease that can affect any organ or system of the body. Diabetes mellitus has long 
been considered as one of the factors causing Candida vaginitis and has the potential to affect sexual function in 
women. Infectious diseases are more prevalent in individuals with Diabetes Mellitus. One of the problems of 
women with diabetes is resistant vulvovaginitis, which is related to some factors such as neuropathy, hypergly-
cemia, allergy and atopy. Women’s interest in, satisfaction with, and ability to participate in sexual activity may be 
influenced globally by the effect of diabetes on their overall health, physical and mental functioning, and inter-
personal relationships. Additionally, sexual function may be adversely affected by diabetes medications or other 
health interventions. This manuscript is a comprehensive review on vulvovaginal infections in diabetic patients. 
 
Keywords: Diabetes, vulvovaginal infections, vaginitis, Candidiasis, recurrent infections, genital yeast infections, 
genital mycotic infections, fungal infections, sexual dysfunction. 
 
 
 
Introduction 
Diabetes is a chronic disease, which occurs 
when the pancreas does not produce enough 
insulin, or when the body cannot effectively use 
the produced insulin. This leads to an increased 
concentration of glucose in the blood (hyper-
glycemia). Type 1 diabetes (previously known as 
insulin-dependent or childhood-onset diabetes) 
is characterized by a lack of insulin production. 
Type 2 diabetes (formerly called non-insulin-
dependent or adult-onset diabetes) is caused by 
the body’s ineffective use of insulin. It often re-
sults from excess body weight and physical in-
activity. Gestational diabetes is hyperglycemia 
that is first recognized during pregnancy. 346 
million people worldwide have diabetes. In 
2004, an estimated 3.4 million people died from 
consequences of high blood sugar. WHO pro-
jects that diabetes death will double between 
2005 and 2030 (WHO, 2011). Diabetes is char-
acterized by elevated morbidity and mortality. 
Diabetes represents an economic burden, with 
serious implications for the public health sys-
tems. Accordingly, the need of effective tools 
aimed to the prevention of its chronic compli-
cations is urgent and cannot be deferred 
(Lavery et al. 1998, 157–62). 
Besides the classical complications of the dis-
ease, DM has been associated with reduced re-
sponse of T cells, neutrophil function, and dis-
orders of humoral immunity (Geerlings and 
Hoepelman 1999, 259–65; Peleg et al. 2007, 3–
13). Consequently, DM increases the suscepti-
bility to infections, both the most common 
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ones as well as those that almost always affect 
only people with DM (e.g. rhino cerebral mu-
cormycosis) (Peleg et al. 2007, 3–13). Such in-
fections, in addition to the repercussions asso-
ciated with its infectivity, may trigger DM com-
plications such as hypoglycemia and ketoacido-
sis. Infectious diseases are more prevalent in 
individuals with DM. The main pathogenic 
mechanisms are hyperglycemic environment in-
creasing the virulence of some pathogens; lower 
production of interleukins in response to infec-
tion; reduced chemotaxis and phagocytic activi-
ty, immobilization of polymorphonuclear leu-
kocytes; glycosuria, gastrointestinal and urinary 
dysmotility. Some infections usually affect only 
diabetic persons, such as malignant external oti-
tis, rhino cerebral mucormycosis, and gangre-
nous cholecystitis. In addition to being poten-
tially more serious, infectious diseases in DM 
may result in metabolic complications such as 
hypoglycemia, ketoacidosis, and coma (Casquei-
ro, Casqueiro and Alves 2012, S27-36). 
Diabetes causes short-term and long-term 
complications and usually its long-term compli-
cations develop 5 to 10 years after the diagnosis 
of both types of the disease (Smeltzer, S. Bare 
2000). One of its long-term complications is a 
neurological complication that includes a disor-
der of sexual functioning. The autonomic sys-
tem causes a wide range of disorders in all sys-
tems of our body including the urinary-sexual 
system. It can be said that sexual dysfunction 
develops frequently as a complication among 
these patients (Chu and Edelman 2002, 60–66). 
Neuropathy, vascular impairment, and psycho-
logical complications are involved in decreased 
libido, low arousal, decreased vaginal lubrica-
tion, orgasmic dysfunction, and dyspareunia 
among women with diabetes.  
Moreover, one of the problems of women with 
diabetes is resistant vulvovaginitis, which is re-
lated to some factors such as hyperglycemia, al-
lergy and atopy. One of the most common 
pathogens associated with this condition is 
Candida spp. (Malazy et al. 2007, 399–404). 
 
Material and methods 
The following sources were searched for the 
original study: The Cochrane Library, MED-
LINE, EMBASE and the Cochrane sexually 
transmitted disease (2000-2014). Selection crite-
ria were: 
 Randomized controlled trials pub-
lished in any language; 
 Women (age 16 years or over) with 
uncomplicated vulvovaginal candidiasis; 
 The vulvovaginal candidiasis to be 
made mycological (i.e. positive culture 
and/ or microscopy for yeast); 
 The primary outcome measure was 
clinical cure. 
 
Data collections and analysis 
Two reviewers screened titles and abstract of 
the electronic search results and full text of po-
tentially relevant papers. Two reviewers per-
formed independent duplicate abstraction. Dis-
agreements regarding trial inclusion or data ab-
straction were resolved by discussion between 
the reviewers. Odds ratios were pooled using 
the fixed effects models (except for two anal-
yses when random effects models were used 
because of potentially important heterogeneity).   
  
Normal vaginal flora 
Anatomically, the female genital tract is consti-
tuted by a succession of cavities that communi-
cate with exterior through the vulvar cleft. Vag-
inal microflora undoubtedly presents one of the 
most of important defense mechanism for the 
reproductive function, maintaining the envi-
ronment healthy and preventing the prolifera-
tion of microorganisms, stranger to the vagina 
(Linhares, Giraldo and Baracat, 370–74). The 
different components of the vaginal ecosystem 
have been observed on the microscope and af-
terwards, identified through culture-specific 
techniques (Larsen and Monif 2001, e69-77). 
However, more recently, identification tech-
niques for independent bacteria in the means of 
culture have revolutionized the study of micro-
organisms. The use of amplification, cloning 
techniques and subsequent analysis of sequenc-
es of bacterial genes (genes that codify for bac-
terial rRNA 16S) in sample of vaginal fluid have 
allowed the identification of the majority of 
common species of Lactobacilli and other mi-
croorganisms.  Thus, these techniques have 
demonstrated that Lactobacilli spp. do not al-
ways correspond to the dominant species in the 
vagina of healthy women. Besides that, vagina 
environment inhabitants until then unknown 
have been identified (Zhou et al. 2004, 2565–
73; Fredricks, Fiedler and Marrazzo 2005, 
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1899–1911). Although vaginal bacterial species 
of healthy women have been initially identified 
as Lactobacillus acidophilus, this knowledge 
represents a simplification, since in women 
whose flora is dominated by Lactobacillus, the 
more frequently detected species through genic 
amplification are L. crispatus and L. inners 
(Zhou et al. 2004, 2565–73; Fredricks, Fiedler 
and Marrazzo 2005, 1899–1911) or L. crispatus 
and L.gasseri (Verhelst et al. 2004, 16). Other 
species as. L. jensenii, L. gallinarum and L. 
vaginalis have also been identified in some 
women. A study on vaginal flora accomplished 
in three continents using method of bacterial 
genes analysis showed that dominant species 
were the same in each region: L. crispatus, 
L.gasseri and L. jensenii (Pavlova et al. 2002, 
451–59) Besides, that, the same study observed 
that, in some women, the normal ecosystem 
was maintained in the absence of Lactobacillus; 
in one woman Atopobium vaginae was identi-
fied as the dominant microorganism in the flora 
and, in two other woman, the bacteria Ato-
pobium, Megasphaera and Leptotrichia were all 
lactic acidic producers similarly Lactobacillus. 
(Zhou et al. 2004, 2565–73; Rodriguez Jovita et 
al. 1999, 1573–76). Therefore, other bacteria, 
not only by Lactobacillus, may keep the vagi-
na’s acidic environment, known as an important 
defense mechanism against the proliferation of 
pathogens. Characteristic of vaginal microbial 
flora is the presence of biofilms. Biofilms are 
formed by colonies of microorganisms that ad-
here among themselves and cover a solid sur-
face. Biofilms have already been identified in 
the surface of vaginal cells, more known in 
women with bacterial vaginosis, where species 
of Gardnerella vaginalis and Atopobium pre-
dominate (Swidsinski et al. 2005, 1013–23). The 
occurrence of species of Lactobacilli producers 
of hydrogen peroxide, which possess a defense 
activity against pathogens, seems to be less fre-
quent in African-American women (Antonio, 
Hawes and Hillier 1999, 1950–56). Studies sug-
gest that for bacterial vaginosis-free women, the 
vaginal pH is higher in African-American wom-
en (Stevens-Simon et al., 168–72) they suggest 
also that such differences are valid only for 
women whose vaginal microflora is not domi-
nated by Lactobacillus (Royce et al. 1999, 96–
102; Fiscella and Klebanoff 2004, 747–50). The 
composition of the vaginal flora is not constant, 
suffering variations in response to exogenous 
and endogenous factors (Priestley et al. 1997, 
23–28; David A. Eschenbach et al. 2001, 913–
18). These factors include the different phase of 
menstrual cycle, gestation, use of contracep-
tives, frequency of sexual intercourse, use of 
showers or deodorant products, use of antibiot-
ics or other medications with immune-
suppressive properties. Alterations occurring in 
the vaginal environment may increase or de-
crease the selective advantages for specific mi-
croorganisms. For example, studies have related 
the loss of Lactobacillus to sexual intercourse 
or the use of antibiotics (Schwebke, Richey and 
Weiss2 1999, 1632–36). 
Nevertheless, another study has demonstrated 
that the sexual act without the use of condom 
had o effects upon the Lactobacillus, but in-
crease the level of Escherichia coli and faculta-
tive gram-negative bacilli (D A Eschenbach et 
al. 2000, 901–7). 
During the menstrual cycle, hormonal varia-
tions interfere in the substrate of different mi-
croorganisms; these variations lead to change s 
in vaginal ph. Yet the levels of Lactobacillus 
remain constant throughout the cycle, the non-
Lactobacillus bacteria increase during the pro-
liferative phase and the concentrations of Can-
dida albicans become higher in the pre-
menstrual period (Witkin 1987, 34–37). 
Candida albicans is tolerant to the acidic envi-
ronment, fund in approximately 10% to 20% of 
women in reproductive age. The concentration 
of the microorganism is low, so the woman car-
rier is asymptomatic. Nevertheless, event lead-
ing to a state of local immune-suppression, 
such as sexual intercourse or local induction of 
allergic response, create adequate conditions for 
the proliferation of the microorganism and fa-
cilitate the transformation into the shape of hy-
phae, more invasive (Witkin 1987, 34–37) Fur-
thermore, Candida albicans appears to be able 
to raise the pH from 4 to > 7, resulting in auto 
induction of yeast-hyphal transition as demon-
strated in study of Vylkova et al. (Vylkova et al. 
2011, e00055-11). When the hyphal form is 
predominant, it results in the emergence of 
symptomatic vaginitis.  The production of lactic 
acid may be essential for the maintenance of 
healthy ecosystem, regardless of the bacterial 
species that may be present in the vagina. Re-
sulting acidic pH prevents the excessive prolif-
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eration of potentially pathogenic microorgan-
isms. It is important yet to remember that the 
Lactobacillus dominance is beneficial for the 
host, since some species produce hydrogen 
peroxide and bacteriocins, factors that inhibit 
the proliferation of the other microorganisms. 
In addition to the protective effects of the en-
dogenous vaginal flora, the protection against 
potentially pathogenic microorganisms is done 
also by the local components of innate immuni-
ty and acquired immunity. The epithelial cells 
layer of the vagina constitutes the initial contact 
point between microorganism and host’s genital 
tract. These epithelial cells possess toll-like re-
ceptors (TRL) in their surface and, therefore, 
are important components of innate vaginal 
immunity (Quayle, 61–79). Vaginal cells also re-
lease molecules with potent non-specific anti-
microbial activity. A class of these molecules, 
known as defensives, include positively charged 
peptides that rapidly bind negatively charged 
bacterial surface (Linhares, Giraldo and Baracat, 
370–74). 
 
Vulvovaginal diseases in diabetic woman 
A. Candidiasis 
One of the problems of women with diabetes is 
resistant vulvovaginitis, which is related to 
some factors such as hyperglycemia, allergy and 
atopy. One of the most common pathogens as-
sociated with this condition is Candida albicans. 
Thus, most physicians begin antifungal therapy 
at the patient’s first visit, even without para-
clinical findings. The prevalence of Candida 
spp. vulvovaginitis and factors that cause dia-
betic women to be prone to this infection were 
analyzed in a study of B.  160 women with dia-
betes mellitus (mean age, 51 - 10 years; age 
range, 16–75 years) were enrolled. Ninety-four 
percent of the patients had type II diabetes 
mellitus and the remaining had type I. Seventy-
five percent of the participants received oral 
hypoglycemic drugs, 15% received insulin and 
the rest were given combination therapy (tab-
lets plus insulin). The mean duration of diabetes 
mellitus in these patients was 9 - 6 years (range, 
0.08–36 years). The subjects were mainly 
homemakers (92.5%), and the rest were work-
ers. There was sexual activity in 86.3% of the 
cases, and none in 13.7% of the cases. Twenty-
one percent of our patients had a history of al-
lergy (rhinitis, sinusitis or atopic dermatitis) 
(Malazy et al. 2007, 399–404). 
In this study, all subjects were asked to fill out 
prepared questionnaires on demographic char-
acteristics, type of diabetes mellitus, duration 
and type of its treatment, past history of allergy, 
methods of washing underwear (detergents, 
heat, etc.) and voiding after sexual intercourse, 
and vaginal examination was done for each par-
ticipant by a general physician. In addition, 
concentrations of fasting blood sugar, 2-hour 
postprandial blood sugar and glycosylated he-
moglobin were measured, and cultures of vagi-
nal discharge were performed.  
71% (113/160) of the women had clinical vagi-
nitis (fungal or bacterial), and 12.5% (20/160) 
had Candida vaginitis. Microscopic findings for 
Candida were positive in 12 patients, of whom 
two had Candida vaginitis. 
The prevalence of Candida vaginitis together 
with positive culture was 2.6% (4/160). After 
including the 10 patients with positive Candida 
culture together with other clinical vaginitis, the 
overall prevalence of Candida vaginitis based 
on positive culture was 8.8% (14/160). There 
was a significant statistical difference between 
either mean fasting blood sugar or educational 
level and infectious vaginal culture. There were 
no significant associations between positive cul-
ture and age, glycosylated hemoglobin, history 
of allergy, genital hygiene, and occupation, kind 
of treatment, and type or duration of diabetes. 
One of the complications experienced by dia-
betic patients is resistant and recurrent infec-
tions. Some believe that malfunctioning leuco-
cytes, especially in the presence of uncontrolled 
blood glucose levels (Wilson and Reeves 1986, 
478–84; Wilson, Tomlinson and Reeves, 37–40; 
Raith, Csató and Dobozy 1983, 557–64) cause 
the condition. Among the infections, vaginal 
inflammation or infection, especially fungal 
vaginitis, is more disturbing in severe hypergly-
cemic conditions (Foster 1998, 2060–81) The 
most common etiologic agent for this infection 
is the yeast (fungal) organism, usually Candida 
(Curry 1994, 689–700; Eckert et al. 1998, 757–
65; Smith 1998, 557–58; Moraes 1998, 165–69; 
Bornstein et al. 2001, 105–11). In a study by 
Eckert et al (Eckert et al. 1998, 757–65) Can-
dida was detected in 28% of cultures of vaginal 
discharge obtained during the initial visit of 
women with vaginitis; the remaining cultures 
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were for other organisms, such as sexually 
transmitted organisms. In this case, the authors 
believed that the causes of recurrent disease or 
resistance to therapy were false diagnosis of the 
pathogenic organism and unsuitable treatment 
(Eckert et al. 1998, 757–65). On the other hand, 
even when correct diagnosis had been made, 
background factors, especially those associated 
with systemic diseases like diabetes mellitus, 
caused treatment failure (Foster 1998, 2060–81; 
Smith 1998, 557–58). Researchers have stressed 
the importance of personal hygiene, history of 
infections and allergic diseases of the upper 
respiratory tract (nose, sinuses), and atopic 
dermatitis in the subject or the relative(s) in re-
current diseases or resistance to therapy 
(Moraes 1998, 165–69). 
In this study, the authors stated that there are 
no significant statistical differences or relation-
ship between positive vaginal Candida culture 
and type of diabetes mellitus, age, and glycosyl-
ated hemoglobin, duration of diabetes mellitus, 
history of allergy, occupation, genital hygiene 
and vaginal intercourse. Diabetes mellitus has 
long been considered as one of the factors 
causing Candida vaginitis (J D Sobel 1993, 153–
65; Scudamore, Tooley and Allcorn 1992, 260–
63). Different studies showed that symptomatic 
infection is more common in women with dia-
betes than in the normal population (J D Sobel 
1993, 153–65; Scudamore, Tooley and Allcorn 
1992, 260–63). The prevalence ranged from 
around 7% to more than 50% (Bohannon 1998, 
451–56; Sonck and Somersalo 1963, 846–52; 
Davis 1969, 40–45) and most of which was at-
tributed to Candida albicans (Duerr et al. 1997, 
252–56; Otero et al. 1998, 526–30). 
Two specialized clinics reported that the preva-
lence of vulvovaginitis caused by non-albicans 
species is around 10–20%, with Candida glabra-
ta dominating (Jack D. Sobel 1997, 1896–1903; 
Spinillo et al. 1992, 343–47). Sobel et al (J D 
Sobel et al. 1998, 203–11) stated that the prob-
able causes of higher non-albicans species: the 
short duration of use for oral or local anti-
Candida regimens; widespread use of over-the-
counter antifungal agents, most of which are 
used incorrectly or inadequately; and the pro-
longed use of antifungal compounds for the 
prevention of recurrent vulvovaginitis, which 
further intensifies the problem. 
The control of blood glucose levels and a suita-
ble antifungal therapy play an important role in 
controlling vaginal Candida spp. infection in di-
abetic women (Bohannon 1998, 451–56). In a 
study of 241 diabetic women, a significant sta-
tistical relationship existed between overall 
prevalence of vaginal infections (bacterial and 
fungal) and mean blood glucose level. In addi-
tion, it was suggested that glucose levels be 
maintained below 200 mg/dL to avoid dehy-
dration, caloric loss and glycosuria and to re-
duce the risk of infection. The authors also 
found a significant statistical difference between 
mean fasting blood sugar and infectious culture 
of vaginal discharge (p = 0.016). It did not find 
a significant statistical difference between gly-
cosylated hemoglobin and infectious vaginitis, 
because acute infections such as vaginitis often 
occur during the hyperglycemic state, but glyco-
sylated hemoglobin reflects the mean blood 
glucose level over the previous 3 months. 
Similar to the study by Mas Martin (R Goswami 
et al. 2000, 162–66) B also found that most of 
the patients with positive vaginal Candida cul-
ture (64%) were older than 45 years. Regarding 
the high prevalence of Candida vaginitis in re-
productive ages (Spinillo et al. 1992, 343–47; 
Deepti Goswami et al. 2006, 111–17) and our 
lack of knowledge about the prevalence of this 
condition in non-diabetic women with similar 
age groups (16–75 years), it is suggested that 
further evaluation be conducted to determine 
the cause. In any case, the incidence of symp-
tomatic infection 
is high among reproductive ages (18–44 years) 
(de Leon et al. 2002, 1). Although it was report-
ed that allergic rhinitis and recurrent Candida 
vaginitis were present concurrently in 70% of 
patients (Moraes 1998, 165–69) we did not find 
any relationship between Candida or non-
Candida vaginitis and history of allergy (sinusi-
tis, rhinitis or atopic dermatitis). According to 
our results, there was significant statistical dif-
ference between educational level and infec-
tious or positive vaginal Candida culture. 
Other factors involved in the pathogenesis of 
Candida vulvovaginitis include lifestyle factors. 
Although vulvovaginal candidiasis is more fre-
quent among sexually active women (during the 
second decade of life) (de Leon et al. 2002, 1) it 
is not considered as a sexually transmitted dis-
ease (Jack D. Sobel 1997, 1896–1903) Candida 
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accounts for 20–50% of the normal vaginal flo-
ra of asymptomatic healthy women (Geiger, 
Foxman and Sobel 1995, 304–7) and Candida 
vaginitis can even occur in single women. Natu-
rally, Candida is transmitted through vaginal 
sexual intercourse, as well as other modes of 
sexual contact. 
There is controversy about the frequency of 
sexual intercourse as a risk factor of vaginitis. 
However, some studies showed that oral sex 
increases the incidence of vulvovaginal candidi-
asis and that vaginal intercourse alone cannot 
change the Candida colonization rates in the 
vagina (Malazy et al. 2007, 399–404). 
Yeast development can be stimulated by glu-
cose and even be promoted to change to a 
more virulent stage. Pregnancy and ⁄ or diabetes 
increase(s) the adherence of C. albicans to vagi-
nal epithelial cells in vitro (Grigoriou et al. 
2006, 121–25). 
Women with type I diabetes had higher Can-
dida colonization rates than those with type II, 
even after adjusting for age, behavioral factors 
and HbA1c.10 Whether this is due to the diabe-
tes type or reflects the different distributions of 
Candida species by age or both remains unclear. 
With the oxidative killing ability of neutrophils 
hindered, diabetics may not be able to clear 
pathogens as efficiently as non-diabetics may. 
Hyperglycemic individuals may have increased 
risk for Candida colonization as their secretions 
contain glucose, which can serve as nutrients 
for Candida species. A fucose (6-deoxy-
galactose) vaginal epithelial cell receptor that 
aids in adhesion of Candida to vaginal epithelial 
cells was reported.30 Fucose acts as one form 
of the receptor site for Candida adhesion; 
therefore, increased Candida colonization may 
be proportional to the glucose level. However, 
glycaemia does not fully explain the observed 
increased risk of Candida colonization. Grigo-
riou et al (Malazy et al. 2007, 399–404) found 
an increased prevalence of vaginal candidiasis in 
diabetic patients compared with non-diabetic 
patients. Likewise, C. albicans was isolated sig-
nificantly more in diabetic patients than non-C. 
Albicans species (Yildirim, Kilic and Kalkanci 
2011, e463-7).  
Large proportion of vulvovaginal candidiasis 
(VVC) in diabetes is due to non–albicans Can-
dida species such as C. glabrata and C. tropical-
is. Observational studies indicate that diabetic 
patients with C. glabrata VVC respond poorly 
to azole drugs. It is evaluated the response to 
oral fluconazole and boric acidic vaginal sup-
positories in diabetic patients with VVC. 
112 consecutive diabetic patients with VVC 
were block randomized to receive either single-
dose oral 150-mg fluconazole or boric acidic 
vaginal suppositories (600 mg/day for 14 days). 
The primary efficacy outcome was the myco-
logical cure in patients with C. glabrata VVC in 
the two treatment arms. The secondary out-
comes were the mycological cure in C. albicans 
VVC, overall mycological cure irrespective of 
the type of Candida species, frequencies of 
yeast on direct microscopy, and clinical symp-
toms and signs of VVC on the 15th day of 
treatment. Intention-to treat (ITT; n = 111) and 
per protocol (PP; n = 99) analyses were per-
formed. 
C. glabrata was isolated in 68 (61.3%) and C. 
albicans in 32 (28.8%) of 111 subjects. Patients 
with C. glabrata VVC showed higher mycologi-
cal cure with boric acidic compared with flu-
conazole in the ITT (21 of 33, 63.6% vs. 10 of 
35, 28.6%; P = 0.01) and PP analyses (21 of 29, 
72.4% vs. 10 of 30, 33.3%; P = 0.01). The sec-
ondary efficacy outcomes were not significantly 
different in the two treatment arms in the ITT 
and PP analyses. 
Diabetic women with C. glabrata VVC show 
higher mycological cure with boric acidic vagi-
nal suppositories given for 14 days in compari-
son with single-dose oral 150-mg fluconazole. 
The 59.9% prevalence of C. glabrata infection 
observed in the current study confirms the 
findings of our earlier studies that non-albicans 
VVC is frequent in diabetic women (R 
Goswami et al. 2000, 162–66; Deepti Goswami 
et al. 2006, 111–17). De Leon et al (de Leon et 
al. 2002, 1) observed the 54% vaginal carriage 
rate of C. glabrata in type 2 diabetes. The com-
parable frequency of clinical symptoms and 
signs between diabetic women with C. glabrata 
or C. albicans infection is similar to that report-
ed by Geiger et al (Geiger, Foxman and Sobel 
1995, 304–7) in nondiabetic women. 
Increased prevalence of C. glabrata infection in 
diabetic women has clinical relevance because 
poor therapeutic response and innate resistance 
to azoles has been reported for C. glabrata 
VVC in nondiabetic women (Vermitsky and 
Edlind 2004, 3773–81) Similar information is 
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lacking in diabetic subjects, as they are often 
excluded in antifungal efficacy studies (Deepti 
Goswami et al. 2006, 111–17) Poor mycological 
cure in diabetic women with C. glabrata VVC 
to single-dose oral 150-mg fluconazole, ob-
served in the current study, is in accordance 
with our earlier case-control study (Deepti 
Goswami et al. 2006, 111–17). In the current 
study, the higher mycological cure (72.4%) to 
boric acidic therapy in diabetics with C. glabrata 
VVC is similar to that reported in nondiabetic 
individuals.   
Boric acidic or boracic [B (OH) 3] is a weak 
acidic, and its mode of antifungal action is not 
clear. Shiohara and Tasker (15) proposed that 
its acidic properties lead to disruption of the 
fungal cell wall. The cause of increased C. gla-
brata isolation in diabetic women is not clear 
but may involve frequent use of antifungal 
drugs leading to its reduced susceptibility to az-
oles (Ruhnke 2006, 495–504) and consequent 
polarization/homing in diabetic women. Feng 
et al (Feng et al. 2005, 445–50) reported lesser 
susceptibility of C. glabrata in comparison with 
Albicans to β-defensins, natural cationic antimi-
crobial/antifungal peptides expressed in human 
epithelia. In diabetic milieu, β-defensins expres-
sion is reduced (Froy et al. 2007, 796–802). Re-
duced expression of defensins in association 
with resistance of C. glabrata to fungicidal ac-
tivity of drugs like fluconazole may also explain 
the high prevalence of C. glabrata VVC in dia-
betic women. Boric acidic therapy could be 
considered as the frontline therapy for treating 
VVC in diabetic women because it is effective 
against both C. albicans and C. glabrata com-
pared with fluconazole, which is effective 
against C. albicans only (Ray et al. 2007, 312–
17). 
Sertaconazole nitrate is a new topical broad-
spectrum antifungal that was developed to pro-
vide an additional agent for the treatment of 
superficial cutaneous and mucosal infections. 
Sertaconazole has been tested in vitro against 
clinical and laboratory isolates of the most 
common fungi present in superficial tinea and 
Candida infections. Sertaconazole is effective 
against a broad spectrum of organisms that 
cause superficial cutaneous fungal infections. 
Clinical trials with Sertaconazole nitrate cream 
2% show efficacy in the treatment of superficial 
cutaneous fungal infections (Zsolt I. 2002, 29-
32). In European clinical studies of other der-
matomycoses caused by Candida spp., 
Sertaconazole was shown to be superior to oth-
er azoles and terbinafine. 
Sertaconazole nitrate has been tested with a va-
riety of in vitro methods, all of which show 
fungistatic activity against dermatophytes and 
fungicidal and fungistatic activity against yeasts 
(Carrillo-Muñoz et al. 2003, 248–51). 
In a similar study, Day (Grossman and Day 
2005, P128) showed that over a 48-h exposure 
period, approximately 38% of the applied dose, 
or 800 Ag, penetrated the skin. These results 
are considerably higher than the concentrations 
(MICs) required in susceptibility studies to 
eradicate fungal growth in vitro. Thus, a short 
course of treatment with Sertaconazole for 4 
weeks will give ratios of Cmax/MIC N1000 for 
dermatophytes and Candida. This level of ex-
posure should be sufficient to obtain successful 
mycological cure rates of the major dermato-
phytes and yeas that cause superficial fungal in-
fections; however, at present, there is insuffi-
cient data relating clinical outcome to drug ex-
posure and MIC to allow us to assign a predic-
tive value to these parameters. In immunocom-
petent patients, the majority of uncomplicated, 
superficial mycoses are yeast and tinea infec-
tions, caused mainly by Candida spp. and der-
matophytes, respectively (Pfaller and Sutton 
2006, 147–52). 
The most common vulvovaginal symptom es-
pecially during candidiasis include irritation, 
burning, erythema and sometimes dyspareunia 
(Lewis et al. 2010, 1598–1607). In particular 
itching is reported as the more discomfort 
symptom (Nowosielski and Skrzypulec-Plinta 
2011, 2532–45). 
 
B. Sexual / Libido diseases 
Diabetic women often deal with low sexual de-
sire, orgasmic dysfunction, dyspareunia, and 
sexual aversion along with decreased lubrication 
often related to neuropathy.  
Nerve problems can occur in every organ sys-
tem, including the digestive tract, heart, and sex 
organs. 
About 60 to 70 percent of people with diabetes 
have some form of neuropathy. People with di-
abetes 
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can develop nerve problems at any time, but 
risk rises with age and longer duration of diabe-
tes. The 
highest rates of neuropathy are among people 
who have had diabetes for at least 25 years. 
Hyperglycemia and oxidative stress also con-
tribute to the abnormal glycation of nerve cell 
proteins and the inappropriate activation of 
protein kinase C, resulting in further nerve dys-
function and ischemia.  
However, more recent large epidemiological 
studies conducted on women in the United 
States, Brazil, and Australia did not find a sig-
nificant relationship between diabetes, desire, 
arousal, or orgasm. In diabetic women, hyper-
tension or the use of hypertensive drugs seem 
to be associated with orgasm and lubrication 
dysfunction as well as decreased sexual interest. 
Stress urinary incontinence is negatively associ-
ated with all aspects of women’s sexual dys-
function (sexual interest, desire, arousal, lubri-
cation, and orgasm), and is positively correlated 
with dyspareunia and vaginismus (Lewis et al. 
2010, 1598–1607). 
Sexual function was examined in a cross-
sectional cohort of ethnically diverse women 
aged 40 to 80 years using self-administered 
questionnaires. Multivariable regression models 
compared self-reported sexual desire, frequency 
of sexual activity, overall sexual satisfaction, and 
specific sexual problems (difficulty with lubrica-
tion, arousal, orgasm, or pain) among insulin-
treated diabetic, noninsulin-treated diabetic and 
nondiabetic women. Additional models as-
sessed relationships between diabetic end-organ 
complications (heart disease, stroke, renal dys-
function, and peripheral neuropathy) and sexual 
function. 
Among the 2,270 participants, mean SD age 
was 55 ± 9.2 years, 1,006 (44.4%) were non-
Latina white, 486 (21.4%) had diabetes, and 139 
(6.1%) were taking insulin. Compared to 19.3% 
of non-diabetic women, 34.9% of insulin-
treated diabetic women (adjusted OR [95%CI] 
=2.04[1.32–3.15] and 26.0% of non-insulin-
treated diabetic women (adjusted OR [95%CI] 
=1.42[1.03–1.94]) reported low overall sexual 
satisfaction. Among sexually active women, in-
sulin-treated diabetic women were more likely 
to report problems with lubrication (OR 
[95%CI] =2.37[1.35–4.16]) and orgasm (OR 
[95%CI] =1.80[1.01–3.20]) than nondiabetic 
women. Among all diabetic women, end-organ 
complications such as heart disease, stroke, re-
nal dysfunction, and peripheral neuropathy 
were associated with decreased sexual function 
in at least one domain. Compared to nondiabet-
ic women, diabetic women are more likely to 
report low overall sexual satisfaction. Insulin-
treated diabetic women also appear at higher 
risk for problems such as difficulty with lubrica-
tion and orgasm. Prevention of end-organ 
complications may be important in preserving 
sexual activity and function in diabetic women. 
For the purposes of analysis, participants were 
categorized into one of three-diabetes status 
groups based on whether they had diabetes, 
and, if so, whether they were using insulin: (1) 
insulin-treated diabetic women, (2) non-insulin-
treated diabetic women, and (3) non-diabetic 
women. These categories were chosen a priori 
based on the recognition that insulin use is a 
widely recognized indicator of diabetes severity 
and represents a higher level of disease man-
agement burden that can interfere with day-to-
day functioning and quality of life. 
Differences in the demographic and clinical 
characteristics of participants in these three cat-
egories were examined using chi-square tests 
for categorical variables and analysis of covari-
ance for continuous variables. Next, it is de-
scribed the distribution of less than monthly 
sexual activity, less than moderate sexual desire, 
and less than moderate sexual satisfaction 
among women in each diabetes status category. 
Among women reporting at least some sexual 
activity in the past 3 months, the prevalence of 
specific sexual problems such as low or very 
low arousal, at least moderate difficulty with lu-
brication, at least moderate difficulty with or-
gasm, or at least moderate pain with vaginal in-
tercourse were also examined among women in 
each diabetes status category. Differences in the 
distribution of these sexual function outcomes 
among women in different diabetes status cate-
gories were examined using chi-square tests. 
Multivariable logistic regression models com-
pared sexual function outcomes among: (1) in-
sulin-treated diabetic versus nondiabetic wom-
en, and (2) noninsulin-treated diabetic versus 
nondiabetic women, adjusting for a core set of 
other factors with potential to influence sexual 
function (i.e., age, race/ethnicity, mari-
tal/relationship status, menopausal status, his-
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tory of sex with men or women, body mass in-
dex, hysterectomy and oophorectomy, selective 
serotonin reuptake inhibitor [SSRI] use, and es-
trogen use.) While models examining frequency 
of sexual activity, desire, and satisfaction in-
cluded all women, models examining specific 
sexual problems were confined to sexually ac-
tive women, and additionally controlled for fre-
quency of sexual activity. 
Sexual activity, desire, and satisfaction out-
comes were examined in all diabetic partici-
pants, while specific problems with lubrication, 
arousal, orgasm, or pain were examined in sex-
ually active diabetic women only.  
Of the 2,270 participants, 139 (6.1%) were insu-
lin-treated diabetic, 347 (15.3%) were noninsu-
lin-treated diabetic, and 1,784 (78.6%) were 
non-diabetic women. Mean (± SD) age was 55 
(± 9.2) years, 1,006 (44.4%) were non-Latina 
white, 443 (19.5%) were African-American, 401 
(17.7%) were Latina, 401 (17.7%) were Asian, 
and 18 (0.8%) were Native American. Overall, 
63.7% of participants reported some sexual ac-
tivity in the past 3 months. Of the 807 women 
who reported no sexual activity in the past 3 
months, 271 (33.6%) indicated that lack of a 
partner and 224 (27.7%) indicated that partner 
health problems contributed to their sexual in-
activity. 
Insulin-treated diabetic women were less likely 
to report at least monthly sexual activity com-
pared to either non-insulin-treated diabetic 
women or non-diabetic women. Insulin-treated 
diabetic women were also more likely to report 
low sexual desire and satisfaction compared to 
non-insulin-treated diabetic women or non-
diabetic women (Nowosielski and Skrzypulec-
Plinta 2011, 2532–45). 
Among sexually active participants, problems 
with lubrication were also more common in in-
sulin-treated diabetic women compared to non-
diabetic women (Carati et al. 2013, 2668–74). 
Among sexually active women, insulin-treated 
diabetic women were also more than twice as 
likely to report difficulty with lubrication and 
80% more likely to report difficulty-achieving 
orgasm compared to non-diabetic women, after 
adjusting for the same demographic and clinical 
factors. When asked if their physical health lim-
ited their sexual activity, insulin-treated diabetic 
women were more likely than non-diabetic 
women to report that their health limited their 
sexual activity “quite a bit” or “extremely,” in 
multivariable analysis (OR[95%CI] = 
2.29[1.49–3.51]). However, non-insulin-treated 
diabetic women were not substantially more 
likely than non-diabetic women to feel that 
their health limited their sexual activity (OR 
[95% CI] = 1.29 [0.92–1.78]). 
Diabetic women with peripheral neuropathy 
were also more likely to report less than month-
ly sexual activity, lower sexual desire, and limi-
tation of sexual activity by physical health, 
compared to those without neuropathy. Among 
sexually active diabetic women, no significant 
associations between specific diabetic end-
organ complications and sexual problems such 
as difficulty with arousal, lubrication, orgasm, 
or pain with intercourse were observed in ad-
justed models. There were also no significant 
associations between number of years since di-
abetes diagnosis and sexual function, after ad-
justment for end-organ complications (P > 0.05 
for all). 
In this cohort of ethnically diverse middle-aged 
and older women, diabetic and non-diabetic 
women reported similar levels of sexual desire 
and frequency of sexual activity, after adjust-
ment for other demographic and clinical fac-
tors. However, both insulin-treated and non-
insulin-treated diabetic women were significant-
ly more likely to report low overall sexual satis-
faction compared to non-diabetic women, and 
problems with lubrication and orgasm were 
more common among insulin-treated diabetic 
women compared to nondiabetic women. 
These findings suggest that while many diabetic 
women are interested and engaged in sexual ac-
tivity, diabetes is associated with a markedly de-
creased sexual quality of life in women, either 
through complications of the disease itself or 
through utilization of treatments. 
This study underlines the importance of distin-
guishing between different aspects of female 
sexual function when evaluating the burden of 
this disease. Based on this research, diabetes 
and its complications appear to have a much 
greater impact on sexual problems such as lu-
brication and orgasm as opposed to sexual de-
sire or subjective arousal. Furthermore, our 
study indicates that the adverse effects of diabe-
tes on sexual function may be concentrated in 
women taking insulin, an apparently high-risk 
group for developing sexual problems. 
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Diabetic women who were less motivated or 
interested in checking and controlling their 
blood sugars may have placed more priority on 
sexual activity and/or function in their daily 
lives, resulting in higher reports of sexual satis-
faction. Alternatively, diabetic women with 
worse glycemic control may have had lower ex-
pectations about sexual activity in the setting of 
their poorly controlled disease, with the para-
doxical result that they retained a stronger sub-
jective sense of sexual satisfaction in spite of 
experiencing the same sexual difficulties. Dif-
ferences in impulse control and other unmeas-
ured personality factors could also have influ-
enced both glycemic control and sexual satis-
faction in diabetic participants. 
Based on this research, clinicians may want to 
consider actively assessing for sexual problems 
in diabetic women, particularly those taking in-
sulin, and counsel diabetic women that preven-
tion of end-organ complications may be im-
portant in preserving their sexual function 
(Copeland et al. 2012, 331–40). 
In Jordanian’s study women were grouped into 
a diabetic married group (n = 613) and a nondi-
abetic married group (n = 524). The age of dia-
betic women ranged from 23 to 68 years (mean 
± SD 46 ± 11 years), and the age of nondiabet-
ic women ranged from 22 to 70 (51 ± 10 years). 
The prevalence of FSD in diabetic women 50 
years of age or older was significantly higher 
compared with that in nondiabetic women. De-
sire, arousal, lubrication, and orgasm were more 
significantly affected in older diabetic women, 
whereas in younger women a significant differ-
ence was only found in desire. Multivariate 
analysis showed that glycemic control, type of 
diabetes, smoking, hypertension, dyslipidemia, 
and peripheral and autonomic neuropathy did 
not have a significant effect on FSD. On the 
other hand, longer duration of diabetes, older 
age, higher BMI, and the presence of coronary 
artery disease, nephropathy, and retinopathy 
had significant detrimental effects on female 
sexual function. This study shows that diabetic 
women in Jordan have more FSD than nondi-
abetic women. The prevalence of FSD in our 
study is in agreement with the global prevalence 
(Erol et al. 2002, 55–62) Neurovascular pro-
cesses that mediate genital vasocongestion are 
impaired in diabetes (Meston and Frohlich 
2001, 603–9) In this study, vaginal dryness was 
found significantly more often-in diabetic 
women than in nondiabetic women. Orgasmic 
dysfunction was more prevalent in older diabet-
ic women in comparison with their nondiabetic 
counterparts. Kolodny reported a higher fre-
quency of orgasmic dysfunction in diabetic 
women than in hospitalized women for various 
reasons (Enzlin et al. 2002, 672–77). 
However, diabetic women were less satisfied 
with their sexual life. This is in agreement with 
the findings of Enzlin et al (Abu Ali et al. 2008, 
1580–81).  
Neuropathy, vascular impairment, and psycho-
logical complaints have been implicated in the 
pathogenesis of decreased libido, low arousabil-
ity, decreased vaginal lubrication, orgasmic dys-
function, and dyspareunia among diabetic 
women. A cross-sectional study was conducted 
on 500 women who were recruited from a dia-
betes center, based on questionnaires complet-
ed by them. Data regarding demographic fea-
tures, physical complications, and sexual disor-
ders were obtained. Medical records of patients 
were used to obtain body mass index (BMI) 
and details of complications. Mean age of par-
ticipants, duration of diabetes, and BMI was 
48.8 ± 0.4, 8.9 ± 0.32 years, and 28.9 ± 0.23, 
respectively. Prevalence of sexual dysfunction 
was 32.3%. Low sexual desire was seen in 
81.8%, disorders of arousal in 78.3%, of or-
gasm in 47.5%, and 35.1% had disorder in reso-
lution area. There was no significant relation-
ship between some factors such as age, dura-
tion of diabetes, BMI, and frequency of sexual 
dysfunction. Frequency of diabetic complica-
tions demonstrated a significant effect on the 
prevalence of sexual dysfunction. Sexual prob-
lems are frequent among diabetic women and 
deserve more attention in clinical practice and 
researches.  
In a research conducted by Amini et al 
(Omidvar et al. 2013, 321–24) in Isfahan in 
2001, a low sexual desire, lack of sexual satisfac-
tion, low vaginal lubrication, and orgasmic dys-
function have been recognized as sexual prob-
lems among women. For every patient with di-
abetes who refers with a reduction in sexual de-
sire, first other reasons (hormonal reasons and 
so on) should be ruled out, and then neuro-
pathic; therefore, the genital organ should be 
examined, and the levels of testosterone, pro-
lactin, thyrotropin, and estrogen should be 
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checked. Sexual dysfunction among women 
with diabetes includes vaginal dryness, a low 
sense of perinea, a lack of orgasm, and so on. 
The average age of the subjects, duration of 
married life, number of children, duration of 
diabetes, and body mass index (BMI) were 48.8 
± 0.04 years, 29.6 ± 0.5 years, 4.2 ± 0.1, 8.9 ± 
0.3 years, and 28.9 ± 0.2, respectively. The re-
sults show a significant frequency of sexual dys-
function in different sexual areas. Majority 
(95%) of the subjects were suffering from type 
2 diabetes; 26.3% of them mentioned a severe 
pain during sexual intercourse. In this study, 
there was no association between age, diabetes 
duration, and BMI with frequency of sexual 
dysfunction, although there was a significant 
association between age and dysfunction in de-
sire (P = 0.02), sexual satisfaction (P = 0.01), 
and pain during intercourse (P = 0.004). It is 
found a significant statistical association be-
tween the number of complications due to dia-
betes and frequency of sexual dysfunction (P = 
0.01). Overall, sexual dysfunction among wom-
en with diabetes was 32.3%. Nearly 82% of 
them were afflicted in the area of dysfunction 
in sexual desire, 78.3% had problems of arous-
al, 47.5% experienced dysfunction in orgasm, 
and 35.1% in the area of resolution. In all, 
45.5% were not satisfied with sexual function-
ing. 39.4% experienced pain during intercourse, 
and 36.1% had disorders in vaginal lubrication. 
Previous reports have shown an increase in the 
prevalence of sexual dysfunction among wom-
en with type 1 diabetes (Omidvar et al. 2013, 
321–24). 
 
Conclusion 
Diabetic women with end-organ complications 
such as peripheral neuropathy, renal dysfunc-
tion, stroke and heart disease were more likely 
to report decreased sexual activity or lower sex-
ual satisfaction than diabetic women without 
these complications. 
Several studies suggest the presence of sexual 
dysfunction among those who suffer from type 
two diabetes (Omidvar et al. 2013, 321–24; Bul-
trini et al. 2004, 337–40). These disorders in-
clude disorders of desire, lubrication, satisfac-
tion, orgasm, and dyspareunia. The etiology of 
sexual dysfunction in patients with diabetes 
needs more attention because patients with dia-
betes are at risk for vascular and psychological 
complications. Therefore, they have a higher 
risk for developing sexual dysfunction (Fatemi 
and Taghavi 2009, 38–39). 
These findings suggest that diabetic end-organ 
complications may play an important role in 
decreasing women’s sexual quality of life, and 
that raise the possibility that prevention of dia-
betic complications may be helpful in prevent-
ing sexual dysfunction in women with diabetes. 
 
The steps to be taken are clear: campaigns 
aimed at  
(1) Prevention of type 2 diabetes 
(2) Screening for early diabetic disease 
(3) Increasing patient awareness of vulvovaginal 
disease 
(4) Using medications of proven strategy and 
finally  
(5) Researching and trialing of new therapies.  
 
The ultimate challenge is to get action from 
primary health care to all higher levels; from the 
individual patient, to those at risk, in various 
health jurisdictions, in all countries despite 
varying economic circumstances and priorities. 
The problem is a global one and yet requires 
action at a local level; prevention, screening, 
and treatment strategies; education, including 
increasing awareness both in diabetic patients 
and those at risk of developing diabetes; and 
health priorities of governments. Basic research 
and clinical trials searching for a new under-
standing and therapies must be supported. It is 
time for strategies that prevent diabetes and its 
sequelae. It is time for programs for health care 
workers to diagnose and treat people with dia-
betic vulvovaginal disease, starting from basic 
hygiene that should be practiced with specific 
product, with specific active addressed to im-
prove moisturisation, lubrication of the intimate 
area and able to exert a soothing action in case 
of irritability and itching. 
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Abstract 
In the Italian language the phoneme-to-grapheme mapping is fairly regular so that children are able to master 
very early reading and spelling skills. However, persisting phonological spelling deficits, were recently described 
in a sub-group of Italian dyslexic children with language delay.  
The study describes spelling and reading deficits of an Italian child suffering from phonological dyslexia and dys-
graphia. As a comparison, a case of surface dyslexia and dysgraphia was reported. Quantitative and error analysis 
were performed on reading and spelling performance. Additionally the locus of the phonological deficit was ex-
amined by means of tasks requiring doubled consonants processing. Results showed a parallelism between the 
reading and the spelling impairments in both children. Phonological dyslexia and dysgraphia was characterized by 
worse pseudoword than word processing; lexicalizations in reading and a high rate of minimal distance misspell-
ings. Concomitant deficits in phoneme manipulation and representation were disclosed. The surface profile was 
characterized by impaired performance on tasks with pseudo-homophones and stress errors in reading, and con-
comitant phonological plausible misspellings. 
 
Keywords: phonological dyslexia, phonological dysgraphia, consistent orthography, doubled consonants 
 
 
Introduction 
Developmental reading and spelling disorders 
are among the most common learning impair-
ment (4-5% of the population, Consensus Con-
ference ISS, 2011), with severe school conse-
quences (Snowling, 1991). Over the past two 
decades, the understanding of these disturb-
ances has grown thanks to cognitive models de-
scribing the normal processing of written lan-
guage.  
The two route model, originally formulated to 
describe reading (Coltheart, Patterson & Mar-
shall, 1980; Patterson, Marshall & Coltheart, 
1985) and later adapted for spelling (Beauvois 
& Dérouesné, 1981; Baxter & Warrington, 
1985; Harris & Coltheart, 1986; Patterson, 
1986), assume the existence of at least two pro-
cedure: a lexical procedure, along which words 
are processed as a whole (direct access) and a 
sub-lexical one, based on orthographic-to-
phonological conversion rules in reading (and 
phonological-to-orthographic conversion rules 
in spelling) that exploits the systematic corre-
spondences between phoneme-to-grapheme 
and vice versa. The sub-lexical spelling proce-
dure is furthermore characterized by an acous-
tic-to-phonological conversion process that 
preventively segments and identifies the phono-
logical string to be converted (Patterson, 1986). 
Accordingly to this approach, studies on devel-
opmental dyslexia and dysgraphia described 
two main forms: a phonological and a surface 
disorder. Some children are selectively impaired 
in using the grapheme-to-phoneme conversion 
rules. Accordingly, they are impaired in reading 
novel words and pseudowords. This disturb-
ance is generally called phonological dyslexia 
(e.g.,Temple & Marshall,1983). Other children 
make appropriate use of orthographic-to-
phonological conversion rules and show a se-
lective deficit in lexical access, with impaired 
reading of irregular words (e.g., yacht). Such a 
deficit is generally called surface dyslexia (e.g. 
Castles & Coltheart, 1993). 
Similarly, developmental spelling deficits have 
been fractionated into phonological 
Developmental phonological dyslexia and dysgraphia in a regular orthography: a case study  
68 
(e.g.,Campbell & Butterwoth, 1985; Snowling, 
Stackhouse & Rack, 1986, Temple, 1986) and 
surface dysgraphia (e.g.,Temple, 1985; 1986). In 
phonological dysgraphia, correct spelling is 
possible for over-learned words, but not for 
less frequent or novel words and for 
pseudowords. In surface dysgraphia, there is an 
impaired spelling of irregular words and homo-
phones (e.g. diar can be transcribed as either 
“dear” or “deer”). In both cases the correct 
transcription cannot be immediately deduced by 
applying the conversion rules. Errors are, for 
the most, phonologically plausible. 
The distinction between phonological and sur-
face disorders was developed on data from 
English and French, two language with quite 
irregular orthography. Generalization of this 
model (and of the predicted disorders) to lan-
guage with more shallow orthographies such as 
Italian requires same considerations and a clos-
er look at Italian orthography.  
In Italian in the oral-to-written direction, the 
almost unique unpredictable condition is the 
site of word stress in three-syllable (or longer) 
words. However, stimuli allowing to test the 
lexical processing may be generated through 
pseudo-homophone contrasts. Italian dyslexic 
children are impaired in tasks with these stimuli, 
such as comprehension of sentence with pseu-
do-homophone contrasts (i.e. “l’ago” (the nee-
dle) or “lago”(lake), suggesting non-proficient 
use of the lexical procedure (Job, Sartori, Mas-
terton, & Coltheart, 1983; Zoccolotti, De Luca, 
Di Pace, Judica, Orlandi, & Spinelli, 1999). 
Moreover, Italian dyslexic children have a selec-
tive deficit in judging the orthographic correct-
ness of phonologically plausible pseudowords 
(e.g., the stimulus ” *quore”1, that is homo-
phonic to the correct word ”cuore”, [kwore] 
(heart)). This difficulty is indicative of a preva-
lent reliance on a phonological procedure and a 
scarce use of the lexical one in performing the 
task (Marinelli, Angelelli, Notarnicola & Luz-
zatti, 2009; Angelelli, Marinelli & Zoccolotti, 
2010). Moreover, different approaches such as 
eye movement recording and vocal reaction 
times have also been successfully used to study 
the reading processes in dyslexic children. Eye 
movement recording showed highly fractionat-
                                                          
1 The asterisk marks spelling errors that lead to pseudowords 
 
ed text analysis, with a robust effect of word 
length (De Luca, Di Pace, Judica, Spinelli & 
Zoccolotti, 1999; De Luca, Borrelli, Judica, Spi-
nelli & Zoccolotti, 2002). Consistent results 
were obtained from vocal RTs to different 
length single words (Zoccolotti et al., 1999; 
Spinelli, De Luca, Di Filippo, Mancini, Martelli 
& Zoccolotti, 2005; Zoccolotti, De Luca, Di 
Pace, Gasperini, Judica & Spinelli, 2005). Over-
all, psycholinguistic analysis of errors, eye 
movement recording and vocal RTs, indicated 
prevalent reliance on sub-lexical procedure. 
Thus, the efficiency of the lexical processing 
seems to be poor in Italian dyslexics, and they 
prevalently suffer from surface dyslexia (Zocco-
lotti et al., 1999; Marinelli et al., 2009).  
Regarding spelling, the grapheme-to-phoneme 
correspondence is fairly regular in Italian; how-
ever, as in most other regular orthographies 
(e.g., Serbo-Croatian, Czech), there is a certain 
degree of ambiguity in the oral-to-written direc-
tion. For instance, the phonemic group kw 
may be transcribed by the orthographic se-
quences QU, CU, (for example, the Italian term 
for “rate” kwota, is written “quota” and not 
“*cuota”, whereas kwoio, (lether) is spelt 
“cuoio” and not “*quoio”); no definite rule al-
lows choosing among these alternatives and 
reference to a lexical entry is required (for a de-
tailed description see also Zoccolotti, Angelelli, 
Judica & Luzzatti, 2005). 
Using a spelling task that capitalizes on these 
oral-to-written ambiguities, a series of studies 
(Angelelli, Judica, Spinelli, Zoccolotti & Luz-
zatti, 2004; Angelelli, Notarnicola, Judica, 
Zoccolotti, & Luzzatti, 2010; Angelelli, et al. , 
2010) reported a majority of surface dysgraphia 
in Italian dyslexic children, i.e. a selective im-
pairment in writing unpredictable transcription 
words and many phonologically plausible er-
rors.  
What about the phonological forms of dyslexia 
and dysgraphia? The high correspondence be-
tween grapheme-to-phoneme in reading (and 
vice-versa in spelling) would suggest that the 
acquisition of such knowledge must be easy to 
learn in regular orthographies; indeed, in lan-
guage such as Italian, cases with a deficient ac-
quisition of the sub-lexical strategy are quite ra-
re.  
In fact, cross-linguistic studies indicate that lit-
eracy acquisition is not the same across lan-
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guages and the facility depends on the degree of 
orthographic consistency of different languages. 
As to reading, Seymour, Aro and Erskine 
(2003), comparing the reading acquisition in 
different European languages, found that Ital-
ian children, at the end of their first year in 
primary school, were able to read in a proper 
way approximately 95% of a list of familiar 
words. Also regarding spelling (for reviews, see 
Caravolas, 2004) data support the view that, the 
sublexical procedure is acquired more rapidly in 
regular than in opaque orthographies. As re-
gards Italian language two recent study compar-
ing spelling (Marinelli, Romani, Burani & 
Zoccolotti, 2015) and reading (Marinelli, Rom-
ani, Burani, McGowan, & Zoccolotti, in revi-
sion) acquisition in Italian and English primary 
school children found greater accuracy in 
spelling and reading among  Italian children 
than English children: former were very accu-
rate after only 2 years of schooling, while 
among English children the performance was 
still poor after 5 years of schooling. Ortho-
graphic consistency produced not only quanti-
tative, but also qualitative differences, with larg-
er frequency and regularity effects in English 
than in Italian children, index of larger reliance 
on larger grain size in English sample. Even 
Orsolini, Fanari, Serra, Cioce, Rotondi, Dassisti, 
and Maronato (2003) found that by the fourth 
month of school 50% of Italian children were 
able to read approximately 80% of words cor-
rectly. For what regards spelling a recent study 
investigating spelling skills in first- to eighth-
grade Italian normal readers (Notarnicola, An-
gelelli, Judica, & Zoccolotti, 2012) found that 
spelling along the sub-lexical conversion proce-
dure was acquired quite early and ceiling effect 
was present for regular stimuli jet by third 
grade. Similarly, a study examining reading ac-
quisition in Italian children from 2ndto 8thgrade 
(Tressoldi, 1996) found very low percentage of 
errors already in the 2nd grade and smaller of 
5% by 3rd grade. Overall, in consistent orthog-
raphies, conversion rules are easily acquired by 
almost children. 
However, also in a very consistent orthography 
such as Italian, children may fail in the acquisi-
tion of phoneme-to-grapheme mapping. Litera-
ture reports a case of phonological dyslexia: 
Marco, a 12 –year-old Italian boy with a very 
evident deficit in reading pseudowords com-
pared to words (Sartori & Job, 1983). With re-
gard to developmental dysgraphia, a recent 
study (Angelelli, Putzolu, Iaia, Marinelli, 
Gasperini, Chilosi & Brizzolara, 2016) on Ital-
ian dyslexic children described long-lasting 
phonological spelling difficulties in those with a 
history of Language delay (LD). In particular, 
LD children were more sensitive to acoustic-to-
phonological variables, showing relevant failure 
especially in spelling stimuli containing gemi-
nate consonants but also polysyllabic stimuli 
and those containing non-continuant conso-
nants. Error analysis confirmed these results, 
with LD children producing a higher rate of 
phonological errors respect to NoLD children 
and controls. It could be worth to further in-
vestigate the uncommon cases suffering from 
phonological dysgraphia, taking into account 
potentially relevant factors such as concomitant 
deficits of phoneme discrimination, processing 
and representation. 
The goal of the present study is to analyze the 
phenomenology of reading and spelling deficits 
of an Italian child suffering from a major deficit 
for phonological processing. As a comparison, 
the spelling and reading performances of child 
suffering from the specular disorder (i.e., sur-
face dyslexia and dysgraphia) were also ana-
lyzed. Additionally, due to the specific difficulty 
of phonological dyslexic and dysgraphic chil-
dren in dealing with geminate consonants, the 
processing of doubled consonants has been ex-
amined more deeply, with the aim to identify if 
the locus of the deficit may be phoneme dis-
crimination, phoneme representation and ma-
nipulation and/or phoneme-to-grapheme con-
version (and vice versa). 
 
Method 
Participants 
The participant was A.S., a 10- year- old boy at-
tending the fifth grade of southern Italy prima-
ry school. The child had great difficulty in read-
ing and spelling when tested with a standard 
examination (see paragraph 2.3) although his 
intelligence, assessed with the Coloured Pro-
gressive Matrices of Raven (1984), was perfectly 
adequate for his age (score of 24, above the 10º 
percentile for this age level according to Pruneti 
et al., 1996). 
A.S was indicated by his teachers as having sig-
nificant difficulty in reading and spelling but he 
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received neither support for that problem. In 
fact, although his parents had been informed of 
A.S’s poor performance, they did not take into 
account any rehabilitation program as they un-
derestimated the seriousness of the problem 
and attributed to excessive teachers’ worrying. 
A.S. was very willing and collaborative in per-
forming the various tests. On the discourse lev-
el no language problems were detectable, how-
ever parents referred a delayed development of 
language.  
A.S’s reading and spelling performance was 
compared to that of one child of the same age, 
G.S. The two boys were schoolmates and 
shared the reputation of problematic children. 
G.S., in fact, had marked reading and spelling 
deficits associated with normal socio-
educational conditions and normal intelligence 
(score of 24 at the Coloured Progressive Matri-
ces of Raven, above the 10º percentile for this 
age level according to Pruneti et al., 1996). G.S. 
was very collaborative in performing the vari-
ous tests.  
 
Reading assessment 
Reading level was evaluated with a standard 
achievement test: the MT Reading Test (Cor-
noldi & Colpo, 1998). In this test, children were 
asked to read two passages. Speed (time in sec-
onds per syllable) and accuracy (number of er-
rors relative to the amount of text read) were 
measured from the reading of the first passage, 
which was read aloud with a time limit of 4 
minutes. Comprehension was evaluated with 
the second passage, which could be read aloud 
or silently as preferred and without a time limit; 
after reading the passage, the child was required 
to answer ten multiple choice questions.  
The nature of the reading disturbance of the 
dyslexic participants was also examined by addi-
tional tasks. The Words and Non-word Reading 
test (Zoccolotti, De Luca, Di Filippo, Judica & 
Spinelli, 2005) was administered. The test con-
sists in four lists of words (varying for frequen-
cy and length) and two of pseudo-words (vary-
ing for length). Thirty stimuli per list were giv-
en; number of errors and reading speed were 
scored. The participants were required to read 
the stimuli aloud as quickly and accurately as 
possible. Number of errors and time (sec per 
list) were recorded and converted to z scores 
according to standard reference data (Zoccolot-
ti et al., 2005). 
Additionally, four tests of the Developmental 
Dyslexia and Dysgraphia Battery (Sartori, Job & 
Tressoldi, 1995) were adopted. In the Graph-
emes subtest participants were asked to name 
21 single letters. It is useful to evaluate the effi-
ciency of the transition from the grapheme to 
its phoneme. In the Lexical Decisions subtest 
children were required to read 48 stimuli and 
indicate if they were words or pseudowords. 
Homophones comprehension was assessed by 
24 questions which required a choice among 
four possible answers (e.g.: “the needle (l’ago) is 
made of… water, wood, earth, metal”), two of 
them were possible if the target was processed 
phonologically. In order to answer the question 
correctly, children must be able to distinguish 
between “l’ago” (the needle) and “lago” (lake). 
Scoring is calculated with the following formula 
(Sartori, 1984): (homophonic errors / homo-
phonic errors + correct answers) x 100. If a 
child scores around 50, he/she is not capable of 
distinguishing homophones, giving prove to re-
ly on phonological processing. In the Correc-
tion of Homophones subtest children are asked 
to read 20 words of which only 8 are correct. 
The incorrect stimuli have been produced by 
inserting an apostrophe (e.g. “l’ametta” instead 
of “lametta” (blade)) or by  segmentations of 
words (e.g. “di vano” instead of “divano” (so-
fa)). Both tests with pseudo-homophones were 
used to assess efficiency of lexical processing. 
Reading speed and number of errors were rec-
orded in tests 1 and 3, while only the number of 
errors were recorded in the other two tests. 
 
Spelling Assessment 
Spelling abilities were tested through a standard 
spelling test (Angelelli, Marinelli, Iaia, Notar-
nicola, Costabile, Judica, Zoccolotti, & Luzzatti, 
2016), composed of four sections: 
Section A: regular words with complete one-
sound-to-one-letter correspondence (N=70). 
Words were selected with different sources of 
phonetic-phonological complexity: (i) words 
made up of continuant sounds only (fricative, 
liquid or nasal consonants) versus words also 
containing non-continuant (plosive) conso-
nants; (ii) words made up only of consonant-
vowel (CV) syllables versus words also contain-
ing consonant clusters and doubled consonants; 
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(iii) disyllabic versus polysyllabic words. Differ-
ent sources of phonetic-phonological complexi-
ty were used in order to determine variables in-
fluencing both segmentation and identification 
of phonemic string to be converted (for in-
stance, continuant phones are, by nature, easiest 
to segment, and hence to identify, than non-
continuant phones). 
Section B: regular words requiring application 
of context-sensitive sound-to-spelling rules 
(N=10). In Italian, context-sensitive rules are 
required when spelling of a consonant depends 
on the following sound. For instance, the pho-
neme [k], is spelled C when followed by a con-
sonant (e.g., CLIMA ([klima], climate) or by A, 
O, U (e.g., CASA [kaza], home) and CH when 
followed by E or I (e.g., BARCHE [barke], 
boats). 
Section C: words with unpredictable transcrip-
tions along phonological-to-orthographic con-
version routine (N=55). This section includes: 
(i) words containing the phonemic group [kw], 
which in Italian may be transcribed by ortho-
graphic sequences QU, CU, or CQU; (ii) words 
containing syllables [t e], e , dʒe , 
which may or may not require an I (e.g., 
[ entsa], science, is spelt SCIENZA and not 
*SCENZA, while [ ena], scene, is spelt SCE-
NA and not *SCIENA); (iii) words containing 
plosive phones followed by liquid consonants 
[r] which are homophones to their doubled 
pairs (e.g., FEBBRE, fever and not *FEBRE, 
but LIBRO, book, and not *LIBBRO); (iv) 
words containing segments [lj] - [ʎ  and [nj] - 
[ɲ], that are homophonous in most Italian vari-
ants to the extent that [biljardo/biʎardo], bil-
liards, is spelt BILIARDO and not 
*BIGLIARDO, while [folja/foʎa], leaf, is spelt 
FOGLIA and not *FOLIA; similarly 
[opinjone/opiɲone], opinion, is spelt OPIN-
IONE and not *OPIGNONE, while [oɲu-
no/onjuno], everyone, is spelt OGNUNO and 
not *ONIUNO. 
Section D: pseudowords with one-sound-to-
one-letter correspondence (N=25). Items were 
controlled for different sources of phonetic-
phonological complexity, as were words in Sec-
tion A: (i) continuance of sounds (pseudowords 
with continuant versus non-continuant conso-
nants); syllabic structure (pseudowords with 
consonant-vowel (CV) syllables versus 
pseudowords also containing doubled conso-
nants; and length (disyllabic versus 3-4 syllable 
pseudowords). Similarly to Section A, phonet-
ic/phonological variables are introduced in or-
der to account for variables influencing acous-
tic-to-phonological analysis that is preliminary 
to an effective phonological-to-orthographic 
conversion procedure. 
Words and pseudowords were given in separate 
sequences and in a single quasi-randomized or-
der. The examiner read each item aloud in a 
neutral tone, i.e., without emphasizing presence 
of clusters, doubled consonants or possible or-
thographic ambiguities. Children were asked to 
repeat each item before writing it down (so that 
the examiner could ensure that they had under-
stood the item). When children failed to repeat 
or upon their request, the examiner read stimu-
lus again. They were permitted to write in either 
capital or lower case letters. No feedback was 
provided on accuracy of written response. Final 
responses were counted, irrespective of cor-
rectness of first attempt. Children were tested 
individually. The number of correct spellings on 
each of the four sections of task was counted 
for every participant.  
The DDO test allow also to perform an error 
analysis, in order to identify nature of spelling 
errors, irrespective of section of test in which 
they emerged. Errors were coded as:  
-Phonologically plausible errors (impaired spell-
ings along lexical route): spelling errors that can 
be pronounced to sound like target words; 
these errors arise from over reliance on pho-
neme-to-grapheme conversion routine (e.g., 
“*cuota” instead of ”quota” (rate));  
-Phonologically non-plausible errors (inaccurate 
spellings via sublexical routine): errors causing a 
change in phonemic makeup of a word reflect-
ing difficulties in phonemic segmentation, pho-
neme-to-grapheme encoding or a phonologi-
cal/graphemic buffer disorder. This category 
included the following error subtypes: 
- Errors based on minimal distance features: 
substitutions of consonants or vowels with oth-
er consonants or vowels that differs only in one 
single distinctive feature [e.g., sonority, “fi-
no”(until) instead of “vino”(wine); continuance, 
“pesta”(crush) instead of “festa”(holiday)]. 
Doubling of a single consonant or of dedou-
bling of a doubled consonant were also consid-
ered in this category;  
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- Other errors:  non-minimal-distance substitu-
tions (e.g., “*balo” instead of “baco” (worm)), 
omissions (e.g., “*vsone” instead of “vi-
sone”(mink)), insertions (e.g., “*manrmo” in-
stead of “marmot”(marble)) and letter transpo-
sitions (e.g., “*patro” instead of “prato”(field)).  
- Context-sensitive sound-to-spelling errors: er-
rors in application of context-sensitive sound-
to-spelling rules (e.g. “*adago” instead of “ada-
go” (slow) or “sceda” instead of 
“scheda”(card)). 
For both quantitative and qualitative data, the 
performance of each participant was compared 
to reference data (Angelelli et al., 2016). 
 
Phonological Awareness Assessment 
Phonological awareness was evaluated with a 
blending test (Di Filippo, Brizzolara, Chilosi, 
De Luca, Judica, Pecini, Spinelli, & Zoccolotti, 
2005). The test consisted in asking the child to 
repeat aloud the whole word (or pseudowords) 
which results from the blend of “sounds” emit-
ted at a frequency of one per second, for a total 
of 19 words and 19 pseudowords (composed of 
5-6 letters). For each item, both the number of 
correct blended pairs of phonemes and the 
number of the whole correct blended items 
were recorded. Before the test itself, a number 
of warm-up tests were run to help the child un-
derstanding the nature of the main test. 
 
Processing of doubled consonants 
Additionally, due to the A.S. difficulty’s in deal-
ing with doubled consonants, the child was 
tested with an experimental protocol prepared 
ad hoc. The aim was investigating if phonologi-
cal difficulties in processing stimuli with dou-
bled consonants were due to inefficiencies of: i) 
phoneme discrimination, ii) phoneme manipu-
lation, iii) phoneme-to-grapheme conversion 
(and vice-versa).  
We  selected 20 pairs of real words differing for 
the presence of doubled vs single consonants 
(e.g., “pala-palla” (shovel-ball)). We also created 
20 pairs of pseudowords (one with a doubled 
consonant, and one without, e.g., “pasu-
passu”), for a total of 80 stimuli. In both the 
word and the pseudoword pairs, half of the 
doubled consonant were continuant phones 
(i.e., the fricatives [f], [v], [s], [S], the liquid [l], 
[r] and the nasal consonants [n], [m], [ñ], [N]) 
that are susceptible to prolongation) and half 
non-continuant consonants (plosive conso-
nants, such as [p], [b], [t], [d]). In fact, acoustic-
to-phonological analysis is subject to acoustic-
to-phonological quality of phones in dyslexic 
children (especially for those with a phonologi-
cal deficit, Angelelli et al., 2016). It is easier to 
isolate, segment and identify continuant phones 
than non-continuant phones (see also Luzzatti, 
Colombo, Frustaci & Vitolo, 2000 for coherent 
data on aphasic patients).  
All the selected stimuli were presented in four 
tasks. In particular, in order to examine the 
acoustic-to-phonological discrimination, as well 
as the phonological buffer and retrieval of the 
phonological output, a repetition task was used. 
In this case, A.S. listened each stimulus and af-
ter repeated it. The ability of manipulate phones 
was examined through phoneme segmentation 
and blending tasks. In the blending task, words 
or pseudowords were presented phoneme-by-
phoneme at a rate of one per second. At the 
end of the sequence, the child was asked to re-
peat aloud the whole stimuli. On the contrary, 
in the segmentation task, the examiner pro-
nounced the whole stimulus and the child was 
asked to segment into the single phonemes 
constituting the stimulus. The phoneme-to-
grapheme conversion skills were tested through 
an acoustic-to-visual matching task: the child 
listened a stimulus and was asked to choose the 
correspondent transcription between a pair of 
stimuli, one containing the doubled consonants, 
the other one did not. The stimuli appeared in a 
sheet in front of him. To avoid attentional laps-
es, each task was performed in a different day. 
Only attended errors regarding doubled conso-
nants processing were computed; while other 
errors were not analysed.2 Self-correction were 
accepted. 
 
Procedure 
Children were tested individually in a quiet 
room. Parents were informed on the screening 
activity and authorized the participation to the 
study by signing the appropriate informed con-
sent paperwork.  
 
 
                                                          
2Other errors were 12.5% in the repetition, 7.5% in segmenta-
tion and 2.5% in blending task; in the visual-acoustical matching 
it was not possible to make other errors except those on dou-
bled consonants 
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Data analysis 
Regarding reading performance, the number of 
errors and the reading speed were analysed re-
spect to proper normative data and trans-
formed into z scores. The performance on Sin-
gle words and non- word -reading test (Zocco-
lotti et al., 2005) was futhermore analysed by 
applying a Multivariate Logistic Regression 
Analysis (Aitkin, Anderson, Francis & Hinde, 
1989) in order to compare accuracy reached in 
words vs pseudowords. The dependent variable 
was the accuracy to each item (1 = passed, 0 = 
failed); independent variables were lexicality (1 
= words; 0 = pseudowords), word length 
(number of letters), presence of clusters (1 = 
item with cluster; 0 = item without cluster) and 
presence of doubled consonants (1 = item with 
doubled consonants; 0 = item without doubled 
consonants).  
An error analysis was also performed on chil-
dren reading performance at Words and Non-
word Reading test (Zoccolotti et al., 2005). In 
particular errors were coded in: 1) stress errors; 
2) visual/phonological errors (more than 50% 
of letter in common with the target stimuli) 
producing a pseudoword; 3) visu-
al/phonological errors (more than 50% of letter 
in common with the target stimuli) producing 
an existing word; 4) words semantically related 
to the target words.  
With regard to the spelling task, the number of 
items transcribed correctly in the four sections 
of the test were computed and transformed in z 
score according to normative data (Angelelli et 
al., 2016). In addition, the spelling performance 
was analysed by Multivariate Logistic Regres-
sion Analysis (Aitkin et al., 1989). Based on 
psycholinguistic models that assume two inde-
pendent spelling procedures, the ability of each 
participant in spelling regular words was com-
pared with that in spelling words with an un-
predictable orthography (as a marker for the 
lexical spelling route) and pseudowords (as a 
marker for the sub-lexical spelling routine). 
Two logistic regression analyses were applied to 
the profile of each participant: the first com-
pared regular words versus words with unpre-
dictable transcription; the second, regular words 
versus pseudowords. The units were the items 
of the spelling test (125 for the first compari-
son, 95 for the second one); the dependent var-
iable was dichotomous (pass or fail). 
Potentially relevant variables such as frequency, 
length (number of letters), cluster presence 
(1=item with cluster; 0=item without cluster) 
and the presence of doubled consonants 
(1=item with doubled consonants; 0=item 
without doubled consonants) were checked in 
both analyses. As reported in the spelling ses-
sion, errors were also classified according to 
Angelelli et al. (2016). For each participant the 
number of errors for each typology was com-
pared to normative data.3 
Regarding the experimental paradigm on dou-
bled consonants processing, accuracy in the dif-
ferent tasks was compared by a Multivariate 
Logistic Regression Analysis (Aitkin et al., 
1989). The dependent variable was the accuracy 
of A.S. in processing each item (1 passed, 0 
fail), and the independent variable was the task 
(repetition vs segmentation, blending and 
acoustic-to-visual matching respectively; seg-
mentation vs blending and acoustic-to-visual 
matching; blending vs acoustic-to-visual match-
ing). Additionally, in order to assess the effects 
of lexicality and acoustic-to-phonological varia-
bles on accuracy, lexicality (1 = words; 0 = 
pseudowords), presence of continuant sounds 
(1 = item with continuant consonants; 0 = item 
with non continuant consonants) and presence 
of doubled consonants (1 = item with doubled 
consonants; 0 = item without doubled conso-
nants) entered in the analysis as independent 
variables. Moreover, analysis were replicated 
separately for words and pseudowords in order 
to check for different pattern in lexical vs non 
lexical stimuli. 
 
Results 
 
Reading 
The performances of the two children on the 
MT Reading Tests (Cornoldi & Colpo, 1998) 
are reported in Table 1.  
 
 
 
 
                                                          
3 Note that, in the error analysis, for both subject we 
classify quality of error irrespective of stimulus sub-test. It is 
obvious that that the probability to commit phonological plau-
sible errors is lower compared to conversion errors. In fact 
phonological plausible errors are possible mainly for irregular 
words; on the contrary conversion errors are possible for each 
grapheme constituting words and pseudowords. 
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Table. 1. Performance of G.C. and A.S. on the MT reading 
Test (Cornoldi & Colpo, 1998). Values in brackets refer to z 
score according to normative data. In all instances negative val-
ues represent a poorer performance. 
 G.C. A.S. 
 
Normative 
sample 
Mean           
d.s. 
sill/sec  
2.15 
(-1.3) 
 
0.75 
(-2.42) 
 
3.77           
1.25 
number of errors  
20 
(-2.27) 
 
27 
(3.4) 
 
5.9               
6.2 
Comprehension: 
Correct answers 
 
4 
(-1.64) 
 
8 
(0.18) 
 
7.6               
2.2 
 
A.S. did not manage to finish reading the pas-
sage in the fixed time, making a high number of 
errors (27 errors, his performance was 3.40 
standard deviations below the normative sam-
ple), which is almost 4 times the number made 
by normal readers of same age (according to 
normative data). He read with a speed of 0.75 
sill./sec. against the 3.77 sill/sec expected for 
his age and grade (on average he was -2.42 
standard deviations below the normative sam-
ple). In fact, he read very slowly, taking several 
pauses over 5 seconds due to difficulty in de-
coding complex graphemes. Overall, his per-
formance placed him, both for speed and accu-
racy, in the category of children requiring “im-
mediate help”. On the comprehension task, af-
ter a long (30 minutes) and arduous process, 
Albert managed to extract from the text the in-
formation necessary to reply correctly to 8 out 
of 10 questions (z = 0.18). 
G.C. made 20 errors when reading his passage 
(z = 2.27); on average he read 2.15 syllables in 
one second (z = -1.3). His comprehension skills 
were impaired (only 4 correct answers out of 
10; z = -1.64). Comparison to normative data, 
his performance  fell in the category of children 
requiring “immediate help for speed, accuracy 
and comprehension.  
Figure 1 reported z scores obtained by G.C. 
and A.S. on the Developmental Dyslexia and 
Dysgraphia Battery (Sartori et al., 1995). 
 
 
Figure. 1. Performance of G.C. and A.S. on the Developmental 
Dyslexia and Dysgraphya Battery (Sartori et al.,1995). In all instanc-
es negative values represent a poorer performance. 
 
A.S.’s performance in grapheme reading was 
impaired for speed, taking 24 seconds without, 
however, making any errors. His performance 
was 3.93 standard deviations below that of con-
trols. 
He also underperformed on lexical decision 
task (approximately - 5 standard deviations be-
low norms for both errors and time). Here A.S. 
made 17 misjudgments and took twice the time 
of controls (193 seconds).  
However, in pseudo-homophone tasks, A.S 
performed as controls both in comprehension 
(z = -0.85, only 2 homophonic errors) and cor-
rection (z = 1.5, only 3 errors), showing dis-
crete lexical access.  
Single word and pseudoword reading was im-
paired for all stimuli categories and for both 
speed and accuracy (see table 2). However, it is 
interesting to note that A.S. scored 67% on 
words and 33% on pseudowords. The differ-
ence between the performance on words and 
pseudowords is 34%. When comparison is lim-
ited to long words and pseudowords, the dif-
ference becomes 38%, which is very close to 
the critical threshold proposed by Sartori (1985) 
as an indication of phonological dyslexia. 
The logistic regression analysis (see table 2), 
confirmed a significant lexical effect (2 = 8.13, 
p < .01), with pseudoword spelled significantly 
worse than words. He showed a word length 
effect too (p < .01).  
 
 
 
 
 
 
 
 Chiara V. Marinelli, Anna Putzolu, Marinella De Salvatore, Marika Iaia, Paola Angelelli 
75 
Table 2. Performance of G.C. and A.S. on the Words and 
Non-word Reading test (Zoccolotti et al., 2005). Values refer to 
z score according to normative data. 
 
 Accuracy Speed 
A.S. G.C. A.S. G.C. 
Short high frequency 
words 7.87 2.5 20.31 1.01 
Long high frequency 
words 5.41 3.83 12.07 1.52 
Short low frequency 
words 6.63 6.02 17.49 0.72 
Long low frequency 
words 7.75 4.06 13.31 1.41 
Short pseudowords 7.18 2.82 14.66 0.81 
Long pseudowords 14.6 3.68 10.92 0.27 
 
On the contrary, G.C.’ grapheme reading was 
normal for errors and time. He took 10 seconds 
(z= -0.73), without making any error. 
He underperformed on lexical decision task, 
approximately 3.5 standard deviations below 
controls, for both  errors (12 misjudgments) 
and time (he concluded the test in 159 seconds, 
almost twice the time taken controls).  
G.C had also difficulties on pseudo-
homophone comprehension  (z= -1.83 SD) and 
correction (z= -2.93 SD). In the comprehen-
sion task, in fact, he chose the homophonic al-
ternative in 61.9% of cases, showing a main re-
liance on phonological processing (he interpret-
ed both “s’offre” (he offers) and “soffre” (he 
suffers) as “sta male” (he is sick); both “vera” 
(true) and “v’era” (there was) as “reale” (real)). 
The limited number of non-homophonic alter-
natives (n= 2) showed that the performance it-
self was valid and that there was no general 
comprehension problem (Sartori, 1984). G.C. 
made a total of 5 misjudgments on pseudo-
homophone correction, for example accepting 
“di vano” for “divano” (sofa), “lerba” insead of 
“l’erba” (grass). 
In single word and pseudoword reading, G.C. 
was below the mean for accuracy in all stimuli 
categories (see table 2). The logistic regression 
analysis showed not significant effect of lexi-
cality (2 = 1.70, ns): words and psudowords 
were comparably impaired. The only variable 
that significantly affected his performance was 
stimulus length (p< .01).  
From a qualitative point of view, we can ob-
serve that A.S. did not commit any stress errors. 
He made prevalently visual/phonological errors 
(sharing more than 50% of letters with the tar-
get stimuli) leading to pseudowords (31.6%) 
and word substitutions semantically/visually re-
lated to the target word (10.6%). It is clear that 
A.S. had difficulties in phonological decoding, 
that tried to compensate by an attempt to re-
trieve the whole word phonology. Morphologi-
cal errors and errors producing a word unrelat-
ed to the target were both about 1.5%.  
At the contrary, G.C. made many stress errors 
(4.2%; note that in the test there were few 
words irregularly stressed, then this percentage 
is relevant). The percentage of visu-
al/phonological errors (sharing more than 50% 
of letters with the target stimuli) leading to 
pseudowords, and word substitution (semanti-
cally or visually related) were substantially lower 
than those reported by A.S. (20% and 3.9% re-
spectively for the two errors). Also for G.C., 
morphological errors and errors producing ex-
isting words, unrelated to the target, were both 
about 1.5%.  
 
Brief summary  
The patterns of reading impairment that 
emerged from children’s performance are com-
plex but suggest that A.S. is affected by phono-
logical dyslexia while G.C. suffers from surface 
dyslexia. 
Different characteristic emerged for the two 
children about the nature of their reading defi-
cits. A.S. performed adequately on pseudo-
homophone tests but was impaired on the oth-
er tasks, including the reading of single graph-
emes. A lexicality effect emerged when reading 
lexical vs non lexical stimuli: pseudowords, in 
fact, were read significantly worse than words. 
From a qualitative point of view, he made no 
stress errors, indicating a certain command of 
lexical procedure, and numerous lexicalizations, 
suggested an incorrect attempt to use the lexical 
procedure. On the contrary, G.C. displayed the 
characteristic of surface dyslexia. In fact, the 
performance on the various tests are indicative 
of reliance on phonological rather than lexical 
procedure. He underperformed on pseudo-
homophone tests (correction and comprehen-
sion), indicating lexical reading deficit, but sin-
gle grapheme reading was normal. Moreover, 
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no lexical effect was present: word and 
pseudoword reading was comparably impaired. 
The analysis of reading errors confirmed a sub-
lexical pattern, as he made many stress and vis-
ual-semantic errors. 
 
Spelling 
Compared to normative data, A.S. had greater 
difficulty in spelling pseudowords (z = -10.17) 
and regular words (z = -8.81 for words with 
one-sound-to-one-letter correspondence and z 
= -2.43 for words requiring syllabic conver-
sion). The performance was not adequate nei-
ther in spelling words with unpredictable tran-
scription (z = -3.64).  
However, results at the logistic regression anal-
yses showed that A.S. had a comparable level of 
accuracy on both regular and unpredictable 
transcription words (X2= 5.34, ns). However, 
he presented a significant lexical effect (X2= 
5.80, p < .05): pseudowords were spelled worse 
than regular words. With regards to other vari-
ables taken into consideration, none appears to 
have a significant effect with the exception of 
presence of doubled consonants (p< .0001). 
On the contrary, G.C.’s level of accuracy on 
spelling regular words and pseudowords was 
good (z= -0.69 and z= -0.17 respectively), but 
his performance on unpredictable transcription 
words and words with syllabic conversion was 
impaired (z = -2.24 and z = -6.71 respectively). 
Logistic regression analysis confirmed a signifi-
cantly effect of regularity (X2= 10.15, p <.01): 
words with unpredictable transcription were 
spelled significantly worse than regular words, 
while accuracy on words and pseudowords was 
comparable (X2= 1.80, ns). No other variables 
affected spelling. 
 
 
Figure 2.  Typology of errors made by the two children on the 
spelling task. 
 
As reported in Figure 2, A.S. committed preva-
lently phonological errors (66.1%). In particu-
lar, the most were minimal distance errors 
(50.8%; z = 20.97) and in particular doubling of 
a single consonant or dedoubling a doubled 
consonant. He also made many syllabic conver-
sion errors (6.8%, z = 4.74) and simple conver-
sion ones (8.5%, z = 3.84). Also phonologically 
plausible errors were not negligible (33.9%, z = 
3.39).  
On the contrary, most of the errors made by 
G.C. were phonologically plausible (51.7%, z = 
2.12). However, minimal distance (10.3%, z = 
1.41), syllabic conversion (13.8%, z = 4.74) and 
simple conversion (24.1%, z = 5.71) errors 
were also present. 
 
Brief summary 
Both the quantitative and the qualitative 
spelling analyses suggest a major impairment of 
the sub-lexical procedure in A.S. He presented 
greater difficulty with pseudowords compared 
to regular words and made numerous minimal 
distance misspellings, in particular on doubled 
consonants. However, in comparison to con-
trols, it appears that the lexical procedure was 
not wholly efficient either. 
On the contrary, G.C. suffered from an ineffi-
cient use of the lexical spelling procedure, while 
the sub-lexical one was better. In fact, he 
showed a selective impairment in spelling un-
predictable transcription words, whose correct 
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spelling  require access to lexical orthographic 
representations. Moreover, error analysis re-
vealed a prevalence of phonologically plausible 
errors, confirming a good knowledge and 
command of phonological processes.  
 
Phonological Awareness 
Figure 3 reports children’ performance on the 
blending test (Di Filippo et al., 2005).  
A.S.’s phonological awareness was impaired. In 
the word condition, he only managed to cor-
rectly produce 11 out of 19 items (58%) and 
made 61 blends out of 83 (73.5%). His perfor-
mance was 1.6 standard deviation below con-
trols on both items. With pseudowords, A.S. 
was significantly worse: he produced only 1 
pseudoword correctly out of 19 (5.3%) and 44 
blends out of 83 (53%). His performance was 4 
standard deviations below controls. 
On the contrary, G.C.’s performance was 
spared for each blending measure examined. 
 
 Figure 3.   Percentage of accuracy on the Blending Test (Di 
Filippo et al., 2015) 
 
Experimental tasks on doubled consonants 
processing 
Accuracy of A.S. on the various tasks tapping 
doubled consonants processing was higher for 
repetition (93.7%) respect to phoneme segmen-
tation (42.5%), phoneme blending (46.3) and 
visual-acoustic matching (65%). Logistic analy-
sis confirmed significantly higher accuracy in 
the repetition than in each other task (at least p 
< .0001). Phoneme segmentation and blending 
did not differ (X2 = 0.24, ns) but both were 
performed with lower accuracy compared to 
visual-acoustic matching (at least p < .01). In 
each analysis the presence of doubled conso-
nants significantly affected performance (at 
least p < .01), except for the analyses compar-
ing repetition vs visual-acoustic matching and 
repetition vs phoneme blending. In fact during 
the repetition task, the child had similar per-
formance with stimuli containing doubled vs 
single consonants (95% and 92% respectively). 
Similarly, in the visual-acoustic matching task, 
he reached 70% and 60% of accuracy with 
stimuli containing single vs doubled conso-
nants. On the contrary, in meta-phonological 
tasks (phoneme segmentation and blending), 
accuracy depended from the presence of dou-
bled consonants. In fact, in segmentation A.S. 
tended to produce always stimuli without gemi-
nate: he obtained 80% of accuracy on stimuli 
containing single consonants and only 5% on 
stimuli with doubled ones (that tended to seg-
ment always without geminate). In blending 
task, he tended to produce the stimuli with 
geminate: the accuracy was 63% and 30% on 
stimuli with doubled vs single consonants, re-
spectively. A significant lexicality affect 
emerged in the comparison between repetition 
and visual-acoustic matching (p < .05). 
In order to deeply examine the lexicality effect, 
separate analysis on words and pseudowords 
were carried out. Accuracy of A.S. on the vari-
ous experimental tasks, separately for words 
and pseudowords, is reported in Figure 4.  
 
 
Figure 4.  Performance of A.S. on experimental tasks tapping 
doubled consonants processing. 
 
With words, all tasks‘ comparisons were signifi-
cant (at least p < .05; for the direction of effect 
see the later paragraph), except for phoneme 
blending and segmentation that were per-
formed with similar accuracy. The unique con-
trolling variable significant was the presence of 
doubled consonants in phoneme segmentation 
vs repetition and visual-acoustic matching 
comparisons (X2 = 9.48, p < .05; X2 = 5.57, p 
< .01; respectively). With pseudowords, the 
performance in visual-acoustic matching  wors-
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ened and reached an accuracy similar to that 
highlighted in meta-phonological tasks (pho-
neme bending and segmentation). The presence 
of doubled consonants affected the perfor-
mance in each comparison (at least p < .05), 
except for the analyses comparing visual-
acoustic matching vs repetition and phoneme 
blending. Moreover, comparing visual-acoustic 
matching vs repetition and phoneme segmenta-
tion, also continuance of sounds was significant 
(at least p < .05). 
 
Brief summary  
A.S.’ performance in tasks tapping doubled 
consonants processing highlighted that difficul-
ties were not limited to phoneme-grapheme 
mapping (investigated through a visual-acoustic 
matching test), but interested also phoneme 
bending and phoneme segmentation abilities. 
Then, it seems that the ability to represent and 
manipulate phonemes was impaired. On the 
contrary, repetition was good showing normal 
sensory elaboration as well as normal phono-
logical output retrieval. Performance in the vis-
ual-acoustic matching worsened with 
pseudowords, probably due to the impossibility 
to compensate phonological difficulty through 
lexical processing. Moreover, with non lexical 
stimuli, also the presence of non continuant 
consonants significantly affected A.S.’ perfor-
mance. 
 
Discussion  
The study reports the case of a child suffering 
from developmental phonological dyslexia and 
dysgraphia, as for control a second case display-
ing the characteristics of surface dyslexia and 
dysgraphia. 
Most Italian dyslexic children have been de-
scribed as suffering from surface dyslexia 
(Marinelli et al., 2009, Zoccolotti et al., 1999) 
and dysgraphia (Angelelli et al., 2004, Angelelli 
et al., 2010), since they showed a prevalent reli-
ance on phonological procedure as highlighted 
by impaired lexical reading and defective irregu-
lar word spelling, with many phonological plau-
sible errors. The reading and spelling perfor-
mance of G.C. was coherent with a diagnosis of 
surface dyslexia and dysgraphia. G.C. showed a 
selective impairment in spelling words with un-
predictable transcription, made mostly phono-
logically plausible errors with better transcrip-
tion of regular one-phoneme-to-one-grapheme 
stimuli. Similarly, in reading G.C. relied on 
phonological rather than lexical procedure: he 
underperformed in task tapping the lexical pro-
cedure such as correction and comprehension 
of pseudo-homophones. Moreover, his phono-
logical awareness was adequate, as demonstrat-
ed by good meta-phonological abilities. On the 
contrary, A.S.’s deficits seemed prevalently due 
to significant inefficiencies of the sub-lexical 
procedure. This would indicate, on the one 
hand, that also in a relatively shallow language, 
the acquisition of phoneme-to-grapheme map-
ping may be difficult in some children, despite 
the its easiness in normal development (e.g., 
Orsolini et al., 2003; Tressoldi, 1996; Seymour 
et al., 2003; Marinelli et al., 2015, Marinelli et 
al., in revision). Given the significant difficulties 
that A.S. was still having in the fifth year of 
primary school, we consider possible that he 
might have adopted a lexical strategy to com-
pensate his problems. This strategy, however, 
deprived by normal sub-lexical procedure de-
velopment, remained incomplete. In fact, A.S. 
performed adequately on homophone tests, but 
underperformed on the other tasks being poor 
also in single graphemes reading. He showed a 
lexicality effect in reading, with worse perfor-
mance in pseudoword compared to stimuli with 
a lexical status such as words. His reading er-
rors were mainly phonological errors, i.e. ineffi-
ciencies of the grapheme-to-phoneme conver-
sion (that in almost case generate 
pseudowords), while no lexical errors (i.e. stress 
errors), were detectable. In pseudoword reading 
A.S. made also numerous lexicalizations, as well 
as visual and semantic errors (words semantical-
ly and visually related to the target word). This 
could suggest incorrect attempts to overuse the 
lexical procedure in order to compensate pho-
nological decoding difficulties. In spelling, both 
the quantitative and the qualitative analyses, 
suggested a main impairment along the phono-
logical procedure: he had greater difficulty with 
pseudowords compared to regular words and 
made numerous minimal distance misspellings.  
The phenomenology of A.S.’ spelling deficit is 
coherent with what found in a recent study 
(Angelelli et al., 2016) examining developmental 
dysgraphia in Italian dyslexic children with a 
history of Language Delay (LD). These children 
produced a higher rate of phonological errors 
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respect to children without LD and controls 
and were more sensitive to acoustic-to-
phonological variables, showing relevant failure 
especially in spelling stimuli containing gemi-
nate consonants but also polysyllabic stimuli 
and those containing non-continuant conso-
nants. In this study we did not directly test A.S. 
linguistic skills, however we can suppose, retro-
spectively, a history of language delay.  
To summarize, in Italian, the high consistence 
of orthographic mapping render  the acquisi-
tion of the phoneme-to-grapheme and graph-
eme-to-phoneme conversion rules very easy. In 
fact almost all children master the phonological 
processing very early (Orsolini et al., 2003), and 
Italian dyslexic and dysgraphic children show 
prevalently a defective lexical procedure acqui-
sition (Angelelli et al., 2010). However, also the 
acquisition of sub-lexical mapping may be diffi-
cult, especially in children with concomitant 
language weakness. For this reason it is very 
important for therapists and teachers to take 
into consideration this possibility and  to pro-
mote a strengthening of reading and spelling 
skills in children with a history of language defi-
cit. Moreover, an open question remains if cas-
es of phonological reading and spelling deficits 
might occur also in absence of a history of lan-
guage deficit.  
Regarding the A.S.’s difficulty in processing 
stimuli with doubled consonant, results high-
lighted that phonetic-to-phonological variables 
such as the presence of doubled consonants 
and also continuance of sounds affected the 
phonological-to-orthographic (and vice versa) 
conversion (for coherent data see Angelelli et 
al., 2016). Also the lexical status of stimuli af-
fected the performance, with better perfor-
mance on words compared to pseudowords. 
This latter phenomenon might be due to great-
er difficulties in retaining stimuli without lexical 
status (absent in the phonological lexicon), as 
well as to the impossibility to compensate pho-
nological decoding difficulties by a lexical sup-
port. Moreover, results highlighted also that 
phonological difficulty in processing stimuli 
with doubled consonants was not limited to 
phoneme-to-grapheme (and vice versa) conver-
sion. A.S., in fact, underperformed not only in 
the visual-acoustic matching but also in tasks 
requiring phonological awareness such as pho-
neme segmentation and phoneme blending. 
However, the spared performance in repetition 
seemed to exclude the possibility of acoustic 
discrimination deficits, as well as deficits in the 
phonological output retrieval. On the other 
hand, jet Marinelli, Di Filippo, Angelelli and 
Zoccolotti (2011) failed to find a deficit in repe-
tition in Italian dyslexic children (while the per-
formance in reading the same stimuli presented 
visually was severally impaired). Data were co-
herent with those on English dyslexic children 
(Ramus et al., 2003) reporting that a phonologi-
cal deficit can appear in absence of sensory dis-
orders.  
The question regarding the functional locus of 
phonological reading and spelling deficits re-
main debated. Some authors support the hy-
pothesis of a primary sensorial deficit which in-
volves the elaboration of both linguistic and 
non linguistic stimuli (Tallal, Miller, Bedi, Byma, 
Wang, Nagarajan, Schreiner, Jenkins, & 
Merzenich, 1996); others support the hypothe-
sis of a phonological coding/decoding impair-
ment, relative to the extraction of phonological 
invariants from an acoustic flow (e.g., Liber-
man, 1998). Alternatively the locus of phono-
logical spelling and reading difficulties may be 
linked to phonological awareness deficits. In 
the present study we have deeply examined on-
ly the ability to process stimuli with doubled 
consonants, and data do not support a sensory 
impairment (as highlight by the good perfor-
mance of A.S. in the repetition task) but indi-
cate both phonological awareness and phono-
logical-to-orthographic conversion deficits. 
Moreover, it is interesting to note that both 
children showed concomitant dyslexia and dys-
graphia as well as a closer parallelism between 
reading and spelling deficits. Comorbidity and 
identical direction of the two deficits suggested 
the use of the same strategy for reading and 
spelling. Regarding lexical deficits, several stud-
ies (see Angelelli et al., 2010 for data on Italian 
children) have found, through an item-by-item 
analysis, that when children have the ortho-
graphic representation of a word in their lexi-
con, they use the lexical procedure regardless of 
the task (reading or spelling). Conversely, when 
this representation is unavailable, both reading 
and spelling are impaired. Data support the hy-
pothesis of a unique orthographic lexicon, used 
for both reading and spelling in dyslexic and 
dysgraphic children as well as in young normal 
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reader (Allport & Funnell, 1981; Behrmann & 
Bub, 1992; Coltheart & Funnell, 1987). Regard-
ing phonological deficits, it is clear that children 
that do not master the phonological processing 
have impaired performance in both oral-to-
written and written-to-oral conversion, and that 
performance will be affected by the same varia-
bles in reading and spelling. These findings also 
have educational/clinical implications, because 
it appears that training reading ability can im-
prove spelling ability, and vice versa. This can 
be advantageous for learning (Conrad, 2008; 
Ehri, 1980; Ehri & Wilce, 1986; Share, 2004) 
and rehabilitation. In fact, several developmen-
tal studies, have reported generalization of read-
ing treatment effects to spelling and vice versa 
(Brunsdon, Hannan, Coltheart & Nickels, 2002; 
Lorusso, Facoetti, & Molteni, 2004; Lorusso, 
Facoetti, Paganoni, Pezzani, & Molteni, 2006; 
Brunsdon, Coltheart, & Nickels, 2005).  
In conclusion the present study examined a rare 
case of phonological dyslexia and dysgraphia in 
Italian, a very consistent orthography, highlight-
ing the role of concomitant deficits of phoneme 
representation and phoneme manipulation. 
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Introduction 
The natural world is still considered a large 
complicated machine, of which we can have 
linear explanations, knowing its functioning 
mechanisms. Human organizations as well are 
considered a complicated gear: for this reason 
actions are taken in order to increase control 
systems and tools, to make the procedures 
more specialised, to produce more advanced 
software, to engineer the type of analysis. How-
ever, an organization – besides goods and ser-
vices – produces meaning: a combination of 
meaning sometimes coherent, sometimes con-
tradictory and chaotic imposes itself among so-
cial players, but that emerges from the interac-
tion between them. Although it is the basis of 
every social form (Luhmann 1995), communi-
cation – and the related production of meaning 
– is taken for granted and therefore misjudged. 
The communicative analysis is crucial to the ex-
tent that it is an expression of shared working 
practices among subjects with different per-
spectives, languages, experiences and 
knowledge. In different fields of study – sociol-
ogy and occupational psychology, managerial 
sciences – recent investigations show how hu-
man organizations set up a complex system, 
where beside the official organizational and 
regulatory structure (top down), a latent infor-
mal structure is strongly attested, which is 
formed in a context of constant relationships 
(bottom up), in which the subjects perceive the 
working environment, themselves, their role, 
norms, values and the other (Alvesson and Berg 
1993; Argyris 1994; Piccardo 1995; Piccardo 
and Benozzo 1996).  
Based on the perspective of complex systems, 
in 2012-2013 a group of sociologists of the 
Salento University carried out a survey on the 
issue of people with dementia and Alzheimer’s 
and their relationship with health care facilities1. 
In order to prepare a program of interventions 
in some sectors of the Local Health Authority – 
with consequences on families and associations 
interested in the issue – and to provide training 
for health employees and patients, the general 
aim of the research project was to get infor-
mation on three areas:  the environment that 
surrounds people with  dementia (health and 
associative resources in the area); the system of 
action of families in which there is a patient 
with dementia/Alzheimer’s; the interaction be-
tween them and the health care facilities. 
Before the explanation of the survey outcomes, 
the perspective of complex systems, especially 
in the social sphere, and the aspects considered 
will be clarified. 
 
A less reductive vision in order to know the 
reality 
Much of the order we observe is spontaneous, a 
natural expression of the surprising capacity of 
self-organization which is in the universe, con-
sidered as a complex network of relationships 
(Kauffman 2001). After the research of Ilya 
                                                          
1
 The action-research “Voglio vivere” – decided by the Local 
Health Authority ASL in Brindisi – had a research team consist-
ing of 9 sociologists and a statistician. The undersigned has as-
sumed the role of scientific director and coordinator of the re-
search group, building tools and choosing methods and tech-
niques of the various phases of the survey. A psychiatrist and a 
trainee, graduated in psychology, supported the investigation on 
behalf of the Local Health Authority. 
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Prigogine, many scholars analyse the reality 
through the approach of complex adaptive sys-
tems (biological and social): characterised by 
numerous and different elements and multiple 
connections, they try to adapt by maximizing 
their evolutionary possibilities. In order to do it, 
systems self-organize: self-organization is an es-
sential feature of complex systems and a pre-
requisite for the ability to evolve, since it gener-
ates adaptive parts and structure in a selective 
way. In the field of natural selection,  self-
organised features can be moulded more quick-
ly because self-organisation emerges from be-
low and has consequences on (and produces) 
higher hierarchical structures (bottom-up) (Co-
lombo, 1991; Bocchi and Ceruti 1985; Capra 
2001). 
Self-organization depends on the close connec-
tion between elements, so that the result is 
much more than the sum of its parts; these 
parts must be considered within a set of rela-
tionships that determine significance and posi-
tion of each component. As a result the systems 
may be, as the conditions change, in a dynamic 
intermediate situation between a completely 
predictable one and another which is chaotic 
and unpredictable. In this situation, the system 
shows “emerging” properties: between order 
and chaos there is the sudden appearance of 
unexpected regularities. While complicated sys-
tems (an assembly line or internal combustion 
engine) are made up of a set of elements, whose 
functioning is predictable and can be organised 
– it consists of a series of processes and straight 
chains of cause and effect (A→B→C→D...) – 
complex systems (weather, brain, families, stock 
markets, hives, companies) are characterized by 
non-linear dynamics. For those systems it is no-
ticed the presence of an internal order that can 
not be inferred a priori, because, although stim-
ulated from the outside, the systems create new 
dynamics in an endogenous way through self-
regulation mechanisms. It means that each sys-
tem, although in need of resources from the 
environment of reference, it is capable of pro-
ducing by itself the elements which are neces-
sary for survival (autopoiesis) through regulari-
ties and its own operating laws (self-
referentiality): if a man eats a chicken, he does 
not become a chicken, but it is the chicken that 
is transformed into the elements necessary for 
the life of the human organism. Moreover, be-
sides the ability to adapt, the success of a sys-
tem depends on its ability to make adaptive 
changes in the environment of reference (mu-
tual influence).  
In the 21st century the connection between the 
parts has gained heuristic significance (connec-
tionism): to understand a complex system, rela-
tionships are just as important as the behaviour 
of the components. In fact, this analysis was 
used when Euler first formulated the “graph 
theory” to solve the problem of Könisberg 
bridges (1736); mechanisms and regularities 
typical of networks have been used to under-
stand complex social systems, “real” and “vir-
tual”: circularity, speed and information man-
agement, power dynamics, resource exchanges, 
hubs, scale free law, redundancy and resilience, 
growth without global order are some of the 
most important aspects of a complex network 
and, therefore, of a complex system.  
The consideration about complex systems has 
guided the entire survey on the social health 
and family situation linked to the issue of de-
mentia in Brindisi social health district: the or-
ganization of the authority and the resources 
(private too) in the territory represent the close 
environment in which families with people af-
fected by dementia operate; national and re-
gional regulations (far environment) were im-
portant to compare the possible distance be-
tween these and the factual situation.  
 
Far system and environment. Global and 
italian health situation  
In 2012 WHO and ADI (Alzheimer’s Disease 
International) detected an annual rate growth of 
7.7 million new cases. The incidence of chron-
ic-degenerative pathology has no geopolitical, 
economic and cultural boundaries, but there are 
considerable differences between countries in 
terms of social  health interventions and legisla-
tive measures: in fact, only 8 out of 194 WHO 
Member States had a National Plan on demen-
tia (WHO and ADI 2012). After four years, the 
global Alzheimer's report places emphasis on 
the quality of life of patients – Improving 
healthcare for people living with dementia. 
Coverage, quality and costs now and in the fu-
ture (Alzheimer’s Disease International 2016) – 
on the replies of the various territories and the 
organizational and community good practices. 
The urgency is given by current figures and 
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evaluations: dementia affects 47 million people 
worldwide and the figure is destined to triple by 
2050, while welfare policies still have a second-
ary role.  Moreover, only about half of the pa-
tients in high-income countries and one in ten 
in the middle and low-income countries re-
ceived a diagnosis. Great emphasis is given to 
assistance: there are no clear “treatment path-
ways”, in which roles and responsibilities are 
defined within the welfare system, setting 
standards to be monitored and respected. In-
stead, treatment pathways, structured and orga-
nized coordination, resources and continued 
assistance are common for people affected by 
other chronic diseases (diabetes, hypertension, 
cancer). 
To carry out a comprehensive analysis of the 
phenomenon on a unitary basis, in December 
2017 WHO launched the Global Dementia 
Observatory (Gdo), a web platform designed to 
provide easy access to the most important data 
and information on dementia in the Member 
States. Three areas are covered: health policies, 
service provision, information and research. 
The aim of Gdo is to provide the various coun-
tries with a support tool to measure the pro-
gress made in this sector, also in the light of 
what has been outlined in the Global action 
plan on the public health response to dementia 
2017-2025: the traditional therapeutic models 
are now abstract and scarcely applicable to a re-
ality that has diversified requests of health and 
care. 
New concepts take over: Disease and Illness. 
The first one is meant to define the health 
problem in terms of physiological malfunction 
with reduction of physical abilities and life ex-
pectancy. Illness refers to the subjective experi-
ence of the disease, to the way in which a sub-
ject represents it and gives it a meaning; howev-
er, the subjective sense is also always socially 
determined (Cipolla, Giarelli and Altieri 2002). 
The Harvard Medical School adds a third con-
cept, Sickness: it corresponds to the social de-
scription of the disease and therefore to the 
way in which a social group interprets and im-
plements strategies related to the disease; be-
havioural and biological signs considered dis-
turbing are converted into illness. The analysis 
of Sickness emphasizes how the medical facts 
are pre-constituted informally outside the clini-
cal research environment (Maturo 2007). This 
conceptual intersection brings out the relational 
nature of health: the centrality attributed to the 
psycho-social connotation of it induces to elab-
orate a planning strategy which, starting from a 
participatory identification of needs, constructs 
aims and defines actions in an intersectional 
perspective; this in order to develop a strong 
interdependence between health services and 
other services in the area (Cipolla 2005). The 
flow of communication and resources will have 
to lead to a systemic pluralism and to the reduc-
tion of the typical separation between the 
health and social welfare system.  
Organizational vacuum and regulatory delay 
created in Italy long distances between patient, 
healthcare network and institutions: even 
though innovative pushes have been proposed 
as well as  the formulation of alternative solu-
tions, redefinition of areas of relevance for the 
different roles, involvement and reconfigura-
tion of skills, the answers in support of Alzhei-
mer's are still lacking. Furthermore, despite the 
Dementia National Plan (2015), the progressive 
increase in the number of patients suffering 
from dementia and the lowering of the average 
age of onset (Istituto Superiore della Sanità – 
National Institute of Health – 2015), the na-
tional policy – and the regional policy in Puglia 
– has continued to reduce health and welfare 
spending without counteracting compensatory 
measures; thereby marginalizing patients and 
those who assist them. 
In this regard, a strong North-Centre-South dif-
ferentiation emerges with regard to social-
welfare and health policies. In line with the 
contemporary local trends, the disease is nar-
rowed by these dominant tendencies. Decen-
tralization and local regulation of social policies 
are the product of a process started at the end 
of last century, that has disregarded the princi-
ple of universalism on which our National 
Health Service is built. Diseases such as Alz-
heimer's must be managed by the entire nation: 
access to and fruition of services can not be 
linked to local dynamics and variability of the 
limitations of the municipalities. For example, 
although Alzheimer's has been a reality for 
some time now, in our country it is still difficult 
to have an official census of updated data on 
the epidemiology; this happens for all mental 
illnesses, about which some shortcomings in 
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the information sources have been listed (Psy-
chopathology Italian Society 2017): 
1. Sources available from different au-
thorities/institutions and various in-
formation not easily usable together. 
2. Unsatisfactory information on supply, 
quality of services and public spending. 
3. Absence of a longitudinal vision of in-
dividuals, essential to design policies 
and to assess their impact. 
4. Integration and partnerships are also 
crucial to fully implement the Mental 
Health Action Plan of WHO which in-
volves the statistics as well in several 
places. 
 
The particularly alarming aspect concerns the 
heterogeneity in the field of ad hoc social and 
health policies. Also the “41st Annual Report on 
the Social Situation of the Country” (Censis 
2007) detects a two-speed health care in the 
North and South: the distance between the two 
parts of the country has led to a worsening of 
the health situation among the citizens of the 
southern regions. The modification of the con-
stitutional framework (State-Regions pact in-
troduced by the Reform of Title V of the Con-
stitution n.3/2001, ratified by the Stability Pact 
between the two orders) unequivocally contrib-
uted to increase the differences. The situation 
got worse ten years later (Censis 2017) with the 
growth of the family spending on health and 
the North-South gap concerning the satisfac-
tion about health in different regions. 
The same outcome emerges from the results on 
non-self-sufficiency: while the needs increased, 
the state funds were cancelled in 2012, 275 mil-
lion were allocated in 2013 for non self-
sufficiency, but it was 60% less than in 2008 
(Non Self Sufficiency Network 2013). Two 
years later Censis (2015) noted that to deal with 
the private cost of assistance to non self-
sufficient people, 910,000 families had to “tax” 
themselves and 561,000 families spent all the 
savings and/or had to sell their house and/or 
got into debt. The last data (Non Self Sufficien-
cy Network 2017/18) shows a worse situation: 
declining trend in the financing of various types 
of services (residences, home assistance, eco-
nomic support), prevalence of cash transfers on 
services (55% versus 45%), ideas regarding the 
need to lower the quality of services, perennial 
uncertainty about the dichotomy cover-
age/intensity. Furthermore, there is an increase 
in the need of families for help in informative 
“paths” and consultancy about activities that 
are often sacrificed for budgetary reasons: 
health, contributions, aids, facilities at work, 
caregivers, barriers, disability, etc... 
To further understand the process of interven-
tions on dementia, the various National Health 
Plans still remained in ambiguity when they 
treated Alzheimer's, generically including it in 
the indefinite category of mental health alt-
hough years before the civil society had com-
mitted to define categories and strategies of ac-
tion. In 1999 the Chart of Patient’s Rights has 
been drafted by Italy Alzheimer’s Federation 
and published in the European Handbook: the 
cornerstone of the declaration concerns safe-
guarding the quality of life of the patients and 
of those who assist them. 
Italy Alzheimer’s Federation (1993) and Italian 
Alzheimer’s Association (1985) have concretely 
contributed to raising awareness about the issue 
related to dementia and the effects on family 
and caregivers, through analysis of the situation, 
consultancy with national and supranational 
government authorities, sharing knowledge 
among citizens and health workers and lastly 
information-assistance to patients and their 
families. As for the creation of protection and 
therapy networks for patients, the achievement 
has been complex and frustrating, given the 
poorly associative culture of Italians, as always 
underlined by Istat report. 
Within this situation, an important institutional 
change is represented by Progetto Cronos 
(2000), the largest clinical-epidemiological study 
carried out in Europe on Alzheimer's disease. 
The nation-wide observational study was possi-
ble on the basis of a network of specialistic cen-
tres, UVA (Alzheimer’s Assessment Units), in 
collaboration with general practitioners and 
pharmacists, thus ensuring care continuity be-
tween hospitals and local assistance. The aims 
were exclusively of medical-pharmaceutical na-
ture, including patient acquaintance, and little 
or nothing worked in the information-
assistance system aimed at families and caregiv-
ers. 
Extension of Progetto Cronos is Commissione 
Alzheimer (D.M. 22 February 2002), estab-
lished for the purpose of developing an accu-
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rate knowledge of the health needs of the 
population affected by Alzheimer’s and the so-
cial consequences of the disease; of fulfilling a 
range of functions, including coordination ac-
tions in the regions through the presentation of 
consultative, study and proposal analysis. How-
ever, from a national survey on the characteris-
tics of UVA, Day Centers, Nursing Homes, In-
tegrated Home Care carried out by Centro na-
zionale di epidemiologia, sorveglianza e promo-
zione della salute (National Institute of Health) 
discomforting results emerged, as they followed 
those of 2006 (Faiella 2015).  
A crucial step forward has been done – as men-
tioned above – with the Dementia National 
Plan  (Gazzetta Ufficiale, n. 9/13-01-2015). The 
critical issues highlighted in the Plan are not 
new: services which are not integrated (diagno-
sis, rehabilitation, welfare); specialistic centres 
(Alzheimer Assessment Units) established 
without need-based programming and with a 
strong disparity in composition and function; 
lastly, after 14 years Alzheimer Assessment 
Units remain the main access point for patients 
with dementia and have in the meantime been 
transformed into permanent services variously 
named in some regions, so it has become nec-
essary to start a process of unification of these 
services. It is necessary to tackle these criticali-
ties through 4 aims: 1. interventions and 
measures of social and health policy; 2. creation 
of an integrated network for dementia and im-
plementation of an integrated management; 3. 
implementation of strategies and interventions 
for the appropriateness of therapy; 4. increase 
of awareness and reduction of social stigma to 
improve the quality of life. 
The National Institute of Health had immedi-
ately started to monitor some key aspects relat-
ed to the implementation of the National De-
mentia Plan by the Regions: the health system 
related to dementia is not very efficient and or-
ganized, rather local and very focused on drug 
therapy and less on assistance. Above all, there 
are no figures or structures capable of activating 
assistance-help-advice services to the family 
members; lastly, there is a cognitive gap for the 
constant monitoring of the general situation 
and specific cases, which are also preparatory 
for the activation of ad hoc interventions. 
Much is being done on the cultural and termi-
nological level to train social health workers and 
citizens, thus avoiding situations of stigma and 
social and institutional exclusion, still rather 
widespread and determining the poor quality of 
life of patients and family members. 
 
Close system and environment. Health sit-
uation in Brindisi 
The survey carried out by the researchers of the 
Salento University aims to investigate the com-
plexity of the socio-structural and relational di-
mensions that characterize the phenomenon of 
dementia in the city of Brindisi, first of all by 
providing a first mapping of the services (public 
and private) specifically addressed to the dis-
ease; identifying also the needs of the families 
of patients with dementia/Alzheimer’s; lastly, 
verifying the role of associations as support for 
families and institutions.  
The research – first detection of the phenome-
non in Brindisi – is composed of 4 phases. The 
first phase concerns the analysis of data from 
the institutions (Osservatorio provinciale sulle 
politiche sociali, Unità di Valutazione Alzhei-
mer, Centro Salute Mentale). A brief overall as-
sessment concerns the organization and storage 
of information: the computerization and the 
standardization of data were absent, making it 
difficult to find information and extending the 
time needed to consult the data. In this regard, 
the information provided in the sections dedi-
cated to the structures and social-health services 
in the province of Brindisi in sanita.puglia.it 
website was empty or insignificant. Secondly, 
information about users with issues related to 
dementia was still in a paper archive. Both ar-
chives consulted were necessary to detect and 
analyse the extent of the phenomenon in the 
city of Brindisi and compare it with the rest of 
the province and with Italy. Furthermore, user 
lists and their characteristics were useful for 
constructing a stratified probabilistic sampling. 
It was not possible to do what was planned be-
cause it was only possible to access the data of 
the Mental Health Centre (CSM). It is striking 
the uncertainty of the diagnosis which does not 
allow an exact placement of the user in the 
health archives. This has an effect on internal 
communication within the Local Health Au-
thority and external relations between the Local 
Health Authority and other public institutions 
with duties related to welfare services. Another 
problem related to communication, this time 
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between Local Health Authority and users, is 
the absence of some telephone numbers of the 
patients, almost always the only way to have a 
quick contact. 
 The second phase involved social health struc-
tures (presence and type): the information was 
collected from the archives and from interviews 
with the managers in charge of the offices. The 
creation of the first social health structures in 
Puglia dates back to 2007 (Regolamento Re-
gionale n. 4/2007, application of Legge Region-
ale 19/2006). The legislative gap, currently still 
very marked in terms of specific structures for 
people with dementia/Alzheimer’s, is partly 
filled with the art. 60ter of Regolamento Re-
gionale 7/2010, which regulates the institution 
of Day Centres specific for demen-
tia/Alzheimer’s, but for individuals who do not 
have severe motor deficit and can be managed 
through semi-residential treatments. A gap re-
mains in the field of ad hoc residential facilities, 
conceived to welcome the patient with Alz-
heimer’s and the therapy needs. A defect to 
which must be added another limit concerning 
the institution itself of the structures that, as 
provided for L.R. 19/2006, is entrusted to 
“management experimentation”. To try to 
compensate for such a regulatory vacuum, Alz-
heimer's patients over 65 years old can be wel-
comed in Residential Homes which foresee – as 
prescribed by the Regional Regulation 4/2007 – 
that there may also be people with demen-
tia/Alzheimer’s under the age of 65, provided 
they do not need complex health services. 
There is also a type of extra-hospital structure 
with high health intensity, the Nursing Home 
(D.G.R. 210 R.R. 8/2002), which includes spe-
cific residential modules for people with Alz-
heimer's.  
A rather lacking picture emerges in several re-
spects. The critical issues are evident on several 
sides and offer a discouraging glimpse of the 
territorial situation examined in the two-year 
period 2012-13. Among the multiplicity of the 
problematic aspects connected to the phenom-
enon, the absence on the territory of ad hoc 
residential structures constituted (and consti-
tutes) the biggest limit (Centro per il controllo e 
la prevenzione delle malattie del ministero della 
Salute 2017). An additional load in terms of 
management derives from the coexistence of 
subjects suffering from different pathologies: 
this can be a source of discomfort for the 
guests, as well as a physiological disorganized 
and sometimes confused work for the opera-
tors. This situation puts a strain on the caregiv-
ers’ ability to orientate in the articulated uni-
verse of care, as well as the ability and patience 
to combine and calibrate the efforts alongside 
those of specialistic figures, especially in rela-
tion to the steps that mark the degenerative 
process.  
This dimension emerges from the other phases: 
the survey on the management of the patient; 
case studies about the experience of some care-
givers; a survey based on privileged witnesses 
(doctors).  
For what concerns the survey only 58 caregiv-
ers have been reached, living in Brindisi, out of 
210 listed in the archives of Centro di Salute 
Mentale (tab. 1). This figure has been increased 
up to 76 individuals, by contacting subjects liv-
ing in other municipalities through the collabo-
ration of some general practitioners. 
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Tab. 1 Overview of contacts with caregivers for the sample survey 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the archives of the Mental Health Centre in Brindisi 
The aim was to identify the emerging needs of 
the people with dementia/Alzheimer’s and of 
caregivers.  
The areas of the questionnaire were: 
1. level of pathology and therapy needs; 
2. caregivers and work-life balance; 
3. social capital of reference; 
4. role of institutions, in particular Municipality, 
local health unit (Asl) and general practitioners; 
5. general assessment of services by the re-
spondents. 
 
Most of the sample – composed of 29 men and 
47 women with an average age of about 59 
(minimum age 35 years, maximum age 83) – is 
included in 45-50 and 60-65. Most of them are 
sons of the patients (56%), followed by spouse 
(28%), daughters/son-in-law (9%), broth-
ers/sisters (4%) and 3% declared to be nephew 
or other. 92% of the sample lived with the pa-
tient. Generally caregivers were over 60 and 
women (wife, daughter, daughter-in-law). 
The analysis of the data clearly shows how the 
disease afflicts not only the patients but also the  
family members and those who assist them, so 
that caregiver and patient become a single sys-
tem of action. Caregivers claimed to dedicate to 
patients more than 16 hours a day, keeping for 
themselves very few hours a week. Facing the 
progress of the disease, they felt more and 
more helpless and this feeling was exasperated  
by the awareness of the absence of effective 
drugs, by effort and stress in the day-to-day 
management of the patient and by the frustra-
tion in not seeing recognized their effort. Last-
ly, the deep sense of loneliness derived from 
the inadequacy of parental and institutional 
supports (public and private), also in the form 
of information on the approach to the patient 
and on the territorial resources. This loneliness 
increases gradually with the progress of the dis-
ease, which becomes a disruptor first on a psy-
chological and physical level, then on a social 
and economic one: with the collapse of the 
psychic faculties, the patient is forced to aban-
don all daily activities, including work, with the 
risk of irreversible impoverishment; while the 
caregivers, especially if alone, can not bear the 
emotional and time load of the situation: in 
fact, both for emotional collapse and for lack of 
time they are absorbed by the needs of the pa-
tient, who tears them away from relational and 
social life. Free time disappears for almost all 
respondents and almost everyone has com-
plained about the burn out situation: psycho-
physical fatigue, muscle aches, headaches, low 
or alternating mood, insomnia and eating dis-
orders were the reasons listed and that consti-
tute a deterrent to the enjoyment of leisure 
moments. Lastly, the respondents found great 
difficulties at each stage of the patient's illness: 
at first incompetence in dealing with the disease 
and approaching health facilities (disorienta-
Relationship between num-
ber of cases and subjects in-
terviewed 
Total number of cases 210 
Questionnaires administered 58 
% of success 28% 
Causes of missed interviews 
through questionnaire 
Refusals 
For disinterest 23 
For psychological status of the caregiver 51 
For wrong diagnosis 12 
Phone numbers 
Inactive 33 
Non existent 13 
No answer on the phone 12 
Missed appointments without apparent rea-
son 
8 
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tion), which is witnessed by the doctors inter-
viewed; later with the advancement of mental 
and behavioural deficits, for which the caregiv-
ers often do not find informal and formal-
institutional supports (isolation and mistrust). 
Thus assistant and assisted live in symbiosis: the 
deconstruction of the personality of the second 
is counterbalanced by the identity decline of the 
first; s/he, especially if alone, begins to inter-
pret the self according to her/his role as 
“nurse”: by changing her/his environment (ill-
ness of the family member), s/he changes the 
identity system (caregiver and no longer work-
er/partner/friend/etc.) and this in turn modi-
fies the environment itself (made of care needs,  
health care assistants and facilities).  
The current society is increasingly based on 
productive efficiency (Giddens 1990) rather 
than on the enhancement of social relations, 
especially intimate, now mostly aimed at achiev-
ing exogenous purposes such as prestige, mon-
ey and power (Fromm 1976). This structural 
and cultural situation determines in psychic sys-
tems (individuals) an ability of action character-
ized by rationality, which develops attitudes not 
aimed at a deep knowledge of others and the 
creation of solid bonds (Bauman 2003). 
This brief digression introduces one of the ele-
ments that contribute to the disorientation and 
solitude of the “assistant-assisted” system 
(Bauman 2006) and emerged from the interview 
with the general practitioners: also the doctor-
patient relationship is based on the efficiency, 
on time and patience in examining the changes 
experienced by the patient through a fruitful di-
alogue. General practitioners are the first and 
fundamental step for an adequate health care 
path, but often they do not know how to rec-
ognize the first signs of dementia/Alzheimer’s 
and not few times several years pass before the 
diagnosis is recognized.  
From the in-depth interviews to doctors and 
caregivers, another topic emerges, which is an 
effect of our social and cultural system: the lack 
of a) an informal community, made up of rela-
tives, friends and neighbours and b) an institu-
tional community, represented by an adequate 
health organization and by sufficient territorial 
structures suitable to welcome/assist the pa-
tient, enhancing the individual.  
Caregivers need concrete references, guides and 
specialists to turn to in order to understand 
how to deal with everyday life and relieve it 
from the burden of the management; they ex-
press the need to have real assistance in their 
territory, possibly a dedicated medical coverage 
that can break down waiting lists and guide 
caregivers and family members on obtaining fi-
nancial aid and information on social-health 
care. To this situation it must be added the lack 
of associations, whose significant presence 
would instead compensate for some shortcom-
ings related to material, informative and moral 
support. 
 
Conclusion.  
A new health humanism from the observa-
tion of complex systems 
The 18th National Congress (2014) of Collegio 
dei Primari Oncologi Medici Ospedalieri (Asso-
ciation of Oncology Head Physicians) clearly 
stated its vision in the title: “Complexity man-
agement in Oncology: ‘swarm intelligence’”. 
The Congress invited to abandon a top down 
and  “monocratic” approach to follow a flexible 
organisational model, that is a complex model 
suitable and consistent with the unpredictable 
and chaotic resources at stake. Until then work-
ers were considered simply production tools 
functional for the organisation, and the head 
physicians were supposed to check the external 
uncertainty through a frantic research of a sim-
plifying rationality. Later it was intended to 
adopt new organizational dynamics character-
ized by adaptability, diversification, designed to 
enhance the subjects involved in their diversity, 
integrating roles, making communication flow 
between the different organizational levels, also 
in order to allow a prompt internal change and 
an efficient openness to technical, technological 
and strategic innovation. This happens because 
the environment – represented by patients, 
people and organisations of different kind – is 
mutable, turbulent, uncertain. This does not 
mean choosing a managerial anarchy, but an 
organisation whose vertexes simplify and foster 
bottom-up solutions, promote collective intelli-
gence, starting a process of amplification of 
power and allowing an efficient interconnection 
among the internal levels and among them and 
the environment.  
The focus of the leadership should be to dele-
gate tasks to foster the development of distrib-
uted intelligence in organizations, that is, the 
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skills of human being in networks. This is cru-
cial for the issue of health and welfare man-
agement of people affected by Alzheimer’s and 
their caregivers: self-organisation is reached 1) 
promoting the creation of a network within the 
company, where the hub is the intelligence of 
people and the connections are represented by 
different interactions among them and through 
2) an external network, involving all the poten-
tial relevant stakeholders from the private sec-
tor too and not directly linked to healthcare ac-
tivities (computer scientists, architects, sociolo-
gists...), in an interdisciplinary view.  
The initial aim is to adopt a simple strategy to 
generate complexity; the opposite of the classi-
cal vision, which starting with complicated rules 
generates simple behaviours (Ashmos et al. 
2002). The simple strategy of participation con-
sists in connecting people to each other, leaving 
them autonomous at the same time with con-
trol mechanisms and small procedures. 
To remedy the abandonment of caregivers and 
patients for what concerns dementia, it is nec-
essary to re-establish a trust relation with the 
territory and to build spaces of profitable inter-
connections. Classical science and modern ra-
tionality outdistanced organizations and their 
territory – conceived as a synthesis of space, 
history, culture and relationships – leading us 
towards a constellation of non-communicating 
fiefdoms. We now understand that the territory 
is a place of distributed intelligence, because it 
constitutes a field of relational and communica-
tive resources, capable of integrating thousands 
of decentralized and interdependent intelligenc-
es: when these interact with each other, they 
produce organized and efficient behaviours 
(Quadrio Curzio and Fortis 2002).  
In order to reach this ambitious goal, a new or-
ganisational humanism is required, a culture of 
participation and first of all, a culture of con-
tinuing training, not only related to professional 
contents. Indeed, it is necessary to have human-
istic attitude and inclination able to foster a 
wise use of techniques and technologies and to 
overcome a general relational and communica-
tive illiteracy. 
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A fundamental right of every human being is 
the right to health, which implies the right to 
life and as such, it is fundamental, unavailable, 
non-erodible and practically enforceable. The 
right to health is a universal principle that 
emerges in the Preamble of the Constitution of 
the World Health Organization (WHO); it is 
universally recognized by the human person, 
and directly ascribable to the supreme value of 
life, which constitutes the capacity for imma-
nent action (Sgreccia, Spagnolo 1999). 
In accomplished democracies, the right to 
health has an absolute value. This absoluteness 
is due to the principle of being recognized by 
everybody as well as from the fact that it guar-
antees an erga omnes value, meaning that nobody 
can assume facts or behaviors that could harm 
such a right. 
For instance, article 32 of the Italian Constitu-
tion defines the Right to health as a fundamen-
tal1 and absolute right, protected by the Consti-
tution in a full and unconditional way with re-
spect to everyone, without distinction of race, 
religion, political belief, economic and social 
conditions, therefore a “precondition” for the 
exercise of all other rights (Luciani 2003). 
In accordance with the Italian Constitution, in 
fact, the need to protect physical health is em-
phasized as much as the psychical one. In par-
ticular, the Constitutional Court focuses on 
health care2, i. e. all the “positive interventions for the 
protection and promotion of human health”, which re-
quires not only care but also an affective and 
relational support. It is then clear that an ex-
                                                          
1 In article 32, the Constituent stated that «Republic protects 
health as a fundamental right of the individual and in the in-
terest of the community, and guarantees free treatment for 
the needy. No one can be obliged to take any particular med-
ical treatment except by legal provision. Under no circum-
stances can the law violate the limits imposed by respect for 
the human person». 
2 Constitutional Court, judgment of 30th September 1999, n. 
382, in Giurisprudenza Costiuzionale, 1999. 
haustive analysis of the dynamics and problems 
connected with the “right to health” issue can-
not be separated from the existing European 
legislation in this field, given the complemen-
tary role that this legislation has in the Member 
States’ legal systems (Cuocolo 2005). 
Since from the initial foundation of the Com-
munity, it is not possible to elicit a comprehen-
sive discipline of social rights. The failure to in-
clude a comprehensive set of social rights in the 
Community texts is due to the historical post-
war situation in Europe, characterized by the 
government control of monetary policy, which 
is crucial for the construction of the State sys-
tem. However, it is possible to find a track of 
social measures from the founding Treaties and, 
above all, relating to health care. In particular, 
article 100A of the treaty establishing the Euro-
pean Community provided that the Commis-
sion should pursue a high level of public health 
protection when adopting measures aimed at 
reconciling Member States’ legislation. 
An important step forward was made in 1986, 
with the Single European Act, which combines 
the three Communities with the European po-
litical cooperation and extends the Communi-
ty’s competences concerning the subject under 
discussion (Cartabia, Weiler 2000). The Single 
Act adds a Title on economic and social cohe-
sion to the EC Treaty (article 130); it also high-
lights the importance of the European Com-
munity to pursuing social justice objectives in 
the Preamble, recalling the principles of the So-
cial Charter of the Council of Europe approved 
in 1961 (D’Intino et alii 2006, 7-9).  
However, these predictions cannot be translat-
ed into a catalogue of fundamental social rights. 
If, therefore, emphasis must be focused on 
launching the development of Community so-
cial policies, it is not possible to identify a real 
breakthrough in the Single European Act in 
terms of protecting the rights of individuals and 
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explicitly in health protection, which must be 
pursued in all Community development poli-
cies. 
In 1992, the Treaty on European Union (TEU) 
known as Maastricht Treaty amended the TEC 
by identifying the achievement of a high level 
of health protection as one of the Union’s main 
aims. Title X of the TEU is dedicated to ‘‘Public 
Health’’ and it is composed of a single article 
129; it underlines the need for Community in-
tervention to complement State action in order 
to achieve a high level of protection of human 
health (Pitino 2003, D’Intino et alii 2006 , 162). 
Finally, article 6 of the TEU, in line with the 
approach developed by the Court of Justice, af-
firms the Union’s obligation to respect funda-
mental rights guaranteed by the European 
Convention on Human Rights as they result 
from the traditions common to the Member 
States as general principles of Community law 
(Ferrari 2001, 4). 
However, this provision does not seem to be 
extendable to social rights: the reference made 
by article 6 in fact, it is apparently restricted to 
the fundamental rights of freedoms, which are 
effectively governed by the above-mentioned 
Convention. The rights set out in the European 
Social Charter and, therefore the right to health 
are thus excluded. 
In the framework set out in the Maastricht 
Treaty, it should be pointed out that the princi-
ple of harmonization of national policies has 
been tending to be replaced by the open meth-
od of coordination, which aims to share infor-
mation between Member States in order to 
identify best practice in individual areas, with-
out imposing minimum requirements for indi-
vidual states  
The real breakthrough in the protection of so-
cial rights came in 1997 with the Amsterdam 
Treaty, which entered into force on 1st May 
1999 (Zanetta 2003, 48). 
Article 3 (p) requires Community action to con-
tribute to the attainment of a high level of 
health protection. The most relevant aspect 
consists in the introduction of the article 152 
TEC, replacing the former Article 129 TEU, 
which enshrines the basic principles of Com-
munity action on the protection of human 
health. More exhaustively, article 152 (1) pro-
vides that a high level of health protection is to 
be ensured in the definition and implementa-
tion of all Community policies and activities. 
This Article provides that Community action is 
to be directed primarily towards the prevention 
of diseases by encouraging research to their 
causes and transmission, as well as health in-
formation and education. It is clear that the 
provision introduced by the Treaty of Amster-
dam differs from Article 129, which provided 
for a very marginal role for the Community in-
stitutions, merely as a subsidy for the action of 
the Member States. On the contrary, article 152 
places health protection as a general criterion to 
be followed in the implementation of all Com-
munity policies. The protection of health is 
therefore not a material matter, but a criterion, 
a Community principle in the light of which the 
action of the Community bodies can be read. It 
is of fundamental importance to clarify that in 
Community law, after Amsterdam, the protec-
tion of human health is almost an obligatory re-
sult, which cannot be sacrificed in balance with 
the other guiding principles of Community ac-
tion. 
Moreover, Article 152 (1) takes into considera-
tion not only the ‘‘healing’’ aspect of health 
protection, but also the preventive aspect; this 
is, in particular, a profile that considers the 
Community provisions more advanced than 
those of the national Constitutions, including 
the provision of Article 32 of the Italian Consti-
tution and that requires new standards of pro-
tection in member states, also with respect to 
prevention aspects. 
Article 152 (2) provides that ‘‘Community shall 
encourage cooperation between Member States 
in the areas covered by this article and, where 
necessary, support their action. The Member 
States in liaison with the Commission shall co-
ordinate among themselves their policies and 
programs in the areas referred to in paragraph 
1. The Commission, in strict contact with the 
Member States, may take any useful initiative to 
promote such coordination’’. The provision in-
corporates some of the principles contained in 
above-mentioned article 129, that reiterates the 
necessary harmonization of Member States’ 
policies. 
Article 152 (3), supplementing the principle of 
harmonization set out in the second subpara-
graph, provides that ‘‘The Community and its 
Member States foster the cooperation with 
third countries and the competent international 
Marco Giannotta  
95 
organizations in the field of public health’’. The 
achievement of the objectives set out in Article 
152 may require Community measures to com-
plement the actions of Member States, but it 
mainly involves encouraging cooperation be-
tween States, in accordance with the principle 
of subsidiarity. 
At institutional level, defined in Article 152, in-
centive actions shall be adopted by the Council 
acting in accordance with the co-decision pro-
cedure, while recommendations shall be adopt-
ed by qualified majority on a proposal from the 
Commission. The Council, therefore, becomes 
one of the main players in achieving health pro-
tection standards. Nevertheless, the provisions 
contained in the fourth subparagraph are not 
exhaustive of Community action in the field of 
health, but are only part of Community compe-
tence; this is also confirmed in the open clause 
of point (c), which requires the Council to 
adopt any incentive measure, provided that it 
does not involve forced harmonization of na-
tional legislation (Pitino 2003, 306).  
One of the most important forecasts intro-
duced by the Amsterdam Treaty is that of Arti-
cle 152 (5), according to which: ‘‘Community 
action in the field of public health fully respects 
the responsibilities of the Member States for 
the organization and delivery of health services 
and medical care’’; direct Community interven-
tion in the provision of health services is there-
fore excluded. The fifth subparagraph, com-
bined with the impossibility for the Council to 
adopt harmonization measures, leads to the 
conclusion that there is still a lack of instru-
ments for regulating the public health service at 
Community level, the definition of which is left 
to the legislation of individual Member States, 
which often differ widely from one another 
(Cilione 2003, 75). 
It is not easy to balance the actual scope of the 
statements of principle contained in the original 
Community law: while the guarantee of high 
levels of health protection is a fundamental 
principle of all Community policies, on the oth-
er hand, the community lacks the means to reg-
ulate the forms of health protection in practice, 
that must be guaranteed to all European citi-
zens (Sciullo 2004). 
These considerations raise a few questions 
about the content of European citizenship, 
which does not seem to identify itself with a set 
of Community social rights yet. 
The final step on the road to European social 
rights before reaching the Constitutional Treaty 
is the Charter of Fundamental Rights of the 
European Union, which was adopted in Nice in 
December 2000. One of the characteristics of 
the Nice Charter is the particular system, which, 
although it acknowledges social rights, does not 
divide them according to traditional genera-
tions. 
In this regard, it should also be pointed out that 
the Nice Charter, although it has a high sym-
bolic value as a result of a solemn proclamation, 
has no binding force in terms of positive law. 
The principles of the Nice Charter are useful 
mainly as interpretative arguments and that has 
a particular significance in consideration of 
what it is expressed by the article 6 of the Maas-
tricht Treaty, which sets out a circular dynamic 
of fundamental rights (Azzena 2001, 135). 
However, it is not possible to compare the ex-
tent of a legally binding act with that of an in-
terpretative instrument, particularly in relation 
to social rights, which, although largely gov-
erned by the Charter, are not covered by the ar-
ticle 6 TCE. 
The Charter’s Preamble strengthens the weight 
of fundamental rights in the Community system 
as they derive from constitutional traditions and 
international obligations common to the Mem-
ber States, the TEU, the Community Treaties, 
the European Convention for the Protection of 
Human Rights and Fundamental Freedoms, 
and the Social Charters adopted by the Com-
munity as well as the Council of Europe. In ad-
dition, the rights recognized by the jurispru-
dence of the European Court of Justice and the 
European Court of Human Rights are reaf-
firmed. The provisions concerning the right to 
health protection are the first three articles in-
cluded in Chapter I, ‘‘Dignity’’.  
In particular, Article 1 recognizes human digni-
ty as inviolable, prescribing the necessary re-
spect and protection; Article 2 guarantees the 
right to life for every individual; Article 3, final-
ly, affirms the right to physical integrity, dictat-
ing specific prescriptions for medical activities. 
These provisions are undoubtedly important 
and clearly demonstrate the protection afforded 
by Community law to aspects of the negative 
right to health, i. e. the right not to receive 
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harm to one’s own health. As far as the positive 
aspects of health protection are concerned, the 
analysis must focus on Article 35 dedicated to 
the’’ Protection of health’’ in Chapter IV dedi-
cated to’’ Solidarity’’. 
Article 35 provides that’’ Everyone has the right 
of access to health prevention and medical 
treatment under the conditions laid down by 
national laws and practices. A high level of hu-
man health protection shall be ensured in the 
definition and implementation of all Union pol-
icies and activities”. While the second period of 
the provision reproduces Article 152 of the 
Treaty of Amsterdam, the first period introduc-
es even more explicitly the right to preventive 
and rehabilitative treatment to protect individu-
al health. 
Despite the limited legal scope of the Nice 
Charter, it is essential to note the definitive sep-
aration between the concept of the protection 
of human health and the pursuit of other 
Community objectives and the qualification of 
the right to health protection as a right of the 
individual. On the other hand, the wording 
used in the Nice Charter does not serve as a ba-
sis for Community competence in regulating 
the public health service; The Charter states 
that the right to prevention and treatment is 
guaranteed within the limits of national laws 
and practices. 
In a certain sense, this provision is the result of 
an obligatory line of action since, from the Pre-
amble onwards, it is detected the scope of the 
rights set out above all in Article 51, which 
states that the Charter’’ does not introduce new 
powers or tasks for the Community and the 
Union, nor does it modify the powers and tasks 
defined in the Treaties’’. 
It is crucial at this point to reflect on the effec-
tive protection of the law at Community level. 
In this sense, first of all, a negative limit can be 
identified, which consists in the choice to refer 
to the laws of the member states the organiza-
tion and the concrete regulation of the public 
health service; a consideration resulting from 
the application of the principle of vertical sub-
sidiarity that requires to allocate functions to 
the level of government as close as possible to 
the citizens (Arena 2006; Albanese, Marzuoli 
2003; Moscarini 2003; D’Intino 2006). 
This choice is due, on the one hand, to the dif-
ferent traditions of social rights in the various 
European experiences, and, on the other hand, 
to the numerous and fragmented forms of 
regulation which are based on different models 
and which provide for different forms of divi-
sion of competences between the state and de-
centralized levels of government (Cuocolo 
2005). 
It can be said, therefore, that the competences 
of the health service are still destined to be 
placed at state or sub-state level for a long time, 
as it is indirectly confirmed in the Green Paper on 
services of general interest (COM-2003-270), which 
attracts only those public services of economic 
importance to the Community competition 
rules. However, this does not detract from the 
fact that the Community institutions can also 
play a leading role in terms of health protection. 
In order to understand the extent to which this 
is happening, it is necessary to wonder what in-
struments and techniques for regulating the 
right to health are permitted by the Treaty that 
establishes a Constitution for Europe, approved 
by the Intergovernmental Conference on 18 
June 2004 in Brussels and signed on 29 Octo-
ber 2004 in Rome (Letta 2006, 14-15). The 
Constitutional Treaty in Part II includes the 
Charter of Fundamental Rights and, in particu-
lar, in article II-35 it takes over article 35 of the 
Charter, which deals with the protection of 
human health. 
On the other hand, article 152 TEC, introduced 
by the Treaty of Amsterdam, is reproduced in 
article III-179 within Section I’’ Public Health’’ 
where Chapter V is dedicated to ‘‘Sectors in 
which the Union may decide to demonstrate 
coordination, integration and support action’’. 
In the adopted perspective, it is relevant the 
wording of the seventh paragraph correspond-
ing to article 152 (5) TEC. In fact, it is well af-
firmed the competence of each member state to 
define public health policies and the organiza-
tion and delivery of the public health service; it 
specifies that ‘‘the responsibilities of member 
states include the management of health ser-
vices and medical care as well as the allocation 
of resources destined to them’’. 
It is evident that Community action in the 
healthcare sector would never lead to the crea-
tion of a European health system. It can be as-
sumed that human health is not a competence 
of the Union, but only a criterion to be fol-
lowed in regulating subjects. In support of this 
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argument, it could be emphasized that the Nice 
Charter did not recognize a subjective right to 
health protection. If this were the case, health 
protection would be a sort of’’ filter’’ through 
which to read every Community act, but not a 
competence of the Union that would legitimize 
the development of autonomous policies.  
On the contrary, it can be assumed that health 
protection, even with all the limitations high-
lighted, is a proper subject that should belong 
to the shared competence of the Union (Pitino 
2003). 
This reconstruction is confirmed by article I-13 
of the Constitutional Treaty that identifies the 
areas of shared competence of the Union in 
point (b) of the second paragraph; it makes ex-
press reference to social policy, as regards the 
aspects defined in Part III. Where this is true, 
the guarantee of a high level of human health 
protection can also be the subject of specific 
policies and, in this context, the provision of 
specific’’ essential Community levels’’ of health 
care could even be envisaged. 
Community protection could thus absorb the 
constitutional principles of the state and, as far 
as Italian law is concerned, the essential levels 
of benefits relating to civil and social rights that 
must be guaranteed throughout Italy. The sce-
nario is certainly stimulating and it is not ex-
cluded that it may have significant develop-
ments in the future (Morbidelli 2004, Cuocolo 
2005). 
 
References 
 
 Albanese A., Marzuoli C. (Eds.) (2003), Servizi di 
assistenza e sussidiarietà, Bologna, Il Mulino. 
 Arena G. (2006), Cittadini attivi, Rome-Bari, La-
terza. 
 Cartabia M., Weiler J.H.H., L’Italia in Europa. 
Profili istituzionali e costituzionali, Bologna, Il Mu-
lino, 2000. 
 Cilione G. (2003), Diritto sanitario, Rimini, Mag-
gioli. 
 Cuocolo L. (2005), La tutela della salute tra neore-
gionalismo e federalismo. Profili di diritto interno e com-
parato, Milano, Giuffrè. 
 D’Aloia A. (2001), Diritti sociali e politiche di egua-
glianza nel processo costituzionale europeo, in M. Scu-
diero (Ed.), Il diritto costituzionale comune europeo, 
Napoli, Jovene. 
 D’Intino G. et alii (2006), Istituzioni europee e sani-
tà, Milano, FrancoAngeli. 
 Ferrari G.F. (2001), I diritti tra costituzionalismi sta-
tali e discipline transnazionali, in Id. (Ed.), I diritti 
fondamentali dopo la Carta di Nizza. Il costituzionali-
smo dei diritti, Milano, Giuffrè. 
 Letta E. (2006), L’Europa a venticinque, Bologna, 
Il Mulino. 
 Luciani M., Brevi note sul diritto alla salute nella 
recente giurisprudenza costituzionale da Il diritto alla 
salute alle soglie del terzo millennio, Giappichelli, 
2003. 
 Morbidelli G. et alii (2004), Diritto pubblico compa-
rato, Turin, Giappichelli. 
 Moscarini A. (2003), Competenza e sussidiarietà nel 
sistema delle fonti, Padua, CEDAM. 
 Pitino A. (2003), LEA e tutela della salute nel diritto 
comunitario originario, in La sanità italiana tra livelli 
essenziali di assistenza tutela della salute e progetto de-
volution, CNEL, Roma. 
 Pizzorusso A. (2002), Il patrimonio costituzionale 
europeo, Bologna, Il Mulino. 
 Sciullo G. (2004), Gestione dei servizi culturali e go-
verno locale dopo la pronuncia 272 del 2004 della Corte 
costituzionale, in «Aedon», available at 
http://www.aedon.mulino.it. 
 Sgreccia E., Spagnolo A. (1999), La vita: origine e 
senso, in E. Sgreccia, A. Spagnolo, M. L. Di 
Pietro, Bioetica: manuale per i diplomi universitari per 
la sanità, Vita e Pensiero, Milano. 
 Zanetta G.P. (2003), L’Europa e la salute, Milano, 
FrancoAngeli. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
JDReAM
http://siba-ese.unisalento.it/index.php/jdream
© 2018 Università del Salento
Lecce
